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The insensitivity of magnetic resonance techniques can be overcome through the use 
of hyperpolarisation methods such as Signal Amplification by Reversible Exchange 
(SABRE). SABRE utilises an iridium catalyst to transfer the latent magnetisation of 
parahydrogen to a substrate by reversible binding. In this thesis, we present a 
comprehensive quantitative study of substrate-iridium ligation effects and evaluate 
the role of the substrate in SABRE catalysis. A range of para-substituted pyridines 
were selected to probe the relationship between their electronic properties and 
SABRE efficiency. These substrates reacted to form [Ir(H)2(SIMes)(substrate)3]Cl as 
the key SABRE-active species. The lifetimes of these complexes were assessed via 
exchange spectroscopy and longer catalyst residence times were clearly linked to 
short substrate T1 times in solution. SABRE efficiency was shown to be optimal where 
the rate of substrate dissociation was 6.69 s-1 and the T1 was 6.42 s, as an 
enhancement of 767 ± 8-fold was observed. These data illustrate that SABRE 
performance is explicitly linked to substrate exchange and relaxation. 
The substrates, 4-hydroxypyridine and isoniazid, were also examined and  found to 
form novel bis-substituted iridium complexes. 4-Hydroxypyridine readily 
tautomerizes to 4-pyridone resulting in the unusual SABRE-active species; 
[IrCl(H)2(SIMes)(κ-O-4-pyridone)(κ-N-4-hydroxypyridine)]. The 4-pyridone tautomer 
ligates to iridium via the oxygen atom in the keto group and lies trans to hydride. This 
ligand undergoes rapid substrate dissociation (18.31 s-1 at 270 K) resulting in low 
levels of hyperpolarisation (−31±1-fold). Isoniazid was found to form the SABRE-
active species [Ir(H)2(SIMes)(κ-N-isonicotinylhydrazide)(isonicotinyl-κ-O-κ-N-
hydrazide]Cl, where the substrate ligand trans to hydride ligates to iridium via the 
pyridine nitrogen. The second substrate ligand chelates to iridium via the terminal 
nitrogen and the oxygen in the hydrazide functional group. This complex undergoes 
slow substrate dissociation (0.04 s-1 at 280 K) and yields high polarisation levels 





Chapter 1 Contents 
Abstract ........................................................................................................................ 3 
Table of Figures .......................................................................................................... 11 
Acknowledgements .................................................................................................... 32 
Declaration ................................................................................................................. 33 
Abbreviations ............................................................................................................. 34 
Chapter 1 Introduction ......................................................................................... 37 
1.1 Nuclear Magnetic Resonance ...................................................................... 37 
 Nuclear Spin ......................................................................................... 37 
1.2 The Sensitivity Problem ............................................................................... 38 
1.3 Hyperpolarisation ........................................................................................ 40 
 Optical Pumping ................................................................................... 41 
 Dynamic Nuclear Polarisation .............................................................. 42 
1.4 Parahydrogen Induced Polarisation ............................................................ 46 
 Spin Isomers of Hydrogen .................................................................... 47 
 Generating Parahydrogen ................................................................... 48 
 PASADENA & ALTADENA ...................................................................... 50 
 Applications of PHIP ............................................................................. 52 
1.5 Signal Amplification by Reversible Exchange .............................................. 53 
 The SABRE Mechanism ........................................................................ 53 
 SABRE Substrates of Interest ............................................................... 60 
 Catalyst Design ..................................................................................... 63 
 Biocompatibility of SABRE ................................................................... 67 
 Exchange in the SABRE-Active Species ................................................ 69 
 Relaxation Effects in the SABRE-Active Species ................................... 71 




1.6 Thesis Aims .................................................................................................. 75 
1.7 References ................................................................................................... 77 
Chapter 2 Comparison of Experimental Methods for SABRE Hyperpolarisation . 85 
2.1 Observation of the Chemical Process of SABRE via NMR ........................... 85 
 Field for Polarisation Transfer in the SABRE Hyperpolarisation Process
 91 
2.2 The  Manual Shaking Method ..................................................................... 93 
 Polarisation Transfer Using the Magnetic Stray Field .......................... 95 
 The Impact of Different Experimenters ............................................... 98 
 Effect of Parahydrogen dissolution Time (Shake Time) on Signal 
Enhancement ................................................................................................... 100 
2.3 The Automated Flow System .................................................................... 102 
 Effect of Parahydrogen Dissolution Time (Bubble Time) on Signal 
Enhancement ................................................................................................... 103 
2.4 Handheld Magnetic Array ......................................................................... 105 
 Design of the Handheld Magnetic Array ............................................ 106 
 Effect of Parahydrogen Dissolution Time (Shake Time) on Signal 
Enhancement ................................................................................................... 108 
2.5 Comparison of SABRE Methods ................................................................ 109 
2.6 Summary .................................................................................................... 112 
2.7 References ................................................................................................. 114 
Chapter 3 SABRE Optimisation for a Series of Para-Substituted Pyridines ........ 116 
3.1 The Substrates ........................................................................................... 116 
 Substituent Effects in Pyridine ........................................................... 116 
3.2 Formation of the SABRE Pre-Catalyst: [Ir(COD)(SIMes)(sub)]Cl ................ 124 





3.3 Formation of the SABRE-Active Species: [Ir(H)2(SIMes)(sub)3]Cl .............. 127 
 Formation of [Ir(H)2(SIMes)(sub)3]Cl with 4-Pyridinecarboxaldehyde
 129 
 SABRE Enhancements in [Ir(H)2(SIMes)(sub)3]Cl ............................... 131 
3.4 Chemical Exchange in [Ir(H)2(SIMes)(sub)3]Cl ........................................... 138 
 Using the Rate of Substrate Dissociation to Determine the Gibbs Free 
Energy 140 
3.5 Measuring the Pseudo 4JHH Coupling in [Ir(H)2(SIMes)(sub)3]Cl................ 149 
3.6 Relaxation Effects [Ir(H)2(SIMes)(sub)3]Cl ................................................. 154 
 T1 and Hyperpolarised T1 Measurements .......................................... 154 
 Effect of Catalyst Deuteration atthe NHC .......................................... 156 
 Optimum Rate of Dissociation for SABRE .......................................... 158 
3.7 Exploring the Effect of Catalyst Modifications on Iridium-Substrate Ligation
 159 
 Gibbs Free Energy in [Ir(H)2(NHC)(sub)3]Cl ........................................ 161 
 Relaxation Effects in [Ir(H)2(NHC)(sub)3]Cl ........................................ 163 
 Enhancement in [Ir(H)2(NHC)(sub)3]Cl ............................................... 165 
3.8 Summary ................................................................................................... 168 
3.9 References ................................................................................................. 172 
Chapter 4 SABRE Optimisation for Oxygen-Bound Pyridines ............................. 175 
4.1 The Substrates ........................................................................................... 175 
 4-Hydroxypyridine ............................................................................. 175 
 Isoniazid ............................................................................................. 182 
4.2 Formation of the SABRE pre-catalyst ........................................................ 183 
 [Ir(COD)(SIMes)(4-Hydroxypyridine)]Cl ............................................. 184 




4.3 Formation of the SABRE-Active Catalyst ................................................... 194 
 [IrCl(H)2(SIMes)(κ-O-4-pyridone)(κ-N-4-hydroxypyridine)] ............... 195 
 [Ir(H)2(SIMes)(κ-N-isonicotinylhydrazide)(isonicotinyl-κ-O-κ-N-
hydrazide]Cl...................................................................................................... 198 
 SABRE Enhancements in the SABRE-Active Catalyst .......................... 204 
4.4 Diffusion Ordered Spectroscopy in the SABRE-Active Catalyst................. 207 
 [Ir(H)2(SIMes)(4-methylpyridine)3]Cl .................................................. 212 
 [IrCl(H)2(SIMes)(κ-O-4-pyridone)(κ-N-4-hydroxypyridine)] ............... 216 
 [Ir(H)2(SIMes)(κ-N-isonicotinylhydrazide)(isonicotinyl-κ-O-κ-N-
hydrazide]Cl...................................................................................................... 219 
4.5 Ligand exchange within these SABRE-active catalysts .............................. 222 
 Gibbs Free Energy .............................................................................. 224 
4.6 Relaxation Effects in the SABRE-Active Catalyst ....................................... 227 
 T1 Relaxation Measurements ............................................................. 227 
4.7 Summary .................................................................................................... 229 
4.8 References ................................................................................................. 234 
Chapter 5 Conclusions and Further Work........................................................... 237 
5.1 Further Work ............................................................................................. 240 
5.2 References ................................................................................................. 241 
Chapter 6 Experimental ...................................................................................... 243 
6.1 Instrumentation......................................................................................... 243 
 Nuclear Magnetic Resonance ............................................................ 243 
 Parahydrogen Rig ............................................................................... 247 
 Flow System ....................................................................................... 248 
 Fourier Transform Infrared (FTIR) ...................................................... 250 




 Synthesis of [IrCl(COD)(NHC)] and Isotopically Labelled Substrates . 250 
 NMR Samples ..................................................................................... 251 
 Manual Shaking Method .................................................................... 251 
 Flow System ....................................................................................... 252 
 Calculating SABRE Enhancements ..................................................... 252 
 Measuring pKa .................................................................................... 253 
 Exchange Spectroscopy...................................................................... 256 
 T1 Relaxation Measurements ............................................................. 264 
 Hyperpolarised T1 Measurements ..................................................... 265 
6.3 Diffusion Ordered Spectroscopy ............................................................... 268 
6.4 References ................................................................................................. 270 
Appendix A ............................................................................................................... 272 
Manual Shaking Method Using the Stray Field of the Spectrometer .................. 272 
Automated Flow System ...................................................................................... 272 
Manual Shaking Using a Handheld Magnetic Array ............................................ 272 
Appendix B ............................................................................................................... 273 
Measuring the pKa for the substrates in Chapter 3 ............................................. 273 
Characterisation of Substrates for the Substrates in Chapter 3 .......................... 283 
4-Chloropyridine .............................................................................................. 283 
4-Methylpyridine ............................................................................................. 284 
4-Methoxypyridine .......................................................................................... 284 
4-Pyridinecarboxaldehyde ............................................................................... 284 
Characterisation of [Ir(COD)(SIMes)(sub)]Cl for the Substrates in Chapter 3 ..... 285 
[Ir(COD)(SIMes)(4-chloropyridine)]Cl .............................................................. 285 
[Ir(COD)(SIMes)(4-methylpyridine)]Cl ............................................................. 286 




[Ir(COD)(SIMes)(4-pyridinecarboxaldehyde)]Cl ............................................... 288 
Characterisation of [Ir(H)2(SIMes)(sub)3]Cl for the Substrates in Chapter 3 ....... 289 
[Ir(H)2(SIMes)(4-chloropyridine)3]Cl ................................................................. 289 
[Ir(H)2(SIMes)(4-methylpyridine)3]Cl ................................................................ 290 
[Ir(H)2(SIMes)(4-methoxypyridine)3]Cl ............................................................. 291 
[Ir(H)2(SIMes)(4-pyridinecarboxaldehyde)3]Cl ................................................. 292 
Enhancements in [Ir(H)2(SIMes)(sub)3]Cl for the Substrates in Chapter 3 ...... 293 
Exchange in [Ir(H)2(SIMes)(sub)3]Cl for the Substrates in Chapter 3 ................... 293 
Variation in enhancement factor with temperature used to calculate optimum 
rates of substrate dissociation ......................................................................... 294 
Measuring the 4JHH Coupling in [Ir(H)2(SIMes)(sub)3]Cl ....................................... 295 
Relaxation effects in [Ir(H)2(SIMes)(sub)3]Cl for the substrates in chapter 3 ...... 299 
T1 graphs for [Ir(H)2(SIMes)(sub)3]Cl ................................................................ 299 
T1 graphs for [Ir(H)2(d22-SIMes)(sub)3]Cl .......................................................... 305 
T1 graphs at optimum SABRE temperature...................................................... 307 
Changing the NHC for the substrates in chapter 3 .............................................. 308 
Gibbs Free Energy ............................................................................................ 308 
Relaxation Effects ............................................................................................. 309 
Enhancement ................................................................................................... 315 
Appendix C ............................................................................................................... 315 
Enhancements in [IrCl(H)2(SIMes)(κ-O-4-pyridone)(κ-N-4-hydroxypyridine)] and 
[Ir(H)2(SIMes)(κ-N-isonicotinylhydrazide)(isonicotinyl-κ-O-κ-N-hydrazide]Cl ..... 315 
Diffusion Ordered Spectroscopy in [Ir(H)2(SIMes)(4-methylpyridine)3]Cl, 
[IrCl(H)2(SIMes)(κ-O-4-pyridone)(κ-N-4-hydroxypyridine)] and [Ir(H)2(SIMes)(κ-N-
isonicotinylhydrazide)(isonicotinyl-κ-O-κ-N-hydrazide]Cl ................................... 315 
[Ir(H)2(SIMes)(4-methylpyridine)3]Cl ................................................................ 315 




[Ir(H)2(SIMes)(κ-N-isonicotinylhydrazide)(isonicotinyl-κ-O-κ-N-hydrazide]Cl . 329 
Exchange in [IrCl(H)2(SIMes)(κ-O-4-pyridone)(κ-N-4-hydroxypyridine)] and 
[Ir(H)2(SIMes)(κ-N-isonicotinylhydrazide)(isonicotinyl-κ-O-κ-N-hydrazide]Cl ..... 333 
Relaxation Effects in [IrCl(H)2(SIMes)(4-hydroxypyridine)2] and 
[Ir(H)2(SIMes)(Isoniazid)2]Cl ................................................................................. 334 
Free Substrate (no catalyst) ............................................................................. 334 
Free Substrate .................................................................................................. 335 
Bound Substrate Trans to Hydride .................................................................. 336 
Bound Substrate Trans to NHC ........................................................................ 337 
Bibliography ............................................................................................................. 339 
 
  
Table of Figures 
11 
 
Table of Figures 
Figure 1 - The Larmor Precession ............................................................................... 37 
Figure 2 - The Boltzmann Distribution of Spins at Thermal Equilibrium Where ΔE = 
energy difference between the two states, γ = gyromagnetic ratio, h = Planck’s 
constant & B0 = magnetic field strength. ................................................................... 39 
Figure 3 - The Boltzmann Distribution at Thermal Equilibrium vs Hyperpolarised. 
Adapted with permissions from L. Frydman, et al.19 ................................................. 40 
Figure 4 - a) Experimental setup for SEOP experiments. Adapted with permissions 
from Raftery et al.29 b) Inside the pumping cell. Adapted with permissions from 
Walker et al.13 c) Electronic transitions that occur between the Rb and Xe atoms in 
the pumping cell. Adapted with permissions from T. Pietrass et al.26 ...................... 42 
Figure 5 - Mechanism for polarisation transfer via the Solid Effect in DNP. Adapted 
with permissions from A. B. Barnes et al.39 ............................................................... 43 
Figure 6 - Mechanism for polarisation transfer for the cross effect in DNP. Adapted 
with permissions from A. B. Barnes et al.39 ............................................................... 44 
Figure 7 - Thermal Mixing mechanism for polarisation transfer in DNP. Adapted with 
permissions from A. B. Barnes et al.39 ....................................................................... 45 
Figure 8 - Hydrogenation of acrylonitrile to propionitrile using p-H2. a) 1H spectrum 
of acrylonitrile under Boltzman conditions b) 1H spectrum of para-hydrogenated 
propionitrile. The blue antiphase peaks are the p-H2 derived protons in the product. 
Spectra a) and b) are reprinted with permissions from C. R. Bowers et al.44 ........... 47 
Figure 9 - The Four Spin States of Dihydrogen. ......................................................... 48 
Figure 10 - Schematic of the p-H2 Generator. Adapted from S. B. Duckett et al.46 ... 49 
Figure 11 - a) o-H2 enrichment as a function of temperature. Population of the ortho 
state has been quantified using the integral of the proton signal of hydrogen, b) p-H2 
enrichment as a function of temperature. Figure has been adapted with permissions 
from P. M. Richardson et al.50 .................................................................................... 50 
Figure 12 - The energy levels of an AX spin system, where the population of each spin 
state is represented by line thickness. The transitions between energy levels and the 
corresponding NMR signals are shown, for a negative value of JAX. 14 Figure adapted 
with permissions from J. Natterer et al.14 ................................................................. 51 
Table of Figures 
12 
 
Figure 13 - a) Comparison of the thermal 1H-NMR spectrum (top) compared to the 
hyperpolarised 1H spectrum for a sample of 6 nmol pyridine. The top spectrum has 
been magnified 128 times so that the 1H resonances can be compared to the 
hyperpolarised spectrum. b) Hyperpolarised 1H decoupled 13C spectrum after 
refocusing for a 6 nmol sample of pyridine. c) Hyperpolarised 1H decoupled 15N 
spectrum with refocusing for a sample contains 25 nmol of 15N-labelled pyridine. 
Figure adapted with permissions from R. W. Adams et al.64 .................................... 53 
Figure 14 - Schematic diagram of the SABRE process. The curved blue arrow indicates 
hydrogen exchange with the free p-H2 in the excess solution. The curved pink arrow 
indicates substrate exchange with the non-polarised free substrate material. The 
blue/pink arrow indicates polarisation transfer from p-H2 to the substrate. In the 1H-
NMR spectra shown, the black is the thermal, non-hyperpolarised spectrum which 
has been magnified 32 times and the pink spectrum is the hyperpolarised spectra.
.................................................................................................................................... 54 
Figure 15 - Full SABRE mechanism illustrating formation of the SABRE species: 
[Ir(COD)(NHC)(sub)]Cl and [Ir(H)2(NHC)(sub)3]Cl ....................................................... 55 
Figure 16 - SABRE couplings according to an AA'BB' system ..................................... 56 
Figure 17 - Representation of the LAC approach to SABRE. Adapted with permissions 
from Buljubasich et al.75 ............................................................................................ 57 
Figure 18 - Schematic Diagram of the SABRE-Relay Polarisation Process ................. 62 
Figure 19 - Structure of the SABRE-Active Species formed from Crabtrees catalyst 63 
Figure 20 - SABRE-active species containing IMes based NHC ligands ..................... 65 
Figure 21 – SABRE-Active species based on the pincer based catalyst,120 the 
phenolate-substituted NHC123 and COE based complex.124 The latter rapidly forms a 
non-SABRE active CH activation product which is shown. ........................................ 66 
Figure 22 - Catalyst modifications for water soluble iridium SABRE catalysts .......... 69 
Figure 23 - Ligand Exchange pathways. a) Illustrated the dissociative substrate 
exchange pathway, b) shows the associative H2 exchange pathway. Image adapted 
with permissions from D. A. Barskiy et al.139 The methanol adduct was adapted with 
permissions from L. S. Lloyd et al.65 ........................................................................... 71 
Figure 24 - a) Plot of the T1 value at the H-5 resonance of methyl nicotinate and 2 of 
its deuterated analogues. The graph compares the T1 in the absence of the catalyst 
Table of Figures 
13 
 
and in the presence of IMes. b) Plot of the T1 value at the H-5 resonance of methyl-
4,6-d2-nicotinate as a function of the catalyst IMes and corresponding deuterated 
analogues for the free substrate, the equatorially bound substrate (trans to hydride) 
and the axially bound substrate (trans to the NHC). Image created using data from P. 
J. Rayner et al.80 ......................................................................................................... 73 
Figure 25 - Pyridazine (a) and associated derivatives and isotopalogues (b-c). Figure 
adapted with permissions from S. S. Roy et al.151 ..................................................... 75 
Figure 26 - The SABRE active species [Ir(H)2(SIMes)(sub)3]Cl .................................... 86 
Figure 27 - Stacked 1H-NMR spectra for [Ir(COD)(SIMes)(sub)]Cl (bottom) and 
[Ir(H)2(SIMes)(sub)3]Cl (top).  Formation of the SABRE active species, 
[Ir(H)2(SIMes)(sub)3]Cl is indicated by the appearance of extra substrate peaks 
(shown in pink) alongside the hydride peak shown in blue (top spectra). The 
disappearance of COD related peaks (shown in green in the bottom spectra) indicates 
that the SABRE precatalyst, [Ir(COD)(SIMes)(sub)]Cl has been consumed. 1 H NMR 
spectra collected on a 300 MHz spectrometer at 298 K using a sample containing 
[IrCl(COD)(SIMes)] (5 mM), 4-methylpyridine (50 mM), methanol-d4 (0.6 mL) (bottom 
spectra) with addition of pH2 (4 bar) (top spectra). .................................................. 88 
Figure 28 - Standard 1H 90° pulse used for SABRE experiments ............................... 89 
Figure 29 -  1H NMR spectra collected for the SABRE active species 
[Ir(H)2(SIMes)(sub)3]Cl under thermal conditions (no pH2, black spectra) compared to 
hyperpolarised spectra (pink) in the presence of pH2 (4 bar). The thermal spectrum 
(black) has been magnified 32 times so that it can be visually compared to the 
hyperpolarised spectrum. 1H NMR spectra was measured on a 400 MHz 
spectrometer at 298 K using the one-shot pulse sequence depicted in Figure 28 and 
a sample containing the SABRE precatalyst [IrCl(COD)(SIMes)] (5 mM), methanol-d4 
(0.6 mL) and the substrate 4-methylpyridine (50 mM) under 4 bar of pH2. The 
hyperpolarised spectrum was collected using the manual shaking method. The 
sample was then left in the spectrometer for 10 minutes after hyperpolarisation 
before the thermal spectra was acquired. The equations for calculation of 
enhancement and percentage hyperpolarisation are also included. ........................ 91 
Figure 30 – a) series of hyperpolarised 1H NMR spectra as a function of field strength 
in the SABRE active species [Ir(H)2(SIMes)(sub)3]Cl where the resonances at the ortho 
Table of Figures 
14 
 
proton are shown in pink and the meta resonances are shown in black. The 
hyperpolarised 1H NMR spectra was collected using the automated flow system using 
the pulse sequence shown in Figure 28 where the field strength was varied over 0-
130 G in 10 G increments. This was measured on a 400 MHz spectrometer at 298 K 
using a sample of [IrCl(COD)(SIMes)] (5 mM), 4-methylpyridine (50 mM), methanol-
d4 (0.6 mL) under a pH2 atmosphere of 4 bar. b) The signal enhancement calculated 
at the ortho proton in the free substrate plotted as a function of polarisation transfer 
field (PTF) ................................................................................................................... 92 
Figure 31 – Schematic diagram describing the manual shaking method. 1) 4 bar pH2 
is added to an NMR tube fitted with a Young’s tap containing the SABRE active 
species, 2) The sample is shaken within the stray field of the spectrometer to allow 
for polarisation transfer from the pH2 to the target substrate via the J-coupled 
network, 3) The sample is quickly transferred into the spectrometer for acquisition 
using the one-shot pulse sequence described in Figure 28, 4) Hyperpolarised 
spectrum is generated and enhancement and polarisation can be calculated by 
comparing to the thermal spectrum and using the calculations shown in Figure 2994 
Figure 32 - Schematic diagram of a nuclear magnetic spectrometer adapted with 
permissions from M. H. Levitt et al.16 ........................................................................ 95 
Figure 33 - Diagram of a solenoid coil. Arrows are used to show the direction of the 
magnetic field. As the field is more concentrated in the centre, this is where the NMR 
sample is placed. ........................................................................................................ 96 
Figure 34 – Stray field plots for the two spectrometers used for SABRE experiments 
where A is the narrow bore spectrometer and b is the wide bore spectrometer. 
Reproduced with permission from the NMR magnet system folder. ....................... 97 
Figure 35 – Box plot showing the enhancement factor as a function of experimenter 
utilising the manual shaking method. The coloured portions indicate the 25% and 
75% quartiles, the whiskers the minimum and maximum enhancement values, the 
median line the mid-point of the data and the square the mean. Samples contained 
the SABRE precatalyst [IrCl(COD)(SIMes)] (5 mM), substrate (50 mM) dissolved in 
methanol-d4 (0.6 mL) and in the presence of pH2 (4 bar). Samples were shaken for 10 
seconds in the stray field of the spectrometer at approximately 60 G at 298 K....... 99 
Table of Figures 
15 
 
Figure 36 – Box plots showing the 1H signal enhancement at the ortho proton, plotted 
as a function of shake time for a sample containing [Ir(COD)(SIMes)(sub)]Cl (5 mM) 
with the substrate 4-methylpyridine (50 mM) and pH2 (4 bar) in methanol-d4. Green 
is used to represent the narrow bore instrument a) and purple the wide bore 
instrument b). The sample was manually shaken at approximately 60 G using the 
stray field of the 400 MHz spectrometers at 298 K. The coloured portions indicate the 
25% and 75% quartiles, the whiskers the minimum and maximum enhancement 
values, the median line the mid-point of the data, the square the mean and the 
diamonds show any outliers in the data. ................................................................. 101 
In general, the data in Figure 37 indicates that the average enhancements (indicated 
by the squares) at the ortho-proton position are slightly higher when measured on 
spectrometer a. For example, an average enhancement of −891 ± 18-fold was 
observed on instrument a compared to −842 ± 43-fold on b. However, the whiskers 
show that the highest enhancement was observed using instrument b, where a 10 
second shake time induced an enhancement of −973-fold. This compares to a 
maximum of 935-fold on a. Generally, larger variations were observed using 
instrument b compared to a. This is indicated by the whiskers which illustrate the 
maximum and minimum enhancement values. For example, for a 5 second shake 
time, the minimum enhancement was −74-fold and the largest was −801-fold. The 5 
second shake time also induced a large variation in results on a, this is highlighted by 
the presence of data anomalies at −556-fold and −767-fold. Henceforth it is difficult 
to reproduce enhancements when shaking for such a short period of time. ......... 101 
Figure 38 – Schematic diagram of the automated flow probe. 1) A sample of 
[Ir(H)2(SIMes)(sub)3]Cl in methanol-d4 is contained in a flow cell where pH2 (4 bar) is 
bubbled through the solution, 2) The hyperpolarised sample is transferred into the 
spectrometer via a nitrogen flow, 3) The hyperpolarised spectrum is acquired using 
the one-shot pulse sequence described in Figure 28, 4) The sample is transferred 
from the spectrometer back to the flow cell using a nitrogen flow. Image adapted 
with permissions from R. E. Mewis et al.6 ............................................................... 102 
Figure 39 – Box plot showing the 1H NMR signal enhancement plotted as a function 
of bubble time for the ortho proton resonance in the free substrate for the SABRE 
active species [Ir(H)2(SIMes)(sub)3]Cl (5 mM) containing the substrate 4-
Table of Figures 
16 
 
methylpyridine (50 mM). Measurements collected on the 400 MHz narrow bore 
instrument a) are shown in green and those collected on the 400 MHz wide bore 
instrument b) are shown in purple. Hyperpolarised measurements were taken using 
the flow method shown in Figure 38 at 298 K and the pulse sequence shown in Figure 
28. The coloured portions indicate the 25% and 75% quartiles, the whiskers the 
minimum and maximum enhancement values, the median line the mid-point of the 
data, the square the mean and the diamonds show any outliers in the data. ....... 104 
Figure 40 shows the variation in the 1H signal enhancement at the ortho proton as a 
function of the p-H2 bubble time. If we first consider the average signal 
enhancements, the data generally follows the same pattern as the manual shaking 
method whereby larger enhancements were observed on spectrometer a. However, 
the largest average signal enhancement of −264-fold corresponding to a 15 second 
bubble time was observed on instrument b. This compares to −227-fold on 
instrument a which resulted from a 10 second bubble time. Furthermore, the largest 
calculated enhancement of −410-fold was observed on b for a 25 second bubble time. 
In Figure 41, this is shown as an outlier (indicated by the diamond) as the remaining 
data points ranged from −40-fold to −126-fold. Figure 42 clearly shows that there is 
a larger variation in signal enhancements using spectrometer b. This is highlighted by 
the larger box plots, for example a 10 second bubble time induced enhancements 
ranging from −0.6-fold to −399-fold (illustrated by the whiskers). Additionally, more 
anomalies were observed in the data using NMR b (shown by the diamonds). 
Henceforth, the data collected using spectrometer b is shown to be less reproducible 
compared to a. It was expected that the  signal enhancements generated on both 
instruments would be very reproducible as this SABRE method is fully automated and 
all experimental parameters (e.g. sample transfer time, p-H2 pressure etc) were 
constant for both spectrometers. It is possible that the larger variation in data is 
caused by solvent evaporation in the sample. This could be induced by the sample 
being shuttled between the spectrometer and the flow cell a number of times via a 
nitrogen flow. However if this were the case, it would be expected that the error 
would increase with bubble time.  . Interestingly, the variation in data across the 
different bubble times is minimal for a. For example, the lowest average 
enhancement of −193-fold was observed for a 5s bubble time, compared to −227-
Table of Figures 
17 
 
fold for a 10 second bubble time. This suggests that the shake/bubble time does not 
influence the enhancement as much as the field strength, transfer time or 
shake/bubble intensity. ........................................................................................... 104 
Figure 43 – Schematic diagram describing the use of the handheld magnetic array. 1) 
4 bar pH2 is added to SABRE active species in an NMR tube fitted with a young’s tap, 
2) The sample is placed inside the handheld magnetic array, 3) The handheld 
magnetic array containing the sample is shaken to allow for polarisation transfer into 
the substrate, 4) the sample is removed from the handheld magnetic array and 
transferred into the spectrometer for detection .................................................... 106 
Figure 44 – The hand-held shaker adapted with permissions from P. M. Richardson 
et al.5 ........................................................................................................................ 106 
Figure 45 – Photo of the hand-held shaker and corresponding magnetic field profile 
measured along the central axis of the cylinder. Image taken with permission from P. 
M. Richardson et al.5 ................................................................................................ 107 
Figure 46 – 1H signal enhancement plotted as a function of shake time for the ortho 
proton in the free substrate for SABRE active species [Ir(H)2(SIMes)(sub)3]Cl 
containing the substrate 4-methylpyridine. The green represent measurements 
taken on the narrow bore 400 MHz spectrometer a, and the purple are used for the 
wide bore 400 MHz spectrometer b. Hyperpolarised measurements were collected 
using the 60 G handheld magnetic array in Figure 43 at 298 K. The coloured portions 
indicate the 25% and 75% quartiles, the whiskers the minimum and maximum 
enhancement values, the median line the mid-point of the data, the square the mean 
and the diamonds show any outliers in the data. ................................................... 108 
Figure 47 illustrates the variation in 1H signal enhancement at the ortho proton as a 
function of shake time. The largest average enhancement was observed for a shake 
time of 10 seconds. On spectrometer a this shake time induced a signal enhancement 
of −497-fold compared to −339-fold on spectrometer b. Furthermore, larger 
enhancements were observed on instrument a compared to b. If the individual data 
points are considered, the largest enhancement was −564-fold on a compared to 
−410-fold on NMR b (outlieing data point for a 5 second shake time). .................. 108 
If the average signal enhancements are considered, there was less variation overall 
in the data using the handheld magnetic array. For example, on NMR a, the minimum 
Table of Figures 
18 
 
average enhancement was −442-fold (15 second shake time) compared to the 
maximum of −497-fold (10 second shake time). However, if the individual data points 
are considered, the minimum measurement was −387-fold (15 second shake time) 
compared to −564-fold (10 second shake time). On NMR b, the lowst average signal 
enhancement was −339-fold (7 and 10 second shake times) compared to the 
maximum signal enhancement of −365-fold (5 second shake time). Considering the 
individual measurements, the lowest signal enhancement was −279-fold (10 second 
shake time) and the highest was 396-fold (15 second shake time). This lower variation 
in data suggests that the sample shake time is less important compared to the 
polarisation transfer field and the transfer time. As the field has been kept constant 
at 63 G, this means that it is the difference in transfer time that has contributed to 
the lower enhancements observed on b compared to a.It is clear that this method is 
less reproducible than both the manual shaking method using the stray field of the 
spectrometer and the automated flow system. This can be observed by the number 
of data anomalies shown in Figure 48 for both spectrometers. The lower 
reproducibility can also be attributed to the differences in transfer time between 
measurements as the sample must be removed from the shaker before being 
dropped into the spectrometer for acquisition. ...................................................... 109 
The effect of p-H2 dissolution time has been compared to the 1H signal enhancements 
for each method. This was observed by plotting the shake time or the bubble time as 
a function of signal enhancement. In order to compare the methods directly, the 1H 
signal enhancements for each method have been plotted for a 10 second shake time 
for spectrometers a and b, this is shown in Figure 49. ............................................ 109 
Figure 50 – Signal enhancement plotted as a function of SABRE methodfor the ortho 
proton in the free substrate 4-methylpyridine in the SABRE-active species 
[Ir(H)2(SIMes)(sub)3]Cl. This is shown for a p-H2 dissolution time of 10 seconds. Plot 
a) in green compares the signal enhancements measured on the 400 MHz narrow 
bore instrument a Plot b) compares the signal enhancements measured on the 400 
MHz wide bore instrument b. The manual shaking method is is labelled ‘M.S’, the 
handheld magnetic array is labelled ‘H.M.A’ and the automated flow system is 
labelled ‘A.F’.  All measurements were collected at 298 K using a sample of 
[Ir(COD)(SIMes)(sub)]Cl (5 mM), 4-methylpyridine (50 mM) and pH2 (4 bar) in 
Table of Figures 
19 
 
methanol-d4. c) Enhancement Factor as a function of SABRE method adapted from 
Richardson et al.5 with permissions. These measurements were collected at 298 K 
using a sample of [Ir(COD)(IMes)(sub)]Cl (5 mM), 4-methylpyridine (50 mM) and pH2 
(4 bar) and a 10 second p-H2 dissolution time. ........................................................ 110 
Box plots a) and b) in Figure 51 compare the 1H signal enhancements for a 10 second 
shake time for each SABRE methods on spectrometers a (graph a) and b (graph b). 
The manual shaking method using the stray field of the spectrometer is indicated by 
‘M.S’, the handheld magnetic array by ‘H.M.A’ and the automated flow system by 
‘A.F’. Both plots a) and b) show that the largest signal enhancements were measured 
using the manual shaking method. On NMR a, this generated a average enhancement 
of – 891-fold compared to −497-fold using the handheld magneti array and −227-fold 
using the automated flow system. If the individual measurements are considered, 
the largest enhancement was −935-fold using the manual shaking method. Similarly, 
on NMR b, the largest enhancements were also observed using the manual shaking 
method. This induced an average enhancement of −842-fold, however the largest 
individual measurement was −974-fold which is larger than the maximum observed 
on NMR b. An average enhancement of −339-fold was observed using the handheld 
magnetic array and −135-fold using the automated flow system. A larger variation in 
the data was generated by spectrometer b compared to a. This is clearly observed by 
the large box plot using the automated flow method. Larger variations were also 
observed with the manual shaking method and the handheld magnetic array. For 
example, the data ranged from −714-fold to −974 fold for the manual shaking 
method. On NMR a, the data ranged from −832-fold to −935-fold. This difference in 
reproducibility is attributed to the longer transfer time induced when using 
instrument b. A longer transfer time means that hyperpolarisation can be lost before 
the data can be acquired. Furthermore, as results were found to be more 
reproducible using NMR a compared to b, this was used for all the SABRE 
experiments in the remainder of this thesis. ........................................................... 110 
Figure 52 – Resonance structures for pyridine. ....................................................... 116 
Figure 53 – comparison of the effect of a) electron withdrawing groups (EWG) and b) 
electron donating groups (EDG) in the para position of pyridine on the metal-ligand 
interaction. ............................................................................................................... 118 
Table of Figures 
20 
 
Figure 54 - The chemical structures of the para-substituted pyridines substrates 
chosen for this study. ............................................................................................... 119 
Figure 55 – The two forms of the substituted pyridine in solution with methanol and 
hydrochloric acid (HCl) used to control the pH of the solution ............................... 120 
Figure 56 – Chemical shift as a function of pH for 4-chloropyridine in methanol-d4. 
HCl was used to reach low pH values and KOH was added to achieve high pH. The 
data points have been fitted using Equation 14. ..................................................... 123 
Figure 57 – 1H-NMR spectra showing the SABRE precatalyst [Ir(COD)(SIMes)(sub)]Cl 
for the substrate 4-methylpyridine. The sample was prepared by adding 
[IrCl(COD)(SIMes)] (4 mM) to 4-methylpyridine (40 Mm) in methanol-d4. The sample 
was measured at 235 K and 500 MHz. .................................................................... 124 
Figure 58 - 1H-NMR spectrum for [Ir(COD)(SIMes)(4-pyridinacarboxaldehyde)]Cl in 
methanol-d4 measured at 500 MHz and 263 K. Black indicates the presence of the 
free aldehyde conformation and the orange highlights the bound and free hemiacetal 
conformation. .......................................................................................................... 126 
Figure 59 – 1H-NMR spectra for the SABRE-active species [Ir(H)2(SIMes)(sub)3]Cl for 
4-methylpyridine. The sample was prepared using [IrCl(COD)(SIMes)] (4 mM), 4-
methylpyridine (40 mM) and p-H2 (4 bar) in methanol-d4. The sample was measured 
at 235 K and 500 MHz. ............................................................................................. 128 
Figure 60 - 1H-NMR Spectrum of [Ir(H)2(SIMes)(sub)3]Cl in methanol-d4 at 500 MHz 
and 263 K. Black indicates the presence of the free aldehyde conformation and the 
orange highlights the bound and free hemiacetal conformation. .......................... 130 
Figure 61 – Thermal 1H-NMR spectrum under Boltzmann conditions (black) compared 
to a hyperpolarised spectrum where the sample was shaken for 10 s in the stray field 
(65 G) of the spectrometer (400 MHz) (pink). These were measured using a sample 
containing 4-methylpyridine (40 mM), [IrCl(COD)(SIMes)] (4 mM) and p-H2 (4 bar) in 
methanol-d4 (0.6 mL). .............................................................................................. 132 
Figure 62 – Thermal 1H-NMR spectrum under Boltzmann conditions (black) compared 
to a hyperpolarised spectrum where the sample was shaken for 10 s in the stray field 
(65 G) of the spectrometer (400 MHz) (orange). These were measured using a sample 
containing 4-pyridinecarboxaldehyde (40 mM), [IrCl(COD)(SIMes)] (4 mM) and p-H2 
(4 bar) in methanol-d4 (0.6 mL). ............................................................................... 133 
Table of Figures 
21 
 
Figure 63 – Enhancements at the ortho proton  resonance in the free substrate as a 
function of substrate pKa for the SABRE-active species; [Ir(H)2(SIMes)(sub)3]Cl for 
each of the substrates tested. The enhancements were observed using the manual 
shaking method. The experiment was repeated five times and the 1H signal 
enhancements at the ortho proton were averaged. The error bars indicate the 
standard error of the experiment. ........................................................................... 134 
Figure 64 – Structures for deuterated isotopologue of IMes. Image adapted from 
Rayner et al. Proceedings of the National Academy of Sciences, 2017. .................. 136 
Figure 65 – Enhancements at the ortho proton  resonance in the free substrate  as a 
function of substrate pKa for the SABRE-active species for the four substrates. SIMes 
is indicated by the darker colour and d22-SIMes by the lighter colour. The 
enhancements were observed using the manual shaking method. The experiment 
was repeated five times and the 1H signal enhancements at the ortho proton were 
averaged. The error bars indicate the standard error of the experiment. .............. 137 
Figure 66 – The dissociation constant (kd) as a function of temperature for the SABRE 
active species for each of the substrates shown. The error bars indicate the error 
associated with kd calculated using the Jacknife method described in Chapter 6, 
Section 6.2.7.2 Associated errors in the calculation of kd. A table of the associated 
errors can be found in Appendix B. ......................................................................... 139 
Figure 67 – Eyring-Polanyi plot for the three substrates where ln(kd/T) is plotted 
against 1/T. The data have been fitted according to the equation y = mx + c. These 
are indicated on the graph alongside the corresponding substrate. ...................... 141 
Figure 68 – Gibbs free energy (ΔG≠298K) as a function of the substrate pKa for the 
SABRE-active species for the substrates shown. ..................................................... 143 
Figure 69 – The modified flow cell used to study the temperature dependence of 
SABRE ....................................................................................................................... 146 
Figure 70 – Enhancement factor plotted as a function of temperature for the SABRE 
active species for each of the substrates shown. .................................................... 147 
Figure 71 - Enhancement plotted as a function of the ΔG≠ value at 298 K using the 
manual shaking method (left) and the optimum temperature for SABRE using the 
automated flow system (right) ................................................................................ 149 
Table of Figures 
22 
 
Figure 72 - Pulse sequence for the selective 1D-COSY experiment. Adapted with 
permissions from P. J. Rayner et al. 28 ..................................................................... 151 
Figure 73 - the relative integral of the ortho proton in the equatorially bound 
substrate as a function of the delay time (d4). The data has been fitted to a sine 
function and the oscillation maxima has been indicated. The example shown is for 
[Ir(H)2(SIMes)(4-methylpyridine)3]Cl. ...................................................................... 152 
Figure 74 - The long range hydride-substrate coupling, 4JHH, as a function of the Gibbs 
free energy (ΔG≠298K) for each of the substrates indited ......................................... 153 
Figure 75 – T1 as a function of ΔG≠298K for the SABRE active species for the substrates 
shown. The graph shows the T1 at the ortho-proton in the free material (dark colour) 
compared to the ortho-proton in the substrate bound trans to the hydride (medium 
colour) and the ortho-proton in the substrate bound trans to the NHC (light colour). 
The error bars indicate the fitting error for the T1 curves shown in Appendix B. ... 155 
Figure 76 – T1 as a function of ΔG≠298K for the SABRE active species, 
[Ir(H)2(SIMes)(sub)3]Cl, for the substrates shown. The graph compares the T1 at the 
ortho-proton when SIMes is used as the NHC (darker colour) to the ortho-proton in 
the substrate when d22-SIMes is used as the NHC (lighter colour). The errors in the T1 
values are calculated from fitting the T1 curves shown in Appendix B. .................. 157 
Figure 77 – T1 values at the ortho-proton in the free substrate for the substrates 
shown as a function of the optimum SABRE temperatures shown in Table 8. ....... 159 
Figure 78 – Basic structure for the NHC ligand ........................................................ 159 
Figure 79 – Structures of the NHCs; SIMes, ITBXy and IMesCl, including the TEP and 
%Vbur values. ............................................................................................................. 161 
Figure 80 – The Gibbs free energy ΔG≠298K as a function of the NHC in the SABRE active 
species, [Ir(H)2(NHC)(sub)3]Cl for the substrates shown. ........................................ 162 
Figure 81 – T1 as a function of the NHC in the SABRE active species, 
[Ir(H)2(NHC)(sub)3]Cl for the substrates shown. The T1 is for the ortho-proton in the 
free substrate. The errors in the T1 values are calculated from fitting the T1 curves 
shown in Appendix B................................................................................................ 164 
Figure 82 - Radiation dampening observed during repeating manual shaking using the 
stray field of the spectrometer, with 4-methylpyridine, ITBXy and 99% p-H2 ........ 165 
Figure 83 - Plot of enhancements against p-H2 percentage .................................... 166 
Table of Figures 
23 
 
Figure 84 – Enhancement factor as a function of the NHC in the SABRE active species, 
[Ir(H)2(NHC)(sub)3]Cl for the substrates shown. The enhancements were observed 
using the manual shaking method. The experiment was repeated five times and the 
1H signal enhancements at the ortho proton were averaged. The error bars indicate 
the standard error of the experiment...................................................................... 167 
Figure 85 - Variation in enhancement factor with [p-H2] for ITBXy and its deuterated 
isotopologue d34-ITBXy ............................................................................................. 168 
Figure 86 - Tautomerism of 4-hydroxpyridine to 4-pyridone .................................. 176 
Figure 87 - FTIR spectra of 4-hydroxypyridine solid (black), dissolved in 
dichloromethane-d2 (red) and dissolved in methanol-d4 (blue). Solid FTIR was 
measured where a <1 mg of substrate was placed directly onto the diamond crystal. 
Solution FTIR was measured using the diamond fibre optic probe submersed into a 
vial containing the sample. ...................................................................................... 178 
Figure 88 - 1H NMR spectra as a function of temperature for a solution of 4-
hydroxypyridine in dichloromethane-d2. The enol tautomer is represented by the 
resonances highlighted in teal and the keto tautomer is indicated by the purple 
resonances. The darker colour represents the ortho 1H resonance and the lighter 
colour the meta 1H resonance. The samples were measured on the 500 MHz 
spectrometer. ........................................................................................................... 179 
Figure 89 - plot of ln(keto/enol) as a function of 1/T according to the linear form of 
the Van't Hoff equation in Equation 17 ................................................................... 181 
Figure 90 - Metal complexes formed with isoniazid. a) adapted with permissions from 
B. Bottari et al. 18 b) adapted with permissions from T. Stringer et al. 19 c) adapted 
with permissions from O. Akinyele et al. 20 ............................................................. 183 
Figure 91 - Schematic diagram of the formation of the SABRE precatalyst 
[Ir(COD)(SIMes)(sub)]Cl with the substrate 4-hydroxypyridine .............................. 184 
Figure 92 - 1H NMR spectra of the SABRE precatalyst; [Ir(COD)(SIMes)(4-
hydroxypyridine)]Cl. The sample contained [IrCl(COD)(SIMes)] (5 mM) and 4-
hydroxypyridine (50 mM) dissolved in methanol-d4 (0.6 mL). The NMR spectrum was 
acquired at 235 K and 500 MHz. .............................................................................. 185 
Figure 93 - 15N/1H HMQC NMR spectrum of a solution containing [IrCl(COD)(SIMes)] 
(5 mM) and 15N-labelled 4-hydroxypyridine (50 mM) in methanol-d4 at 9.4 T and 253 
Table of Figures 
24 
 
K. The purple highlighted resonance indicates the 15N-labelled pyridine nitrogen in 
the bound 4-hydroxypyridine in the SABRE precatalyst; [Ir(COD)(SIMes)(sub)]Cl. . 186 
Figure 94 - 1H NMR spectra as a function of temperature for a solution of 4-
hydroxypyridine (40 mM) and [IrCl(COD)(SIMes)]Cl (4 mM) in dichloromethane-d2. 
The enol tautomer is represented by the resonances highlighted in teal and the keto 
tautomer is indicated by the purple resonances. Only the resonances at the ortho 
proton are shown. These spectra were measured on a 500 MHz spectrometer. .. 187 
Figure 95 - plot of ln(keto/enol) as a function of 1/T according to the linear form of 
the Van't Hoff equation in Equation 1 ..................................................................... 189 
Figure 96 - Schematic diagram for the formation of the SABRE precatalst 
[Ir(COD)(SIMes)(sub)]Cl for the substrate isonaizid showing the major and minor 
forms. The major species binds to the iridium via the oxygen in the hydrazide group 
and the minor binds via the pyridine nitrogen. ....................................................... 190 
Figure 97 - 1H NMR spectrum of the SABRE precatalyst [Ir(COD)(SIMes)(isoniazid)]Cl. 
Sample initially contained [IrCl(COD)(SIMes)(sub)] (5 mM) and isoniazid (50 mM) in 
methanol-d4 (0.6 mL) and was measured at 500 MHz and 235 K. .......................... 191 
Figure 98 - 1H/15N HMQC NMR spectrum of a solution of [IrCl(COD)(SIMes)] (5 mM) 
and isoniazid (50 mM) in methanol-d4 at 9.4 T and 263 K. ..................................... 193 
Figure 99 - 15N NMR spectrum of the SABRE precatalyst [Ir(COD)(SIMes)(isoniazid)]Cl 
with i15N-labelled labelled isoniazid. 15N NMR spectrum measured at 40.56 MHz and 
263 K. The strong signals are due to the free ligand ............................................... 194 
Figure 100 - Schematic diagram showing the formation of the SABRE-active species 
[IrCl(H)2(SIMes)(κ-O-4-pyridone)(κ-N-4-hydroxypyridine)] from the precatalyst 
[Ir(COD)(SIMes)(4-hydroxypyridine)]Cl .................................................................... 195 
Figure 101 - 1H NMR spectrum of the SABRE-active species [IrCl(H)2(SIMes)(κ-O-4-
pyridone)(κ-N-4-hydroxypyridine)] . Sample contains [IrCl(COD)(SIMes)] (5 mM), 4-
hydroxpyridine (50 mM) and p-H2 (4 bar) dissolved in methanol-d4 (0.6 mL) in a 
young's tap NMR tube. Sample was measured at 500 MHz and 235 K. ................. 195 
Figure 102 - 1H/13C -HMQC NMR spectrum of [IrCl(H)2(SIMes)(κ-O-4-pyridone)(κ-N-4-
hydroxypyridine)]. Sample containing [IrCl(COD)(SIMes)] (5 mM), 4-hydroxypyridine 
(50 mM) and p-H2 (4 bar) dissolved in methanol-d4 measured at 11.74 T at 235 K. 
Resonance for the keto carbon shown at 180 ppm (13C)/7.35 ppm (1H) is highlighted 
Table of Figures 
25 
 
in lilac and resonance for the enol carbon shown at 164 ppm (13C)/7.69 ppm (1H) 
highlighted in purple. ............................................................................................... 197 
Figure 103 –1H/15N -HMQC of [IrCl(H)2(SIMes)(κ-O-4-pyridone)(κ-N-4-
hydroxypyridine)]. Sample containing [IrCl(COD)(SIMes)] (5 mM), 4-hydroxypyridine 
(50 mM) and p-H2 (4 bar) dissolved in methanol-d4 measured at 500 MHz (1H) and 51 
MHz (15N) at 235 K. Resonance for the nitrogen in the keto tautomer  shown at 215 
ppm (15N)/7.35 ppm (1H) is highlighted in lilac and the resonance for the nitrogen in 
the enol form is shown at 148.8 ppm (15N)/7.69 ppm (1H) highlighted in purple. .. 198 
Figure 104 - Schematic diagram showing the formation of the SABRE-active species 
[Ir(H)2(SIMes)(κ-N-isonicotinylhydrazide)(isonicotinyl-κ-O-κ-N-hydrazide]Cl from the 
pre-catalyst [Ir(COD)(SIMes)(sub)]Cl. ....................................................................... 199 
Figure 105 - 1H NMR spectra of the SABRE-active catalyst formed upon the reaction 
of [IrCl(COD)(SIMes)] (5 mM) with isoniazid (50 mM) and p-H2 (4 bar) in methanol-d4 
(0.6 mL). Spectra measured at 500 MHz and 235 K. ................................................ 199 
Figure 106 – 1H/15N-HMQC NMR spectrum of the product formed when 
[IrCl(COD)(SIMes)] (5 mM), isoniazid (50 mM) and p-H2 (4 bar) react together in 
methanol-d4 (0.6 mL), measured at 500 MHz (1H) and 51 MHz (15N) and 235 K. The 
15N resonance of the pyridine bound isoniazid ligand is highlighted at 261.1 ppm 
(15N)/8.07 ppm (1H) in light blue and the resonance for the chelate bound isoniazid is 
shown at 311 ppm (15N)/8.81 ppm (1H) in dark blue. .............................................. 201 
Figure 107 – 1H/13C-HMQC NMR spectrum of the product formed when 
[IrCl(COD)(SIMes)] (5 mM), isoniazid (50 mM) and p-H2 (4 bar) react in methanol-d4 
(0.6 mL). Measured at 500 MHz (1H) and 125 MHz (13C) and 235 K. The 13C resonance 
of pyridine bound isoniazid is highlighted at 165 ppm (13C)/8.07 ppm (1H) in light blue 
and the resonance for the chelate bound isoniazid is shown at 170 ppm (13C)/8.81 
ppm (1H) in dark blue. .............................................................................................. 202 
Figure 108 – 15N NMR spectrum of 15N labelled isoniazid measured at 41 MHz and 
298 K for a sample containing [IrCl(COD)(SIMes) (5 mM), isoniazid (50 mM) and p-H2 
(4 bar) in methanol-d4 (0.6 mL). 15N resonances for the pyridine bound hydrazide 
nitrogen atoms are highlighted in light blue while those for the chelate bound form 
are shown in dark blue. ............................................................................................ 203 
Table of Figures 
26 
 
Figure 109 - Thermal 1H-NMR spectrum under Boltzmann conditions (black) 
compared to a hyperpolarised spectrum where the sample was shaken for 10 s in the 
stray field (65 G) of the spectrometer (400 MHz) (purple = 4-hydroxypyridine, blue = 
isoniazid). These spectra were measured using a sample containing the substrate (40 
mM), [IrCl(COD)(SIMes)] (4 mM) and p-H2 (4 bar) in methanol-d4 (0.6 mL). The 
thermal spectrum has been magnified 8 times for 4-hydroxypyridine and 16 times for 
isoniazid in the stacked spectra. The enhancements at the ortho and meta 
resonances have been calculated. ........................................................................... 205 
Figure 110 – 1H NMR signal Enhancement factor as a function of substrate 
enhancement for the SABRE-Active species containing 4-methylpyridine, 4-
hydroxypyridine and isoniazid in methanol-d4 measured at 400 MHz and 298 K. . 206 
Figure 111 - Suggested dimer structures for the SABRE active species for (a) 4-
hydroxypyridine and (b) isoniazid ............................................................................ 207 
Figure 112 - The PFG-SE pulse sequence ................................................................. 210 
Figure 113 - Signal intensity as a function of the gradient strength. The data has been 
plotted according to Equation 21. The delays used for δ and Δ have been indicated 
alongside the calculated diffusion coefficient (D) ................................................... 211 
Figure 114 - 2D DOSY spectra of [Ir(H)2(SIMes)(4-methylpyridine)3]Cl. Sample 
contained [IrCl(COD)(SIMes)] (5 mM), 4-methylpyridine (50 mM)), p-H2 (4 bar 
absolute) dissolved in methanol-d4 (0.6 mL) measured at 400 MHz and 298 K. This 
figure is used for illustrative purposes only. ............................................................ 213 
Figure 115 - 2D DOSY 1H NMR spectra of [Ir(H)2(SIMes)(4-methylpyridine)3]Cl. Sample 
contained [IrCl(COD)(SIMes)] (5 mM), 4-methylpyridine (50 mM)), p-H2 (4 bar) 
dissolved in methanol-d4 (0.6 mL) measured at 400 MHz and 273 K. This figure is 
used for illustrative purposes only. ......................................................................... 214 
Figure 116 - 2D DOSY 1H NMR spectra of [IrCl(H)2(SIMes)(κ-O-4-pyridone)(κ-N-4-
hydroxypyridine)] . Sample contained [IrCl(COD)(SIMes)] (5 mM), 4-hydroxypyridine 
(50 mM) and p-H2 (4 bar) dissolved in methanol-d4 (0.6 mL) measured at 400 MHz 
and 298 K. This figure is used for illustrative purposes only. .................................. 217 
Figure 117 – 2D DOSY 1H NMR spectra of [IrCl(H)2(SIMes)(κ-O-4-pyridone)(κ-N-4-
hydroxypyridine)]. Sample contained [IrCl(COD)(SIMes)] (5 mM), 4-hydroxypyridine 
Table of Figures 
27 
 
(50 mM) and p-H2 (4 bar) dissolved in methanol-d4 (0.6 mL) measured at 400 MHz 
and 253 K. This figure is used for illustrative purposes only. .................................. 218 
Figure 118 - 2D DOSY 1H NMR spectra of  [Ir(H)2(SIMes)(κ-N-
isonicotinylhydrazide)(isonicotinyl-κ-O-κ-N-hydrazide]Cl Sample contained 
[IrCl(COD)(SIMes)] (5 mM), isoniazid (50 mM) and p-H2 (4 bar) dissolved in methanol-
d4 (0.6 mL) measured at 400 MHz and 298 K. This figure is used for illustrative 
purposes only. .......................................................................................................... 220 
Figure 119 – 2D DOSY 1H NMR spectra of [Ir(H)2(SIMes)(κ-N-
isonicotinylhydrazide)(isonicotinyl-κ-O-κ-N-hydrazide]Cl. Sample contained 
[IrCl(COD)(SIMes)] (5 Mm), isoniazid (50 Mm) and p-H2 (4 bar) dissolved in methanol-
d4 (0.6 Ml) measured at 400 MHz and 273 K. This figure is used for illustrative 
purposes only. .......................................................................................................... 221 
Figure 120 – Rate of ligand dissociation (kd) as a function of temperature for the 
complexes form when [IrCl(COD)(SIMes)]Cl (5 mM), the indicated substrate (50 Mm) 
and p-H2 (4 bar) are probed in methanol-d4 (0.6 mL) at 500 MHz. Data points 
corresponding to isoniazid are shown in blue squares, 4-hydroxypyridine are 
represented by purple circles and 4-methylpyridine are shown by pink triangles. The 
error bars indicate the error associated with kd calculated using the Jacknife method 
described in Chapter 6, Section 6.2.7.2 Associated errors in the calculation of kd. A 
table of the associated errors can be found in Appendix C. .................................... 223 
Figure 121 - Eyring polanyi plot for the SABRE-active species containing 4-
hydroxypyridine, isoniazid and 4-methylpyridine. .................................................. 225 
Figure 122 – Gibbs free energy as a function of substrate in the SABRE-active species.
 .................................................................................................................................. 226 
Figure 123 – Comparison of the OrthoH T1 values for 4-hydroxypyridine (purple) and 
isoniazid (blue). The T1 for the substrate without catalyst was measured using at 40 
mM in methanol-d4. The T1 in the presence of catalyst was measured using a sample 
containing [IrCl(COD)(SIMes)] (4 mM), substrate (40 mM) and p-H2 (4 bar) in 
methanol-d4. All measurements were taken at 298 K and 400 MHz. The error bars 
indicate the fitting error for the T1 curves shown in Appendix C. ........................... 228 
Figure 124 - hmqcgpqf pulse sequence ................................................................... 244 
Figure 125 - zgig pulse sequence ............................................................................. 244 
Table of Figures 
28 
 
Figure 126 - standard zg pulse sequence ................................................................. 245 
Figure 127 - selnogp pulse sequence ....................................................................... 245 
Figure 128 - selcogp pulse sequence ....................................................................... 246 
Figure 129 - ledbpgp2s pulse sequence ................................................................... 246 
Figure 130 - invrec pulse sequence ......................................................................... 247 
Figure 131 – Schematic diagram of the automated flow probe. 1) A sample of 
[Ir(H)2(SIMes)(sub)3]Cl in methanol-d4 is contained in a flow cell where pH2 (4 bar) is 
bubbled through the solution, 2) The hyperpolarised sample is transferred into the 
spectrometer via a nitrogen flow, 3) The hyperpolarised spectrum is acquired using 
the one-shot pulse sequence described in Figure 28, 4) The sample is transferred 
from the spectrometer back to the flow cell using a nitrogen flow. Image adapted 
with permissions R. E. Mewis, K. D. Atkinson, M. J. Cowley, S. B. Duckett, G. G. Green, 
R. A. Green, L. A. Highton, D. Kilgour, L. S. Lloyd, J. A. Lohman and D. C. Williamson, 
Magn. Reson. Chem., 2014, 52, 358-369.6 .............................................................. 249 
Figure 132 – The modified flow cell used to study the temperature dependence of 
SABRE ....................................................................................................................... 250 
Figure 133 - The two forms of the substituted pyridine in solution with methanol and 
hydrochloric acid (HCl) used to control the pH of the solution ............................... 254 
Figure 134 - Exchange species for substrate dissociation in 
[Ir(H)2(NHC)(substrate)3]Cl. The asterix, *, is used to denote the 1H resonance that is 
selectively excited. ................................................................................................... 257 
Figure 135 - Movement of excited signal from the bound substrate to the free 
substrate over time .................................................................................................. 259 
Figure 136 - Percentage signal intensity as a function of the delay time. The diamond 
and square markers are used to signify the experimental data set and the lines the 
simulation. Dark blue represents the bound substrate and the light blue signifies the 
free substrate. .......................................................................................................... 259 
Figure 137 - Table showing how the uncertainties are generated using the Jackknife 
method alongside the experimental data set. ........................................................ 260 
Figure 138 - Eyring plot where ln(2kd/T) is plotted as a function of 1/T. The data is 
fitted using a linear fit of the form y = mx + c. ........................................................ 262 
Table of Figures 
29 
 
Figure 139 - Summary output from the linear regression analysis from the Eyring plot 
shown in Figure 1. Red is used to indicate numbers relevant to the gradient and blue 
indicates those related to the intercept. In the equations, R = gas constant and T = 
temperature (K) ........................................................................................................ 263 
Figure 140 - The magnetisation (MXY) for a spin ½ nuclei as a function of time (τ) after 
exposure of the system to a magnetic field. M0 is the magnetisation at thermal 
equilibrium and T1 is the spin-lattice/longitudinal relaxation time. ........................ 265 
Figure 141 - Single-shot hyperpolarised T1 variable flip angle pulse sequence ...... 266 
Figure 142 - Signal intensity as a function of the gradient strength. The data has been 
plotted according to Equation 21. The delays used for δ and Δ have been indicated 
alongside the calculated diffusion coefficient (D) ................................................... 270 
Figure 143 - Ortho 1H resonance in 4-Chloropyridine ............................................. 273 
Figure 144 - Meta 1H resonance in 4-chloropyridine ............................................... 274 
Figure 145 - Ortho 1H resonance in 4-pyridinecarboxaldehyde .............................. 275 
Figure 146 - Meta 1H resonance in 4-pyridinecarboxaldehyde ............................... 276 
Figure 147 - Para 1H resonance in 4-pyridinecarboxaldehyde ................................ 277 
Figure 148 - Ortho 1H resonance in 4-methylpyridine ............................................. 278 
Figure 149 - Meta 1H resonance in 4-methylpyridine .............................................. 279 
Figure 150 - Para 1H resonance in 4-methylpyridine ............................................... 280 
Figure 151 - Ortho 1H resonance in 4-methoxypyridine .......................................... 281 
Figure 152 - Meta 1H resonance in 4-methoxypyridine ........................................... 282 
Figure 153 - Para 1H resonance in 4-methoxypyridine ............................................ 283 
Figure 154 – Oscillation frequency for 4-chloropyridine ......................................... 295 
Figure 155 - 4-methylpyridine .................................................................................. 296 
Figure 156 - 4-methoxypyridine ............................................................................... 297 
Figure 157 - 4-pyridinecarboxaldehyde ................................................................... 298 
Figure 158 - T1 for 4-chloropyridine ......................................................................... 299 
Figure 159 - T1 for 4-methylpyridine ........................................................................ 300 
Figure 160 - T1 for 4-methoxypyridine ..................................................................... 300 
Figure 161 - T1 for 4-pyridinecarboxaldehyde ......................................................... 301 
Figure 162 - 4-chloropyridine ................................................................................... 301 
Figure 163 - 4-methylpyridine .................................................................................. 302 
Table of Figures 
30 
 
Figure 164 - 4-pyridinecarboxaldehyde ................................................................... 302 
Figure 165 - 4-chloropyridine .................................................................................. 303 
Figure 166 - 4-methylpyridine ................................................................................. 303 
Figure 167 - 4-methoxypyridine .............................................................................. 304 
Figure 168 - 4-pyridinecarboxaldehyde ................................................................... 304 
Figure 169 - T1 for substrate 4-chloropyridine ........................................................ 309 
Figure 170 - T1 for substrate 4-methylpyridine ....................................................... 310 
Figure 171 - T1 for substrate 4-methoxypyridine .................................................... 310 
Figure 172 - T1 for substrate 4-pyridinecarboxaldehyde ......................................... 311 
Figure 173 - A single-shot pulse sequence for measuring the lifetime of 
hyperpolarisation ..................................................................................................... 312 
Figure 174 - Hyperpolarised T1 for substrate 4-chloropyridine ............................... 313 
Figure 175 - T1 for substrate 4-methylpyridine ....................................................... 313 
Figure 176 - T1 for substrate 4-methoxypyridine .................................................... 314 
Figure 177 - T1 for substrate 4-pyridinecarboxaldehyde ......................................... 314 
Figure 178 - orthoH enhancement factor for different substrate concentrations for 
the substrates in Chapter 4 ...................................................................................... 315 
Figure 179 - Free substrate ...................................................................................... 316 
Figure 180 - Trans to H- ............................................................................................ 317 
Figure 181 - Trans to NHC ........................................................................................ 318 
Figure 182 – SIMes ................................................................................................... 319 
Figure 183 - Free substrate ...................................................................................... 320 
Figure 184 - Trans to H- ............................................................................................ 321 
Figure 185 - Trans to NHC ........................................................................................ 322 
Figure 186 – SIMes ................................................................................................... 323 
Figure 187 - Free Substrate ...................................................................................... 324 
Figure 188 – SIMes ................................................................................................... 325 
Figure 189 - Free substrate ...................................................................................... 326 
Figure 190 - Nitrogen bound substrate ................................................................... 327 
Figure 191 - Oxygen bound substrate ...................................................................... 328 
Figure 192 – SIMes ................................................................................................... 329 
Figure 193 - Free substrate ...................................................................................... 330 
Table of Figures 
31 
 
Figure 194 - Chelate bound substrate...................................................................... 331 
Figure 195 - Pyridine bound substrate ..................................................................... 332 
Figure 196 - SIMes .................................................................................................... 333 
Figure 197 - dissociation constant (kd) ..................................................................... 333 
Figure 198 - dissociation constant (kd) and associated errors calculated using the 
Jackknife method for the substrates in Chapter 4 ................................................... 334 
Figure 199 - 4-hydroxypyridine ................................................................................ 334 
Figure 200 - isoniazid ............................................................................................... 335 
Figure 201 - 4-hydroxypyridine ................................................................................ 335 
Figure 202 - isoniazid ............................................................................................... 336 
Figure 203 - 4-hydroxypyridine (oxygen bound) ...................................................... 336 
Figure 204 - isoniazid (nitrogen bound) ................................................................... 337 
Figure 205 - 4-hydroxypyridine (nitrogen bound) ................................................... 337 







Firstly I would like to thank my supervisor Professor Simon Duckett for all his support 
and advice throughout my PhD. He encouraged me to publish a first author paper 
and had faith in me when I did not believe in myself. 
I would also like to thank the Duckett research group for their support, 
encouragement, help and advice throughout my research. I would particularly like to 
thank Peter Richardson, not only for helping me conduct many of my experiments 
whilst I was pregnant and unable to, but for keeping me sane and constantly making 
me laugh. I would like to thank my office mates (and friends!) Peter Rayner, Peter 
Richardson, Jenny, Olga, Liz, Barby, Kate and Rhianna for distracting me from writing 
with drinks, dinners, trips away and plenty of laughter! I’d like to thank Vicky and 
Richard for all their technical support and always answering my questions, no matter 
how stupid they may seem. Thank you also to Peter Rayner and Phil Norcott for the 
synthesis of the metal complexes and isotopically labelled substrates. 
Lastly and most importantly, I’d like to thank my family. Mum and dad thank you for 
your never-ending love, support and encouragement. Mum thank you for all the 
times you’ve taken James so that I can focus on writing and making sure I’m fed and 
taken care of. Dad thank you for always being on the other end of the phone with 
your advice and reassurance. Harry and Katie thank you for taking absolutely zero 
interest in my research and always making me laugh. I’d also like to thank my 
partner’s parents, Alan and Wendy for their support.  
My partner Sam, without you this thesis probably would have never made it onto 
paper. Thank you for your continuous encouragement to achieve my goals. Finally, 
my son James, thank you for keeping mummy laughing and smiling throughout this 
difficult time (especially writing during a worldwide pandemic and lockdown!). I hope 
that this shows you that even when everything is against you, you can make the 





I declare that this thesis is a presentation of original work and I am the sole author. 
This work has not previously been presented for an award at this, or any other, 






A.F Automated Flow System 





DNP Dynamic Nuclear Polarisation 
DOSY Diffusion-Ordered Spectroscopy 
EXSY Exchange Spectroscopy 
FID Free Induction Decay 
FTIR Fourier Transform InfraRed Spectroscopy 
ΔG≠ Gibbs free energy  
ΔH≠ Enthalpy 
H.M.A Handheld magnetic array 
HMQC Heteronuclear Multiple Quantum Coherence 





IMesCl 1,3-Bis(2,4,6-trimethylphenyl)-4,5-dichloroimidazol-2-ylidine  
ITBXy 1,3-Bis(4-tert-butyl-2,6-dimethylphenyl)imidazole-2-ylidine  
Ka Ionisation constant 
kd Dissociation rate constant 
LLS Long-lived states 
M.S Manual shaking method using the stray field of the spectrometer 
MRI Magnetic Resonance Imaging 
NMR Nuclear Magnetic Resonance 
o-H2 Orthohydrogen 
OP Optical Pumping 
PASADENA Parahydrogen And Synthesis Allows Dramatically Enhanced 
Nuclear Alignement  
p-H2 parahydrogen 
PHIP Parahydrogen Induced Polarisation 





SABRE Signal Amplification by Reversible Exchange 
SEOP Spin Exchange Optical Pumping 
SIMes 1,3-Bis(2,4,6-trimethylphenyl)-4,5-dihydroimidazol-2-ylidene 
TEP Toleman Electronic Parameter 
T1 Longitudinal Relaxation Time 






Chapter 1 Introduction 
1.1  Nuclear Magnetic Resonance            
 Nuclear Spin 
NMR is observed through the fundamental property of nuclear spin, which is defined 
by the quantum number, I. All elements possess this fundamental property but they 
can only be observed via NMR if I is larger than zero. If I is equal to zero, they are 
termed ‘NMR silent’ and cannot be probed by NMR. However, almost all of the 
elements in the periodic table have at least one isotope which is NMR active, but the 
most commonly exploited elements for NMR are: 1H, 13C, and 15N.  
Spinning nuclei possess angular momentum, P, and charge, Ω. The motion of this 
charge gives rise to an associated magnetic moment, μ. When these small magnetic 
moments are placed in an external magnetic field, they align themselves relative to 
the field in a discrete number of orientations.1 
For a spin of magnetic quantum number, I, there are 2I+1 possible spin states. For 
example, 1H has a spin quantum number, I = ½, therefore it has two possible 
orientations. These are, +½ (α) or −½ (β), where α is parallel to the magnetic field 
(B0) and β is antiparallel to B0. As B0 is a static field, it imposes a torque on the spinning 
nuclei meaning it traces a circular path about the applied magnetic field. This is called 
the Larmor precession and is depicted in Figure 1.2 The rate of this precession 
depends on the field strength and the gyromagnetic ratio (the ratio of the magnetic 
moment to the angular momentum).3, 4 
 




One description of nuclear magnetic resonance states that it is observed when the 
nucleus changes its spin state after irradiation via radio waves, the frequency of 
which must match that of the Larmor Precession (Equation 1). 




Equation 1, where h = Planck’s constant, ν = resonant frequency, γ = gyromagnetic ratio, B 0= field strength 
Equation 1 shows that the rate of precession is dependent on the field strength and 
the gyromagnetic ratio (constant relative to the nucleus of interest).  
Modern NMR methods utilise radiofrequency (rf) pulses to induce magnetisation 
differences between the energy levels. This rf pulse creates a weak oscillating 
magnetic field which is dependent on the magnetic field strength of the 
spectrometer and the resonant frequency of the nuclei under observation. The 
precession of the nuclear spins about B0 generates a voltage in the detection coil of 
the spectrometer. This precession occurs at the intrinsic Larmor frequency of the 
nuclei. A second, resonant RF pulse then flips the spins into the transverse (xy) plane, 
allowing detection by the spectrometer. Modern pulsed NMR methods have been 
well described in the literature.5   
1.2 The Sensitivity Problem 
The limiting factor of NMR is its inherent sensitivity. If we consider an assortment of 
similar spin ½ nuclei, in the absence of a magnetic field, the spin states are 
degenerate. However, once a magnetic field is applied, they may orient themselves 
along the field (α) or against the field (β) (where I = ½). The spins in the parallel state 
are lower in energy than those in the antiparallel orientation and therefore there is 





Figure 2 - The Boltzmann Distribution of Spins at Thermal Equilibrium Where ΔE = energy difference between 
the two states, γ = gyromagnetic ratio, h = Planck’s constant & B0 = magnetic field strength. 
The distribution of the spins amongst the α and β states is determined by the 






Equation 2 , where Nα = number of nuclei in the α state, Nβ = number of nuclei in the β state, ΔE = energy 
difference between the two states, kB = Boltzmann constant & T = temperature 
According to Equation 2, the population between the two states is miniscule, for 
example, only 1 in 31, 000 1H nuclei are detected in a 400 MHz spectrometer at 298 
K. Although this population difference can be extended by lowering the temperature 
or using a larger magnet, this only imposes minute differences. For instance, the 
world’s largest magnet in operation is 1020 MHz and was developed by JEOL 
Resonance in Japan.7 However, even at this high magnetic field only 1 in 15, 000 1H 
molecules are detected. It is for this reason that there is a requirement for techniques 




1.3  Hyperpolarisation 
The term ‘hyperpolarisation’ is used to describe any method which has been 
designed to enhance the sensitivity of the NMR experiment. There are 3 principal 
techniques which are employed for                                                                                                                                                                                                
this; Dynamic Nuclear Polarisation (DNP),8-10 Optical Pumping11-13 and Parahydrogen 
Induced Polarisation (PHIP).14-16 Although these techniques adopt different 
approaches they are based on the same principle; to increase the population of the 
α spin state by greatly increasing the energy difference between the spin states α 
and β.17, 18 
 
Figure 3 - The Boltzmann Distribution at Thermal Equilibrium vs Hyperpolarised. Adapted with permissions 
from L. Frydman, et al.19 
Increasing the sensitivity of the NMR experiment via hyperpolarisation is important 
because it allows for the detection of low concentration analytes in solution. 
Potentially, this could be used for the characterisation of mixtures, reaction 
intermediates or impurities that were not previously visible under thermal conditions 
(without hyperpolarisation).155, 156 
One of the most important applications of hyperpolarisation is its application to 
magnetic resonance imaging (MRI). MRI is a diagnostic tool used for the clinical 
diagnosis of disease by creating 3-dimensional images of anatomy and physiological 
processes within the body.20-22 In NMR, protons can be used to produce a spectrum 




the body. Generating these detailed images of the body can take a long time (15-90 
minutes is typical) which can be uncomfortable for the patient. Therefore coupling 
hyperpolarisation techniques with MRI could reduce patient scan times as detailed 
images could be generated in seconds rather than minutes or hours.23 Furthermore, 
hyperpolarisation methods could be used to highlight specific abnormalities to aid in 
the early diagnoses of disease (see section 1.3.2).24 There are three main 
hyperpolarisation techniques: spin exchange optical pumping (SEOP, often referred 
to as optical pumping, OP), dynamic nuclear polarisation (DNP) and parahydrogen 
induced polarisation (PHIP). SEOP and DNP utilise unpaired electrons for the 
hyperpolarisation of NMR-active nuclei, whereas PHIP employs the singlet state of 
hydrogen, parahydrogen. 
  Optical Pumping 
In 1966, Kastler was awarded the Noble Prize in physics for the development of 
optical pumping in alkali atoms.11, 25 This hyperpolarisation method uses light to 
excite electrons within a system which is then transferred to the nuclear spins of 
NMR-active nuclei of interest. Typically the NMR-active nuclei of interest are helium 
(3He) and xenon (129Xe) which have widespread applications in both NMR 
spectroscopy and MRI. Due to their chemical inertness, they are ideal probes for 
surfaces with porous structures and have been used clinically for the imaging of lungs 
and other organs in the human body.13, 26, 27 
To achieve non-Boltzmann nuclear spin polarisation, a vapour of alkali atoms is first 
irradiated with circularly polarised light. Rubidium (Rb) is commonly used as the alkali 
metal as the energy required for excitation (794.7 nm) can be generated by titanium 
sapphire lasers or high power diode lasers.26 The electronic ground state of Rb (52S½) 
and the corresponding excited state (52P½) are split into two spin states, one with 
spin up and the other spin down. Irradiation with circularly polarised light induces 
transitions from −½ ground spin state to the +½ excited spin state. Relaxation into 
either of the ground states occurs with equal probability due to collisional mixing in 




pumping, polarisation builds up in the +½ spin state (Figure 4c). When xenon (Xe) is 
introduced, collisions between Xe and Rb atoms lead to the formation of Van der 
Waals pairs. The lifetime of these pairs allows for spin exchange to occur via 
hyperfine interactions (Figure 4b).13 The pumping cell is held within a small magnetic 
field provided by either the fringe field of the superconducting magnet or using NMR 
coils. This exposes the degeneracy of the nuclear spin states of xenon, allowing for 
polarisation build-up. The magnetic field also prevents spin lattice relaxation of the 
polarised xenon gas. Chemically inert nitrogen (N2) is also introduced to the pumping 
cell to quench reabsorption of photons emitted in a radiative decay process.  
The polarised xenon gas nuclei exhibit much larger NMR signals compared to thermal 
Boltzmann conditions. Polarisation levels of >65% Xe has been observed using a high-
powered (210 Watt) laser diode array system.28 Whilst large polarisations are 
observed using this technique, it can only be applied to noble gases which limits its 
applications. 
 
Figure 4 - a) Experimental setup for SEOP experiments. Adapted with permissions from Raftery et al.29 b) 
Inside the pumping cell. Adapted with permissions from Walker et al.13 c) Electronic transitions that occur 
between the Rb and Xe atoms in the pumping cell. Adapted with permissions from T. Pietrass et al.26 
 Dynamic Nuclear Polarisation 
Similarly to optical pumping, dynamic nuclear polarisation (DNP) employs the high 
polarisation of electrons. In this technique the source of electrons are typically 
exogenous stable free radicals.30, 31 There are four mechanisms of polarisation 




effect,33, 34 the cross effect35, 36 and thermal mixing.9 The dominant mechanism is 
dictated by the number of unpaired electrons involved. The solid effect is typically 
observed for a single electron, the cross effect for paired electrons and thermal 
mixing for extended networks of electron spins.37  
The solid effect is a two spin process involving an electron spin (s) and a nuclear spin 
(l), as shown in Figure 5.38 Forbidden zero quantum and double quantum transitions 
become slightly allowed when they are driven by microwave irradiation. Positive 
enhancements are observed for zero quantum transitions and negative 
enhancements for double quantum transitions. 
 
Figure 5 - Mechanism for polarisation transfer via the Solid Effect in DNP. Adapted with permissions from A. 
B. Barnes et al.39 
The cross effect dominates when a biradical containing two coupled electrons also 
couple to a nuclear spin (Figure 6). Microwave irradiation then saturates transitions 





Figure 6 - Mechanism for polarisation transfer for the cross effect in DNP. Adapted with permissions from A. 
B. Barnes et al.39 
Thermal mixing is an extension of the cross effect where couplings among electrons 
induce manifolds of states (Figure 7).39 Overlap between these manifolds maximises 
electron nuclear transfer. This mechanism requires a high concentration of 





Figure 7 - Thermal Mixing mechanism for polarisation transfer in DNP. Adapted with permissions from A. B. 
Barnes et al.39 
DNP can be conducted in both solids and liquids, but to be effective it is necessary 
that the radical is homogeneously distributed within the sample.10 In liquid or 
dissolution DNP, nuclear polarisation is preserved during the transition from solid-
liquid state. First, the free stable radical and target molecule (typically 13C-enriched) 
is dissolved into a glass forming solvent (glycerol/glycol) and then placed into a high 
magnetic field. The compound is cryogenically cooled (<3 K) and then irradiated with 
microwaves.41 Addition of the glass forming agent prevents crystallisation and 




is rapidly warmed to room temperature before transfer into the NMR spectrometer 
for detection. This hyperpolarisation technique has yielded polarisation levels of 64 
%.42 Furthermore, performing DNP in this way enables real-time investigation of in-
vivo metabolism via MRI. The enhanced sensitivity provided by DNP means that the 
kinetics of conversion of metabolites into other cell metabolites can be integrated 
with traditional MRI methods. The most famous example of this is the use of 13C-
pyruvate which has been used to observe the evolution of tumour cells. However, 
the main drawback of this technique is that hyperpolarisation of the target molecule 
can take hours. Furthermore, once hyperpolarised, the target molecule can only be 
used once as the hyperpolarisation is limited by the substrates T1 which is typically 
on the order of a few seconds to minutes.42 
1.4 Parahydrogen Induced Polarisation  
Parahydrogen induced polarisation (PHIP), is a hyperpolarisation technique that 
employs parahydrogen (p-H2) for the enhanced detection of a target substrate. This 
is achieved using a metal catalyst which catalyses the incorporation of p-H2 into the 




Weitekamp and co-workers via para-hydrogenation of acrylonitrile to propionitrile 
using Wilkinson’s catalyst [RhCl(PPh3)3] (see Figure 8).43, 44  
 
Figure 8 - Hydrogenation of acrylonitrile to propionitrile using p-H2. a) 1H spectrum of acrylonitrile under 
Boltzman conditions b) 1H spectrum of para-hydrogenated propionitrile. The blue antiphase peaks are the p-
H2 derived protons in the product. Spectra a) and b) are reprinted with permissions from C. R. Bowers et al.44 
 Spin Isomers of Hydrogen 
PHIP utilises p-H2, the singlet state of hydrogen as the source of polarisation. 
Molecular hydrogen is comprised of two hydrogen atoms bound through a single, 
covalent bond. The nucleus of both these atoms possesses a spin, rendering it NMR 
active. There are four allowed spin configurations of hydrogen (Figure 9) which 





Figure 9 - The Four Spin States of Dihydrogen. 
The first three spin configurations are triply degenerate where the spins are aligned 
parallel (↑↑ or ↓↓) so that there is a net component of spin in either the z direction 
or the x-y plane.45 This triplet state is known as o-H2 and is symmetric with respect to 
the exchange of nuclei. The final configuration is recognised as p-H2 where the spins 
are antiparallel (↑↓) so that there is no net spin in either direction, it is also 
antisymmetric with respect to the exchange of nuclei.46 It is important to note that 
symmetric nuclear states (ortho) occupy odd rotational states and antisymmetric 
nuclear states (para) occupy even rotational states. It is for this reason that p-H2 is 
considered more stable as its lowest rotational state has J=0 compared to J=1 for o-
H2. This difference in energy leads to a Boltzmann distribution among the isomers, 
where p-H2 is favoured at low temperatures.  
 Generating Parahydrogen  
Interconversion between the ortho- and para- states of hydrogen is symmetry 




material. To produce p-H2 enriched gas, hydrogen is cooled in the presence of a silica 
or iron (II) chloride interconversion catalyst (Figure 10).46 Once the desired level of p-
H2 enrichment has been achieved, the gas is heated in the absence of catalyst for use 
at room temperature. This can then be stored at room temperature for long periods 
of time.47-49 
 
Figure 10 - Schematic of the p-H2 Generator. Adapted from S. B. Duckett et al.46 
The level of p-H2 enrichment depends on the conversion temperature (see Figure 11). 
For example, at room temperature, the populations of the ortho and para states is 
governed by Boltzmann statistics, such that 75 % is o-H2 and the remaining 25% is p-





Figure 11 - a) o-H2 enrichment as a function of temperature. Population of the ortho state has been 
quantified using the integral of the proton signal of hydrogen, b) p-H2 enrichment as a function of 
temperature. Figure has been adapted with permissions from P. M. Richardson et al.50 
 PASADENA & ALTADENA 
P-H2 is NMR silent, therefore, to unlock its latent polarisation, the symmetry must be 
broken. In PHIP this is achieved by transfer to an unsaturated substrate via 
hydrogenation. The hydrogenated product contains the p-H2 derived protons which 
occupy magnetically inequivalent sites. 
There are two main types of hydrogenative PHIP: PASADENA (parahydrogen and 
synthesis allow dramatically enhanced nuclear alignment) where the hydrogenation 
reaction and NMR detection occurs at high magnetic field (> 1 T) and ALTADENA 
(adiabatic longitudinal transport after dissociation engenders net alignment) where 
the hydrogenation reaction occurs at low magnetic field (< 10mT) and the 
hydrogenation product is transferred to high magnetic field for detection.51  
The magnetic field of hydrogenation is based on the homonuclear spin-spin or J-
coupling of the nascent p-H2 derived hydrogen atoms in the hydrogenated product.52 
In ALTADENA, the J-coupling is strong, however, in PASADNA, the J-coupling is weak. 
This means that the difference in chemical shift between the p-H2 derived protons is 
much larger than the corresponding J-coupling (in Hz). As the chemical shift depends 




realised. ALTADENA is typically associated with a faster rate of hydrogenation and a 
more reactive hydrogenation catalyst.53 
In an AX-spin system there are 4 spin states: αα, αβ, βα and ββ (see Figure 12). Under 
thermal conditions, microscopic differences between populations of these energy 
states arises from the Boltzmann factor (approx. 10-5) hence it appears that all four 
states are equally populated. This means that four transitions are possible. In 
PASADENA, only the αβ and βα states are populated, resulting in a larger population 
difference compared to the Boltzmann distribution. Again, four transitions are  
possible, however, 2 antiphase doublets are observed as either spin may undergo 
absorption or emission with equal probability. In ALTADENA, the spin system is 
generated at low field, therefore it becomes strongly coupled.14 Consequently, once 
the sample is measured at high field, either the αβ or βα states are populated. This 
means that only two transitions are possible, yielding two singlets in the 1H-NMR 
experiment. 
 
Figure 12 - The energy levels of an AX spin system, where the population of each spin state is represented by 
line thickness. The transitions between energy levels and the corresponding NMR signals are shown, for a 
negative value of JAX. 14 Figure adapted with permissions from J. Natterer et al.14  
PHIP can also be applied to heteronuclei whereby the polarisation is transferred from 
1H to the heteronuclei via an INEPT (insensitive nuclei enhancement by polarisation 





 Applications of PHIP 
PHIP hyperpolarisation typically involves the para-hydrogenation of an unsaturated 
molecule. This limits the application of PHIP to substrates that contain an 
unsaturated precursor as the hydrogenated product is hyperpolarised. In 2015, 
Cavallari et al.57 presented a modification of this hyperpolarisation method termed 
PHIP-SAH, where SAH = side arm hydrogenation. This technique has been used to 
hyperpolarise a number of carboxylic acids by functionalisation with an unsaturated 
alcohol (side arm) followed by hydrogenation of this moiety by p-H2. 
Hyperpolarisation transfer from the p-H2 spin order to the 13C carboxylate signal then 
ensues. The hydrogenated alcohol side arm can subsequently be removed by 
hydrolysis. PHIP-SAH has allowed the hyperpolarisation of a number of biologically 
relevant molecules, widening the applicability of PHIP. The most valuable application 
is the hyperpolarisation of [1-13C]-pyruvate, an unsaturated metabolite which thus 
far had only been successfully polarised via DNP. Hyperpolarised [1-13C]-pyruvate has 
been the subject of intense scrutiny as a potential imaging probe for the assessment 
of prostate cancer in humans.58 Furthermore, [1-13C]-pyruvate could be applied to in 
vivo studies of metabolism in diseases such as cancer, heart failure and stroke.59 
Whilst DNP is an effective hyperpolarisation method, achieving polarisation levels 
exceeding 64%, it is an expensive and time consuming process. Hyperpolarisation via 
PHIP-SAH is a cost-effective method which does not require any specialist 
equipment. Hyperpolarisation of [1-13C]-pyruvate via this technique has yielded 
polarisation levels of 5%, however this could be improved by optimisation of the 
para-hydrogenation reaction, polarisation transfer and p-H2 purity.60 Despite these 
advances in PHIP, the target molecule cannot be rehyperpolarised as 
hyperpolarisation requires hydrogenation. There is a non-hydrogenative form of 
PHIP, called signal amplification by reversible exchange (SABRE) that achieves 
hyperpolarisation of a target molecule without chemically changing it. This means 




1.5 Signal Amplification by Reversible Exchange 
SABRE is a non-hydrogenative form of PHIP where p-H2 enhances the NMR response 
of a substrate but is not chemically incorporated into the molecule.61-63  This 
phenomenon is observed when a metal catalyst reversibly binds both p-H2 and 
substrate molecules thereby facilitating polarisation transfer. SABRE was first 
reported in 2009 by Duckett et al.64 when pyridine was hyperpolarised using an 
iridium dihydride complex of the form [Ir(H)2(PCy3)(pyridine)3][BF4]. A 550-fold 
increase in signal was observed in the resulting 1H-NMR spectrum and enhanced 
signals were also observed using 13C and 15N-NMR methods (Figure 13). 
 
Figure 13 - a) Comparison of the thermal 1H-NMR spectrum (top) compared to the hyperpolarised 1H 
spectrum for a sample of 6 nmol pyridine. The top spectrum has been magnified 128 times so that the 1H 
resonances can be compared to the hyperpolarised spectrum. b) Hyperpolarised 1H decoupled 13C spectrum 
after refocusing for a 6 nmol sample of pyridine. c) Hyperpolarised 1H decoupled 15N spectrum with 
refocusing for a sample contains 25 nmol of 15N-labelled pyridine. Figure adapted with permissions from R. 
W. Adams et al.64 
 The SABRE Mechanism 
1.5.1.1 Chemical Process 
SABRE is a catalytic process whereby two hydrogen atoms, derived from p-H2,and the 
target molecule (substrate) are brought together through the temporary formation 
of a scalar coupled network which is facilitated by an inorganic catalyst.63, 65-68 SABRE 
catalysis requires the formation of a complex with two cis hydrides in the same plane 




derived hydride ligands to the substrate can occur.69 Dynamic exchange between the 
hydride ligands and free p-H2 and the substrate ligands with free substrate present 
then ensues. As the free substrate and free p-H2 are in excess in solution, these 
exchange processes allow for polarisation build-up in solution, yielding SABRE 
enhanced NMR spectra. This process is illustrated in Figure 13. 
 
Figure 14 - Schematic diagram of the SABRE process. The curved blue arrow indicates hydrogen exchange 
with the free p-H2 in the excess solution. The curved pink arrow indicates substrate exchange with the non-
polarised free substrate material. The blue/pink arrow indicates polarisation transfer from p-H2 to the 
substrate. In the 1H-NMR spectra shown, the black is the thermal, non-hyperpolarised spectrum which has 
been magnified 32 times and the pink spectrum is the hyperpolarised spectra. 
Typically, the SABRE precatalyst is a square planar iridium complex containing an N-
heterocyclic carbene (NHC), chloride and cyclooctadiene (COD) (see section 1.5.3 
Catalyst Design). Addition of the substrate displaces the chloride ligand to form a 16-
electron square planar species: [Ir(COD)(NHC)(substrate)]Cl (see Figure 15). Once this 
complex formation has been confirmed by NMR characterisation experiments, p-H2 
is added. Hydrogenation of the COD ligand to form cyclooctane then ensues.70 As the 
substrate and p-H2 are in excess, they promote formation of an 18-electron 
octahedral complex where the axial sites are normally occupied by the NHC ligand 
and a substrate ligand. The equatorial plane then contains two substrate ligands 





Figure 15 - Full SABRE mechanism illustrating formation of the SABRE species: [Ir(COD)(NHC)(sub)]Cl and 
[Ir(H)2(NHC)(sub)3]Cl 
1.5.1.2 Mechanism of Polarisation Transfer 
SABRE employs the singlet state of hydrogen, p-H2 for the enhanced detection of a 
target molecule.17, 52 The hydrogen atoms in p-H2 are  both chemically and 
magnetically equivalent and therefore they have no magnetic moment meaning it is 
NMR silent.44, 74 In order to make the magnetisation visible, the symmetry of the p-
H2 molecule must be broken. This can be realised by coupling  p-H2 to a 3rd nucleus 
which can result in two chemically equivalent but magnetically inequivalent 
protons.75 In SABRE this condition is achieved as the SABRE-active species, such as 
[Ir(H)2(NHC)(sub)3]Cl, consists of two hydride ligands bound trans to two substrate 
ligands within the equatorial plane and form a scalar coupling network (see Figure 
15). For polarisation transfer to occur from the p-H2 derived hydrides to the substrate 
nuclei of interest, the chemical shift difference between the hydrides and the 
substrate nuclei must equal the dominant J-coupling in the network.76 Typically this 
is the  hydride-hydride coupling which is of the order of 10 Hz.63 This resonance 
condition can be satisfied at low magnetic fields of ~65 G for the 1H hyperpolarisation 
of N-heterocycles such as pyridine.64 
The SABRE-active species shown in Figure 16 can be modelled as a 4 spin system 
where the p-H2 hydrides are represented by AA’ and the 1H nuclei of the substrate 
by BB’ (see Figure 16).77 In this network, the spins can couple to each other in 
different ways, giving rise to the couplings; JAA’, JBB’, JAB, JA’B’, JA’B and JAB’. As the 





Figure 16 - SABRE couplings according to an AA'BB' system 
Whilst there are a number of different methods for deriving the magnetic field at 
which polarisation transfer occurs, here the level-anticrossing (LAC) approach will be 
considered.77-79 In order to do this, we must also acknowledge the eigenstates of 
both pairs of protons: 
 |𝑇+1⟩ =  |𝛼𝛼⟩ 
|𝑇0⟩ =  
1
√2
|𝛼𝛽⟩ + |𝛽𝛼⟩ 
|𝑇−1⟩ =  |𝛽𝛽⟩ 
|𝑆⟩ =  
1
√2
|𝛼𝛽⟩ − |𝛽𝛼⟩ 
Equation 3 - The eigenstates of the AA' and BB' spin pairs 
When p-H2 is considered, only the AA’-singlet state is populated, which is NMR silent. 
This population must be transferred to the AA’-triplet state in order to observe NMR 
signal. Furthermore, if the couplings JAB and J’AB are identical, the p-H2 protons, AA’, 
remain magnetically equivalent and therefore transfer to the AA’-triplet cannot 
occur. If these couplings are different (JAB – J’AB ≠ 0), the AA’-singlet and AA’-triplet 
experience a level anticrossing where they approach each other but do not cross 





Figure 17 - Representation of the LAC approach to SABRE. Adapted with permissions from Buljubasich et al.75 
At specific magnetic fields (B0), different sets of these energy levels in the AA’BB’ 
system experience anticrossing which permits efficient polarisation transfer from the 
p-H2 (AA’) to the substrate protons of interest (BB’) (Equation 4).  
𝐵0(𝑇𝑟𝑎𝑛𝑠𝑓𝑒𝑟) =  
∆𝜈
𝛾𝐴(1 − 𝜎𝐴) − 𝛾𝐵(1 − 𝜎𝐵)
 
Equation 4 - Where Δν = the Larmor frequencies shown in Figure 17 for specific LAC interactions, γ = 
gyromagnetic ratio (MHzT-1) and σ = chemical shielding (δ = 106 x (σref – σsample)). 
Where polarisation transfer to 1H nuclei is targeted, the gyromagnetic ratios of A and 
B are equivalent (γ for 1H = 42.58 MHzT-1).4 Therefore, the matching condition is 
determined by the chemical shift difference between A and B. For N-heterocycles 
such as pyridine, this polarisation transfer field (B0(Transfer) or PTF) is satisfied at 
approximately 65 G (6.5 mT).75 
Whilst the proton is the most popular SABRE nuclei of interest, SABRE has 
successfully been used for the hyperpolarisation of 13C, 15N, 19F, 29Si, 31P and 129Sn.77, 
80-85 Hyperpolarisation of these nuclei can either proceed via indirect intramolecular 
transfer from hyperpolarised 1H resonances or via the direct polarisation of the 




The SABRE hyperpolarisation of 15N was first reported by Theis et al.77 15N magnetic 
resonance is predicted to be more useful for in vivo SABRE experiments due to the 
longer signal lifetimes, the lack of background signal and facile chemical shift 
discrimination.86 This contrasts to 1H nuclei which rapidly depolarises due to short 
signal lifetimes and must compete with the background signal within the body. 
Furthermore, even if high polarisation levels are observed in 1H nuclei, significant 
losses will be induced during preparation, in vivo administration, circulation and 
tissue penetration in SABRE-MRI.86 However, 15N nuclei are low in natural 
abundance, therefore this technique typically requires 15N isotopic enrichment of the 
target analyte which can be expensive. Furthermore, 15N nuclei have a lower 
gyromagnetic ratio compared to 1H (≈ 1:10) which results in low detection 
sensitivity.87  
The SABRE-SHEATH (SABRE in shield enables alignment transfer to heteronuclei) 
method, as it was later named, was utilised for the hyperpolarisation of 15N in 
pyridine. In order to transfer polarisation from the p-H2 derived hydrides to the 15N 
nucleus, a polarisation transfer field of 0.4 μT was required. This method induced a 
polarisation of 10%, corresponding to an enhancement of 30,000-fold at 9.4 T.17  
1.5.1.2.1 High Field SABRE 
SABRE enhancements depend on polarisation transfer from p-H2 to the substrate 
nuclei of interest. It has previously been discussed (section 1.5.1.2 Mechanism of 
Polarisation Transfer) that this occurs at low magnetic fields which satisfy the 
resonance condition for polarisation transfer (see above). For 1H nuclei, this method 
can be performed in a number of ways: either via manual shaking of the sample using 
the stray field of the NMR magnet, manual shaking using a handheld magnetic array 
or an automated flow system.76 These methods are described in more detail in 
Chapter 2. However, these approaches, which require the sample to be moved 
between low field and high field (where detection occurs) are problematic as the 




Theis et al.88 proposed the use of low power continuous wave (cw) pulses for 
coherent polarisation transfer from p-H2 to the substrate. This method can be used 
at any magnetic field provided the p-H2 are chemically equivalent but magnetically 
inequivalent. Furthermore, the cw-power must match the sum of the hydride-
hydride and 15N-15N coupling (γB1 = 2π(JHH ± JNN). This hyperpolarisation strategy is 
termed LIGHT-SABRE, where LIGHT = low-irradiation generation of high tesla-SABRE 
and can be performed on any modern high-resolution NMR spectrometer. 
Hyperpolarisation via this method yielded a 15N enhancement of 480-fold for a 2.5 
mM sample of pyridine in a single shot experiment.  
Pravdivtsev et al.89 demonstrated the use of RF fields for high field SABRE. They 
showed that the application of a RF field enables rapid transfer of the p-H2 spin order 
(within 1s), therefore removing the need for field cycling methods. For successful 
polarisation transfer, the amplitude and frequency of the RF field must be carefully 
set to enable modelling of low-field conditions at high magnetic field. However, lower 
enhancements were observed in this method compared to the magnetic field cycling 
approach. For example, a 1H enhancement of 100-fold was observed for a range of 
heterocyclic substrates at 4.7 T. 
ADAPT-SABRE, where ADAPT = alternating delays achieve polarisation transfer, is 
another high field SABRE method.90 This method has been used for the 
hyperpolarisation of other spin ½ heteronuclei such as 13C, 15N, 19F and 31P. SABRE 
hyperpolarisation of these nuclei is technically demanding as the optimal field for 
polarisation transfer is weaker than the Earth’s magnetic field. This method was 
exemplified using 15N nuclei and was shown to be faster and more robust than the 
magnetic field cycling approach. For example signals that were 3 orders of magnitude 
larger than the thermal signals were achieved for 15N within 2 seconds of RF pulsing. 
Polarisation transfer via ADAPT-SABRE is achieved by alternate pulse and delay on 
the 15N nuclei.  
There are a number of advantages of high-field SABRE over the magnetic field cycling 




hyperpolarisation with high efficiency.89 Furthermore, ADAPT-SABRE allows for 
constant field shuttling and is inherently simple as it can be easily augmented for the 
hyperpolarisation of spin ½ nuclei in any SABRE-active species.90 Moreover, LIGHT-
SABRE, RF-SABRE and ADAPT-SABRE all prevent unnecessary signal losses during 
transport as the sample is maintained within the spectrometer for the entirety of the 
experiment. However, these methods induce smaller enhancements compared to 
the magnetic field cycling approach. This indicates that magnetic field cycling induces 
efficient transfer of the spin order of p-H2 compared to high-field SABRE. Additionally, 
these high-field approaches are harder to transfer to in vivo SABRE-MRI applications.  
 SABRE Substrates of Interest 
1.5.2.1 Pyridine and its Derivatives 
The most commonly exploited substrates for SABRE are pyridine and its derivatives.72 
Pyridine is an example of a simple heterocycle analogous to benzene - a highly 
conjugated system with 6 π electrons delocalised across the ring.91 Pyridine is known 
to be more reactive than benzene towards nucleophiles and exhibits properties 
comparable to tertiary amines.92 This is due to the nitrogen atom containing a lone 
pair of electrons which occupy the same plane as the ring.93 It is this geometry which 
makes it easily accessible for donation to metals when forming metal complexes.  
In SABRE, the substrate is required to reversibly bind to the iridium catalyst. Pyridine 
is capable of ‘soft’ binding where it weakly coordinates to the metal centre.91 It is this 
mechanism of association/dissociation which allows for polarisation to be built up in 
the solution. The substrate must be bound to the catalyst long enough for sufficient 
magnetisation to be transferred from the p-H2 before dissociation, thus enabling a 
new substrate molecule to bind to the metal for polarisation. If the substrate does 
not bind for long enough, then insufficient polarisation can be transferred to the 
solution. However, if it binds for too long, then relaxation effects  takeover as 
coordination to iridium promotes relaxation.94 
In addition to the electronic considerations of using pyridine as a SABRE substrate, it 




rings are a motif used in common pharmaceuticals, ranging from anti-viral to anti-
cancer treaments.95 This is particularly important for the application of SABRE in 
clinical MRI, where pyridine-like molecules could be used as MRI contrast agents. For 
example, pyrimidine, an anti-cancer agent,96, 97 has previously been examined as a 
SABRE candidate, where total signal enhancements of −2300-fold were observed.84   
1.5.2.2 Biologically Relevant Substrates 
SABRE has also successfully been used for the hyperpolarisation of biologically 
relevant molecules including: nicotinic acid,  nicotinamide, vitamin B3, pyruvate and 
isoniazid.80, 98, 99 Pyruvate was also hyperpolarised using the SABRE-active complex 
[Ir(H)2(η2-pyruvate)(DMSO)(IMes)] where DMSO (dimethoxy sulfoxide) is used as a 
co-ligand to overcome poor pyruvate-iridium ligation. It was demonstrated that 
hyperpolarisation was possible in a 70:30 solvent mixture of D2O:ethanol-d6; which 
is more suitable for biological applications.100 Without optimisation of the SABRE 
system, 13C polarisation levels of 2% were observed.101, 102 Therefore modifying the 
catalyst, the co-ligand or increasing the p-H2 pressure could induce polarisation levels 
comparable to DNP methods which are currently used in the clinic for hyperpolarised 
MRI. 
1.5.2.3 Diazirines 
Diazirines have been proposed as an attractive class of potential molecular tags for 
molecular imaging by Shen et al.103 Diazirines can be incorporated into a variety of 
biologically relevant small molecules, metabolites and biomolecules. Furthermore, 
they are known to be both biocompatible and stable under acidic and basic 
conditions.104 15N2-labelled diazirines yielded 15N enhancements of 15,000-fold via 
the complex [Ir(H)2(IMes)(diazirine)2(Lewis Base)]Cl or [Ir(H)2(IMes)(diazirine)(Lewis 
Base)2]Cl. The Lewis base is required to generate the SABRE-active species for 
polarisation transfer as without it, hyperpolarisation is observed. Hyperpolarisation 
of 15N-diazirine-containing choline derivatives demonstrates potential application 




1.5.2.4 SABRE-RELAY via Proton Exchange 
In 2018, Iali et al.105, 106 reported the direct polarisation of amines via the SABRE-
active species [Ir(H)2(IMes)(RNH2)3]Cl which has previously been used to catalyse 
hydrogenation reactions. Hyperpolarisation of a number of primary amines was 
noted to induce the subsequent polarisation of residual water within the solvent. 
This process was termed SABRE-RELAY via proton exchange where the ammonia is 
utilised as the hyperpolarisation transfer agent. Hyperpolarisation is first transferred 
to ammonia (or another primary amine) via the SABRE catalyst 
[Ir(H)2(IMes)(RNH2)3]Cl. The hyperpolarised proton of the amine is then transferred 
to the analyte via proton exchange. This method has vastly expanded the substrate 
range amenable to SABRE, allowing the polarisation of amines, amides, carboxylic 
acids, alcohols, phosphates and carbonates. For example, direct polarisation of free 
amine yielded an enhancement of 10- to 120-fold per 1H resonance. This polarisation 
was then transferred to propanol where an enhancement between 250- and 500-
fold for the OH resonance was observed. Polarisation was then transferred into the 
aliphatic 1H resonances of propanol, inducing enhancements of 650- and 790-fold.
 
Figure 18 - Schematic Diagram of the SABRE-Relay Polarisation Process 
This method has also been used for the hyperpolarisation of glucose and fructose 
allowing the tautomeric composition of these to be determined.107 For example, a 
13C enhancement of 250-fold was yielded at 9.4 T for both glucose and fructose, 
corresponding to a polarisation of 0.02%. This allowed for the rapid quantification of 
the distribution between isomers, taking just 15 seconds. Quantification using 




 Catalyst Design 
1.5.3.1 Crabtrees Catalyst 
The polarisation transfer catalyst initially used for SABRE is derived from Crabtree’s 
catalyst, [Ir(COD)(PCy3)(py)]PF6 which is a well-known hydrogenation catalyst (Figure 
19).108-110 The SABRE-active complex of this, [Ir(H)2(PCy3)(pyridine)3]PF6, induced 
signal enhancements in excess of 100-fold in 1H, 13C and 15N NMR spectra.64 
Experimental studies have demonstrated that sterically bulky phosphine ligands such 
as PCy3, deliver the highest levels of hyperpolarisation.111 The SABRE-active complex 
[Ir(H)2(PCy3)(pyridine)3]BF4 induced signal enhancements of 110-fold in the 1H, 116-
fold in 13C and 128 in 15N hyperpolarised spectra of free pyridine.  
 
Figure 19 - Structure of the SABRE-Active Species formed from Crabtrees catalyst 
1.5.3.2 N-Heterocyclic Carbenes 
Evidence has suggested that N-heterocyclic carbene-metal catalysts surpass 
phosphine-based metal catalysts in both activity and scope.112 This is due to their 
higher electron donating power and steric bulk which offers lower stability to the 
complex but rapid formation and exchange.65 This is driven by donation from the 
nitrogen lone pairs into the formally empty p(π) orbital of the carbene atom.113 




atoms. Furthermore, related N-heterocyclic carbene complexes have been shown to 
be excellent catalysts for the hydrogenation of olefins.114  
N-heterocyclic carbenes were first reported in SABRE in 2011 by Cowley et al.73 
Where the square planar complex [IrCl(COD)(IMes)] was utilised as the SABRE pre-
catalyst for the enhancement of pyridine. Here, 1,3-bis(2,4,6-trimethyl-
phenyl)imidazole-2-yilidene (IMes) was employed as the NHC. The SABRE-active 
species [Ir(H)2(IMes)(py)3]Cl  (Figure 20) was confirmed by NMR spectroscopy and 
mass spectrometry methods. This catalyst delivered an 8100-fold increase in 1H-NMR 
signal strength relative to non-hyperpolarised pyridine at 127.74 MHz. Substitution 
at the nitrogen atoms in the carbenes and its effect on SABRE efficiency has been 
thoroughly explored by various groups. For example, the introduction of chloride to 
the imidazolium backbone in IMes yields a 78% increase in net polarisation of the 1H 
resonances in methyl 4,6-d2-nicotinate compared to IMes.  These substitution effects 
are discussed in more detail in Chapter 3 (section 3.7 Exploring the Effect of Catalyst 
Modifications on Iridium-Substrate Ligation). 65, 115-117 Whilst IMes and its derivatives 
are the most popular SABRE catalysts for the 1H, 13C and 15N hyperpolarisation of 
pyridine-based substrates, it struggles to catalyse the hyperpolarisation of ortho-
substituted pyridines or other bulkier substrates. Wong et al.118 illustrated the 
behaviour of asymmetric NHC-based catalysts and how these can be used to improve 
the SABRE efficiency of sterically encumbered substrate ligands. These asymmetric 
ligands contained 1 mesityl arm to maintain steric congestion, and a smaller 
substituent bound to the second imidazole nitrogen atom (Figure 20). Pyridine and 
3,4-lutidine were shown to have poor SABRE activity which was attributed to slow 
ligand loss due to reduced steric bulk at the NHC relative to IMes. Conversely, 3,5-
lutidine was shown to enhance under SABRE conditions where a 258-fold 1H 
enhancement was observed at the ortho resonance.  
Colell et al.119 have recently expanded on modifications of the catalyst ligand sphere 
for the hyperpolarisation of sterically demanding substrates such as provitamin B6 
and caffeine using the NHC ligand PHOX (2-(2-(diphenylphosphanyl)phenyl)-4,5-
dihydrooxazole) (Figure 20). This complex has previously been used for the 




1000-fold and 19F enhancements of 30-fold at 8.5 T in the biologically relevant 
molecules provitamin B6 and caffeine.   
 
Figure 20 - SABRE-active species containing IMes based NHC ligands 
1.5.3.3 Alternative Ligands 
In 2015, Holmes et al.120 discussed the use of a pincer-based catalyst for SABRE 
catalysis. Cyclometalated phosphine-based pincer complexes (Figure 21) had 
previously been shown to be efficient catalysts for dehydrogenation reactions and 
the reduction of carbon dioxide.121 They were also shown to have a unique set of 
properties capable of enhancing the reactivity, stability and reaction selectivity of the 
metal catalyst.122 They were shown to enable efficient polarisation transfer into a 
single substrate molecule as three of the iridium coordination sites are blocked by 
the pincer ligand. This pincer complex yielded a 1H enhancement of 12.3-fold at the 
ortho proton in pyridine. Interestingly, both the 1H nuclei in the pyridine within the 
pincer arm and the pyridine ligand hyperpolarised under SABRE conditions. Isotopic 
labelling of the protons (to 2H) in the pincer arm prevented polarisation wastage, 
increasing catalytic efficiency by 35%. However, this pincer complex yields smaller 
enhancements compared to IMes as polarisation is transferred to a single substrate 
molecule.  
Ruddlesden et al.123 have also controlled SABRE catalysis via a bidentate phenoxide 
derivative of the NHC IMes. They reported on the use of a pendant alkoxide ligand 
which binds to iridium via the carbon of the imidazole group and the oxygen of the 
phenoxide arm. This forms the SABRE active species [Ir(H)2(κ-C,O-IMesPhen)(sub)3] 




of this complex took five days, however it yielded SABRE enhancements of pyridine, 
quinoline and nicotine in non-polar solvents. For example, a 500-fold enhancement 
was observed for the ortho protons in pyridine. Whilst this complex allows the SABRE 
catalytic cycle to be controlled, the enhancements are far inferior to those 
demonstrated using IMes based catalysts.  
In 2016, Iali et al.124 reported a cyclooctene based iridium catalyst for the successful 
hyperpolarisation of pyridine, nicotinamide, nicotine, 5-aminopyrimidine and 3,5-
lutidine. The SABRE-active catalyst, [IrCl(H)2(COE)(sub)2] (Figure 21) was shown to be 
highly effective for hyperpolarisation in aprotic solvents. The COE ligand was proven 
to bind to iridium in an η2 fashion and is much simpler than NHC ligands and therefore 
easier to employ for SABRE catalysis. However, this complex rapidly undergoes C-H 
bond activation which has been shown to quench SABRE catalysis, thus preventing 
further hyperpolarisation.118 
 
Figure 21 – SABRE-Active species based on the pincer based catalyst,120 the phenolate-substituted NHC123 and 




 Biocompatibility of SABRE 
The majority of SABRE studies have been conducted in methanol-d4.125 However, this 
solvent is not biologically compatible and therefore alternative solvents are required 
for use in clinical MRI. Cyclotoxicity studies of the solvent composition demonstrated 
that the most biocompatible solvent mixture is a 30:70 ratio of ethanol-d6:D2O.126 
The main cause of SABRE toxicity arises from the iridium catalyst, as this was shown 
to be the dominant factor in cell death, even at low concentrations. Manoharan et 
al.100 demonstrated a biocompatible bolus of <2 ppm iridium catalyst content which 
is below the limit for intravenous administration. Therefore the concentrations 
typically used for SABRE experiments (≈ 5mM) are not suitable for clinical use.127, 128 
This can be negated by catalyst removal methods via catalyst deactivation,129 
removal by ion exchange chromatography126 or biphasic catalysis,98 catalyst capture 
using solid phase scavengers and filtration130 or heterogenous methods combined 
with filtration.131-133 
In 2015, Mewis et al.129 reported that the SABRE catalyst could be deactivated using 
2,2’-bipyridine (bpy). Addition of bpy to [Ir(H)2(IMes)(substrate)3]Cl lead to the partial 
displacement of the substrate, thus effectively quenching the active catalyst. A 
further benefit of bpy was that it extended the lifetime of the hyperpolarised signal 
such that the potential for SABRE in clinical MRI was increased. Removal of the SABRE 
catalyst using SiO2 microparticles functionalised with 3-mercaptopropyl or 2-
mercaptoethyl sulfide moieties has also been reported.134 This method was utilised 
alongside the 15N-SABRE hyperpolarisation of metronidazole. Addition of the 
functionalised SiO2 microparticles was shown to be successful as the catalyst could 
no longer hyperpolarise the 15N spins in the sample. High 15N signal enhancements 
of >100,000-fold at 9.4 T were recorded, corresponding to nuclear polarisation levels 
of 34%. 
Water soluble catalysts for SABRE polarisation have also been extensively  reported 
(Figure 22).116, 135, 136 Fekete et al.116 reported the synthesis of  




(ptppds), mono-meta-sulfonated triphenylphosphine (mtppms) or meta-tri-
sulfonated triphenylphosphine (mtppts). However these complexes yielded very low 
enhancements of 3-hydroxypyridine. A second class of these catalysts were 
suggested where the carbene was functionalised to include water-soluble azolium 
salts, however this also induced small signal enhancements. Shi et al.135 expanded on 
these water-soluble catalysts in 2016. They described two synthetic approaches 
using iridium-based catalysts for SABRE. The first utilised a novel catalyst where  
PEGylation was employed at the NHC ligand. This complex was shown to be soluble 
in water, however SABRE efficiency was 50% lower than in ethanol solutions. The 
second strategy employed a novel di-iridium complex precursor where the COD 
ligand was replaced by CODDA (1,2-dihydroxy-3,7-cyclooctadiene). This complex was 
dissolved and activated with p-H2 (1 atm) in water and yielded enhancements of 32-
fold for the 1H resonances of pyridine. Spannring et al.136 have also reported that 
changes at the NHC can lead to the observation of SABRE in D2O. They synthesised 
the SABRE precatalyst [IrCl(COD)(IDEG)], where IDEG=1,3-bis(3,4,5-
tris(diethyleneglycol)(benzyl)imidiazole-2-ylidene). Activation and hyperpolarisation 
was achieved in D2O and resulted in 1H signal enhancements of nicotinamide, 
pyridine, methylnicotinate and N-methylnicotinamide at 7 T. 15N enhancements of 
approximately 1000-fold at 7 T were also yielded for 15N-pyridine, however catalyst 






Figure 22 - Catalyst modifications for water soluble iridium SABRE catalysts 
The most promising advancement towards biocompatible SABRE is the investigation 
of biphasic solutions using CASH-SABRE, where CASH = catalyst separated 
hyperpolarisation.98 In this technique, chloroform-d and D2O were used as the 
solvent mixture which are immiscible. The catalyst was then dissolved in the organic 
phase (chloroform-d) along with the substrate. Shaking of the sample then ensued, 
causing emulsification of the two phases, phase separation then occurred over 60 s. 
The two phases were then analysed where the catalyst was found in the organic layer 
and the hyperpolarised substrate was found in the aqueous layer. 1H signal gains of 
up to 3000-fold were yielded per 1H resonance at 9.4 T for pyrazine, 5-methyl-
pyrimidine, 4,6-dimethyl nicotinamide and pyridazine.  
 Exchange in the SABRE-Active Species 
1.5.5.1 Exchange Pathways 
In SABRE, hyperpolarization is transferred from the p-H2 to the bound substrate 
through the temporary formation of a scalar, J-coupled network, facilitated by the 
iridium centre.64 As the ligation between the iridium and the nitrogen substrate is 
labile, the bound substrate can exchange with the ‘free’ excess substrate in 
solution.138 Hydrogen exchange between the bound p-H2 derived hydrides and p-H2 




optimal, it is essential that these two exchange process allow for sufficient 
polarisation to be transferred before dissociation occurs. Furthermore, higher 
substrate exchange rates only result in larger signal enhancements if the polarisation 
transfer process is fast enough. Contrastingly, if the exchange rate is too slow, 
insufficient polarisation can be built-up in solution and decay occurs due to relaxation 
processes.115 
SABRE exchange pathways have been extensively scrutinised as these processes are 
critical to the level of SABRE enhancement achieved. In 2011, Cowley et al.73 used 
DFT calculations alongside experimental calculations of ligand and hydride exchange 
pathways via exchange spectroscopy (EXSY). These experiments revealed that 
substrate loss via the ligand bound trans to the NHC (IMes) did not occur on the 
timescale of the NMR experiment. Therefore ligand exchange is driven by the 
substrate bound trans to the hydride. Using the Eyring-Polanyi equation, they 
established that substrate exchange is a dissociative process (SN1 reaction). This was 
indicated by a positive value of entropy (ΔS≠) and supported by the fact that 
increasing substrate concentration did not significantly alter the observed exchange 
rate. Conversely it was found that H2 exchange was dependent on the concentrations 
of both p-H2 and the substrate. For example, H2 exchange was directly proportional 
to H2 concentration but inversely proportional to substrate concentration.70 
Consequently, H2 exchange was shown to be an associative process (SN2 reaction). 
These findings were confirmed by Lloyd et al.65 and Barskiy et al.79 The former 
established that substrate loss proceeds via formation of the 16 electron species 
[Ir(H)2(NHC)(sub)2]Cl. However formation of this intermediate also provides a route 
for the solvent to bind to iridium via [Ir(H)2(NHC)(MeOH)(sub)2]Cl (Figure 23). 
Although this complex is highly reactive, it is present in low concentrations and 
therefore plays a minimal role in SABRE. Formation of this species was confirmed by 
the 1H resonances for the hydrides which were observed at −23.44 ppm and −25.49 
ppm. The former is known to bind to iridium trans to the nitrogen bound substrate 
and the latter was found to lie trans to the oxygen bound methanol. The formation 
of this complex also provides a route to H/D exchange leading to the formation of 




that both substrate and hydrogen exchange require formation of the intermediate 
[Ir(H)2(NHC)(sub)2]Cl.  
As substrate loss leads to the build-up of the hyperpolarised substrate in solution, 
there must be an optimal rate constant that allows for sufficient polarisation to be 
transferred prior to substrate dissociation. Barskiy et al.79 used computational 
methods to calculate that the optimum rate constant for substrate dissociation is 4.5 
s-1 for pyridine-based substrates. This value was also supported by Rayner et al.117 
where the largest SABRE enhancements were observed for catalysts where the ligand 
loss rate was 4 s-1. 
 
Figure 23 - Ligand Exchange pathways. a) Illustrated the dissociative substrate exchange pathway, b) shows 
the associative H2 exchange pathway. Image adapted with permissions from D. A. Barskiy et al.139 The 
methanol adduct was adapted with permissions from L. S. Lloyd et al.65 
The rate of substrate and hydrogen dissociation determines the level of 
hyperpolarisation that is built up into the excess solution. The rate of relaxation 
determines how long the substrate remains hyperpolarised. 
 Relaxation Effects in the SABRE-Active Species 
Relaxation quantifies the mechanisms that allow nuclear spins to lose energy and 
drop from the excited state to the ground state non-radiatively.140 Two forms of 
relaxation exist; spin-lattice relaxation and spin-spin relaxation. In spin-lattice 
relaxation, the spins of a nucleus are permitted to flip between the energy levels, 
thus establishing the Boltzmann population difference essential to the NMR 
experiment. As the nuclei return to the equilibrium state, the energy released is 




is necessary to understanding how molecules behave in NMR and is characterised by 
a time, T1 (spin-lattice relaxation time).  
There are several different relaxation mechanisms, however for spin 
1
2
 nuclei the 
most dominant mechanism arises from dipole-dipole interactions. Nuclei with low 
gyromagnetic ratios, such as 13C and 15N have longer relaxation times compared to 
1H, particularly if the heteronuclei is not attached to a proton.141 For example, 
relaxation decay constants of up to 20 minutes have been observed for 13N nuclei in 
diazirines.142, 143 Whilst the lifetime of the proton permits the imaging of some 
metabolic processes, it is vastly shorter than those associated with other molecular 
imaging modalities, for example, the 18F positron emission tomography (PET) signal 
decays in ≈ 2 hours.144 In MRI, T1 weighted images are used for imaging the brain as 
the T1 between grey and white matter is significantly different.145 
It has been discussed that SABRE can be utilised to enhance the detection of a target 
nuclei within a substrate. The SABRE phenomenon is observed via an iridium catalyst 
that facilitates polarisation transfer from the p-H2 derived hydrides to the substrate 
nuclei of interest. The formation of this SABRE-active species is temporary as the 
substrate and hydride ligands undergo exchange processes. Signal enhancements are 
then observed via the build-up of the hyperpolarised substrate in the excess solution. 
Whilst the catalyst provides a route to polarisation build-up, it also provides a route 
to polarisation depletion via relaxation mechanisms.81  
The SABRE-active species [Ir(H)2(NHC)(sub)3]Cl acts as a polarisation transfer catalyst 
by redistributing the magnetisation at a molecular level. Therefore it was predicted 
that the equilibrium process of hyperpolarisation operates in both directions and 
therefore could provide a route to enhanced rate of signal relaxation. This was 
proved using experimental methods by Lloyd et al.65 in 2014. The 1H substrate T1 
values were determined in the presence of catalyst and with and without the 
presence of H2 gas. It was established that the free substrate T1 was significantly 
affected by the presence of [Ir(COD)(NHC)(sub)]Cl and [Ir(H)2(NHC)(sub)3]Cl. This 
dramatic increase in T1 efficiency was attributed to the formation of these catalysts 




catalyst in solution reduces the steady-state level of hyperpolarisation as it takes 
several seconds for the sample to move from the position where polarisation transfer 
occurs (eg. outside the NMR magnet) to the final position where high field 
measurement occurs. 
It was proposed that the effect of the catalyst on the substrate T1 could be mitigated 
by deuteration of the NHC ligand and the substrate, thus increasing bound T1 times 
such that higher free substrate T1 values could be achieved.69, 80, 146-148 For example, 
deuteration of IMes to form the isotopologue d22-IMes was shown to increase the T1 
by 21% for each proton in the substrate methyl-4,6-d2-nicotnate.80  
 
Figure 24 - a) Plot of the T1 value at the H-5 resonance of methyl nicotinate and 2 of its deuterated analogues. 
The graph compares the T1 in the absence of the catalyst and in the presence of IMes. b) Plot of the T1 value 
at the H-5 resonance of methyl-4,6-d2-nicotinate as a function of the catalyst IMes and corresponding 
deuterated analogues for the free substrate, the equatorially bound substrate (trans to hydride) and the 
axially bound substrate (trans to the NHC). Image created using data from P. J. Rayner et al.80 
Figure 24 a) clearly illustrates the T1 effect induced by the catalyst as the T1 in the 
absence is much larger compared to when the catalyst is added. Figure 24 b) 
highlights the positive influence of deuteration of the catalyst on the substrate T1. 
For example, the d22-IMes isotopologue extended the T1 of the H-5 resonance in 
methyl-4,6-d2-nicotinate for the free substrate. Furthermore, graph b) also 




the presence of the catalyst. For example, the bound substrate T1 values are 
substantially lower than the free substrate T1. 
Other methods to reduce the T1 effect of the catalyst include quenching of the 
catalyst by addition of a chelate, or the conversion of SABRE-derived 
hyperpolarisation into long lived states.143, 149-151 
 Long Lived States 
The lifetime of the hyperpolarised substrate is typically on the order of seconds, 
however for advancement of SABRE towards integration with MRI, hyperpolarisation 
must survive transfer to a diagnostically relevant region of the body.151 This means 
that the hyperpolarisation lifetime must be on the order of minutes to be considered 
suitable for in vivo MRI. Selective deuteration at the carbene ligand and the substrate 
has been shown to extend hyperpolarisation lifetimes. For example, selective 
deuteration of nicotinamide was shown to induce a 75% increase in the substrate T1 
to 25.1 s.80 Whilst the T1 is significantly improved, it is not sufficiently long enough 
for integration with MRI. A second technique for extending the lifetime of 
hyperpolarised substrates via SABRE, is the use of long-lived states (LLS) which have 
been suggested as potential clinical imaging probes.152 Such states were first 
reported in 2004 by Levitt et al.153 who demonstrated that non-magnetic singlet 
states between two spin ½ nuclei that are magnetically inequivalent have lifetimes 
much longer than T1. LLS have been prepared under PHIP and applied to 15N SABRE 
hyperpolarisation via SABRE-SHEATH.143, 154  
For 1H LLS to be created, the substrate must contain a coupled 1H pair that resonate 
at a similar frequency but are magnetically inequivalent. This has been illustrated by 
Roy et al.151 using the substrate pyridazine. Pyridazine contains 4 protons in 2 proton 
resonance environments (Figure 25). The protons H-4 and H-5 are magnetically 
equivalent and therefore to create the LLS, the symmetry between these two protons 
must be broken. This was achieved by modifications at the α-proton sites shown in 
Figure 25. The most successful of these modifications was structure 3, where one α-




gave an LLS of 255 s. The storage of the created LLS was then explored, where the 
sample was either retained in the NMR spectrometer without intervention, kept in 
the spectrometer with a spin-lock applied or removed from the magnet and placed 
in a 10 mT field. The most effective storage strategy was the latter example which 
allowed for the successful detection of magnetisation 15 minutes post-creation. 
Thus, this technique provides a suitable route for SABRE integration with in vivo MRI 
methods.  
 
Figure 25 - Pyridazine (a) and associated derivatives and isotopalogues (b-c). Figure adapted with permissions 
from S. S. Roy et al.151 
1.6 Thesis Aims 
NMR is inherently insensitive. This is due to the small population difference between 
states as defined by the Boltzmann distribution that NMR probes. This population 
difference can be enhanced by hyperpolarisation methods such as: optical pumping 
(OP), dynamic nuclear polarisation (DNP), hydrogenative parahydrogen induced 
polarisation (PHIP) and non-hydrogenative PHIP (SABRE). Hyperpolarisation 
techniques have allowed for the detection of low concentration analytes in solution 




intermediates or impurities that are not visible under thermal conditions.155, 156 
Applying hyperpolarisation techniques to MRI is critical for the reduction in patient 
scan times,23 to highlight specific abnormalities to aid in the early diagnosis of 
disease, or for the observation of disease metabolites.24 DNP has already been 
coupled with MRI to aid in the clinical diagnosis of prostate cancer via the 
hyperpolarisation of [1-13C]-pyruvate. Despite yielding large polarisation levels of 64 
%,42 this technique requires costly equipment which also demands specialist training. 
Furthermore hyperpolarisation of the target molecule can take hours and once 
hyperpolarised can only be used once. SABRE provides a quick and cheap alternative 
to DNP. It also has the ability to re-hyperpolarise a substrate without chemically 
modifying it.61 Additionally, it has been used to hyperpolarise a number of 
heteronuclei including: 1H, 13C, 15N, 19F, 29Si, 31P and 129Sn.77, 80-85  
SABRE employs an iridium catalyst and p-H2 for the hyperpolarisation of a target 
molecule (substrate). Large signal enhancements are observed whereby the latent 
polarisation of p-H2 is transferred into the substrate nuclei of interest. Polarisation 
transfer occurs via the J-coupled network which is facilitated by the iridium catalyst 
which holds the p-H2 derived hydrides in the same plane as the substrate. Substrate 
and p-H2 exchange then occurs with the excess substrate and p-H2 allowing for 
hyperpolarisation to be refreshed and then built up into the surrounding solution.  
The research detailed in this thesis focuses on the role of the substrate in the SABRE 
hyperpolarisation method and is aimed at advancing catalytic efficiency and 
understanding of the hyperpolarisation process. This was achieved by the completion 
of the following objectives: 
1. Hyperpolarisation of a series of para-substituted pyridine derivatives 
using the SABRE pre-catalyst [IrCl(COD)(SIMes)]Cl. 
2. Complete characterisation of the SABRE species 
[Ir(COD)(SIMes)(substrate)]Cl and [Ir(H)2(SIMes)(substrate)3]Cl where the 
latter is the SABRE-active catalyst. This included the characterisation of 






3. Analysis of the exchange pathways in the SABRE-active species and 
optimisation of these parameters to improve catalytic efficiency in the 
hyperpolarisation process. Furthermore, to use this information to 
understand the consequences of the strength of the substrate-iridium 
ligation on SABRE performance. 
4. Investigation of the relaxation methods and their impact on SABRE 
efficiency. Moreover, how the strength of the substrate-iridium ligation 
effects substrate relaxation.  
A number of para-substituted pyridine derivatives were selected in order to assess 
ligation effects to the iridium catalyst. The pKa of these substrates was measured and 
it was assumed that increasing the basicity at the pyridine nitrogen would increase 
the strength of the pyridine-iridium association. This would be assessed using rates 
of exchange and the rate of relaxation. Furthermore, to improve catalytic efficiency 
within the SABRE process by optimising these parameters. Full characterisation of 
each of the SABRE-active species has also allowed the identification of novel species. 
A summary of the research conducted in the Chapters 2,3 and 4 is provided in 
Chapter 5 including the scope for further study. 
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Chapter 2 Comparison of Experimental Methods for 
SABRE Hyperpolarisation 
SABRE experiments can be performed using three different methods: manual shaking 
(using the stray field of the spectrometer), the automated flow system and manual 
shaking using a handheld magnetic array. In this chapter, these methods will be 
compared and contrasted according to the magnitude of signal enhancement and 
reproducibility of the method. This was achieved by varying the p-H2 dissolution time 
across these three methods and calculating the respective 1H signal enhancements. 
It was established that none of these methods can generate both reproducible and 
large signal enhancements; signal enhancements are either large with high error (not 
very reproducible) or low enhancements that are highly reproducible. The impact 
and the importance of this trade-off between the magnitude of the signal 
enhancement and the reproducibility is also considered.  
2.1 Observation of the Chemical Process of SABRE via NMR 
SABRE is a hyperpolarisation technique which employs p-H2 and an iridium catalyst 
for the enhanced detection of a target molecule (substrate). The SABRE-active 
species is usually an octahedral complex of the form [Ir(H)2(NHC)(sub)3]Cl, where the 
axial positions are occupied by an N-heterocycle  (NHC) and a substrate ligand.1-3 The 
other two substrate molecules lie in the equatorial plane with the p-H2 derived 
hydrides in a cis configuration (Figure 26). As the substrate and the hydrides are held 
within the same plane, the non-equilibrium spin order of hydrogen can be 
transferred to the substrate, as described in the introduction.4 




Figure 26 - The SABRE active species [Ir(H)2(SIMes)(sub)3]Cl 
The hyperpolarised response of the species in Figure 26 can be detected using three 
different methods; manual shaking using the stray field of the spectrometer,1 manual 
shaking using a handheld magnetic array5 or an automated flow system.6 Each of 
these will be discussed in more detail in this chapter. Formation of the SABRE active 
catalyst of type [Ir(H)2(SIMes)(sub)3]Cl begins with the reaction of the precatalyst 
[IrCl((COD)(SIMes)] with the substrate in a methanol solution under a pressure of 
hydrogen. Practically, this typically involves the preparation of a 5 mM solution of 
[IrCl(COD)(SIMes)] in methanol (0.6 mL). To this, the target substrate (50 mM) is 
added. This addition causes the displacement of the chloride ligand and forms 
[Ir(COD)(SIMes)(sub]Cl. The sample is then degassed to ensure complete removal of 
any oxygen in the sample. This step is critical as oxygen is paramagnetic, therefore it 
can catalyse the interconversion of p-H2 back to thermal equilibrium, significantly 
reducing, if not preventing substrate polarisation.7 The presence of oxygen may also 
decrease the relaxation time (T1) of the substrate and promote degradation of the 
SABRE-active species which is air-sensitive. P-H2 (4 bar) is then added, causing the 
solution to become colourless, suggesting formation of the SABRE-active species 
[Ir(H)2(SIMes)(sub)3]Cl, which can be characterised  via different analytical methods 
including  NMR, mass spectrometry and infrared spectroscopy.1 Usually, this is 
indicated by the disappearance of all COD related peaks and the appearance of a 
single hydride peak at approximately −23 ppm (see Figure 27 for more details). 
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Figure 27 compares the 1H-NMR spectra for the SABRE precatalyst [Ir(COD)(SIMes)(4-
methylpyridine)]Cl (bottom) and the SABRE-active catalyst [Ir(H)2(SIMes)(4-
methylpyridine)3]Cl (top) which is formed upon addition of p-H2 to the precatalyst. 
Firstly it is noted that the resonances for the CH in COD highlighted in green at 4.07 
and 3.21 ppm in the bottom spectra are shown to disappear  alongside the CH2 
resonances at 1.91 and 1.62 ppm when [Ir(COD()(SIMes)(sub)]Cl is consumed. 
Secondly, additional substrate peaks are observed in the spectra for 
[Ir(H)2(SIMes)(sub)3]Cl (top). These are shown in pink at 8.12, 7.80, 6.96 and 6.81 ppm  
indicating the presence of the octahedral complex containing two different substrate 
environments. One of these contains two substrate ligands trans to the hydrides and 
the other one substrate ligand trans to the NHC in a 2:1 ratio. Finally, the hydride 
resonance is highlighted in blue at -22.4 ppm. The formation of the SABRE active 
species is described in more detail in the introductory chapter.  
SABRE experiments are performed using a standard approach one-shot (1 scan) 
proton experiment with a 90° pulse, recycling delay (d1) value of 1 μs and a receiver 
gain (RG) of 1 (see Figure 28).1 The lifetime of the hyperpolarised signal is dictated by 
the T1 value of the substrate as relaxation destroys hyperpolarisation.8 The T1 at the 
ortho proton for the substrate used in this chapter (4-methylpyridine) is 6.50 s.  
Therefore, a short recycling delay (d1) value ensures a minimal amount of 
hyperpolarisation is lost before acquisition. The hyperpolarised signal is significantly 
larger than the non-hyperpolarised (thermal) spectrum and therefore a short RG 
value is used to prevent clipping of the NMR signal.  
 
Figure 28 - Standard 1H 90° pulse used for SABRE experiments 
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It is also important to acquire a spectrum under thermal polarisation (i.e. no p-H2) to 
compare to the hyperpolarised spectrum and calculate the signal gain. This ‘thermal’ 
spectrum is usually acquired under exactly the same conditions and includes the 
same sample used for the hyperpolarised measurements. It is essential that the same 
conditions are applied for the thermal spectrum so that the two spectra are directly 
comparable. For example if different samples were used then there may be minute 
differences in substrate concentration meaning that the calculated signal 
enhancement is unreliable. An example of a thermal and hyperpolarised spectrum is 
depicted below in Figure 29 for the SABRE-active species, [Ir(H)2(SIMes)(sub)3]Cl 
containing the substrate 4-methylpyridine. The thermal spectrum is shown in black 
and has been magnified 32 times so that it can be seen on the same scale as the 
hyperpolarised spectrum shown in pink. The 1H resonances for the three different 
proton environments (ortho, meta and para) on the substrate have been highlighted 
on the spectrum. The largest level of hyperpolarisation is observed in the ortho 
proton resonance, followed by the meta proton resonance and finally the para 
proton resonance. The ortho signal enhancement is larger than the meta and the 
para resonances because it is situated closer to the hydrides from which polarisation 
is transferred within the active complex and therefore exhibits the largest 
propagating spin-spin coupling.9 The signal enhancement (ε) is calculated by dividing 
the integrals of the thermal equilibrated spectrum by the integrals of the 
hyperpolarised spectrum (Figure 29).1 The example shown in Figure 29 corresponds 
to a signal enhancement of −600-fold at the ortho proton, although signal 
enhancements of >10,000-fold have been observed using this method.10 This signal 
enhancement can then be converted to percentage polarisation (% P) using Equation 
5 where, ε is the signal enhancement, γ is the gyromagnetic ratio in rads-1T-1, B0 is the 
field strength in T, ℏ is the reduced Planck’s constant in Js, kB is the Boltzmann 
constant in m2kgs-2K-1 and T is the temperature in K.  
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The ortho proton enhancement in Figure 29 is equivalent to a percentage 
polarisation of 1.93%. 
 
Figure 29 -  1H NMR spectra collected for the SABRE active species [Ir(H)2(SIMes)(sub)3]Cl under thermal 
conditions (no pH2, black spectra) compared to hyperpolarised spectra (pink) in the presence of pH2 (4 bar). 
The thermal spectrum (black) has been magnified 32 times so that it can be visually compared to the 
hyperpolarised spectrum. 1H NMR spectra was measured on a 400 MHz spectrometer at 298 K using the one-
shot pulse sequence depicted in Figure 28 and a sample containing the SABRE precatalyst [IrCl(COD)(SIMes)] 
(5 mM), methanol-d4 (0.6 mL) and the substrate 4-methylpyridine (50 mM) under 4 bar of pH2. The 
hyperpolarised spectrum was collected using the manual shaking method. The sample was then left in the 
spectrometer for 10 minutes after hyperpolarisation before the thermal spectra was acquired. The equations 
for calculation of enhancement and percentage hyperpolarisation are also included.   
 Field for Polarisation Transfer in the SABRE Hyperpolarisation 
Process 
SABRE employs p-H2 for the enhanced detection of a target molecule or substrate. 
The latent polarisation is then unlocked by coupling the p-H2 to a 3rd nucleus. This 
breaks the symmetry of the p-H2 molecule allowing the polarisation to flow to the 
substrate nuclei of interest via the J-coupling of the catalyst. However, for optimum 
polarisation transfer the chemical shift difference between the hydrides and the 
substrate nuclei must equal the dominant J-coupling in the network. In the SABRE 
catalysis that serves as the basis of this thesis ([Ir(H)2(SIMes)(substrate)3]Cl) this is 
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the hydride-hydride coupling. This resonance condition is satisfied at low magnetic 
field of approximately 65 G for the 1H hyperpolarisation of substrate such as pyridine. 
More detail of this process can be found in Chapter 1, Section 1.5.1.2 Mechanism of 
Polarisation Transfer.  
To demonstrate the effect of polarisation transfer field on SABRE efficiency, an 
example of a PTF plot is shown in Figure 30. At 0 G the signal enhancement was −15-
fold, this rose to −247-fold at 70 G before decreasing at higher magnetic fields. 
Therefore polarisation transfer is most efficient at 70 G for 4-methylpyridine, which 
is the substrate used for all the experiments throughout this chapter. 
 
Figure 30 – a) series of hyperpolarised 1H NMR spectra as a function of field strength in the SABRE active 
species [Ir(H)2(SIMes)(sub)3]Cl where the resonances at the ortho proton are shown in pink and the meta 
resonances are shown in black. The hyperpolarised 1H NMR spectra was collected using the automated flow 
system using the pulse sequence shown in Figure 28 where the field strength was varied over 0-130 G in 10 G 
increments. This was measured on a 400 MHz spectrometer at 298 K using a sample of [IrCl(COD)(SIMes)] (5 
mM), 4-methylpyridine (50 mM), methanol-d4 (0.6 mL) under a pH2 atmosphere of 4 bar. b) The signal 
enhancement calculated at the ortho proton in the free substrate plotted as a function of polarisation 
transfer field (PTF) 
There are three main methods for performing SABRE. The first is a manual shaking 
approach which uses the stray field of the superconducting magnet to provide the 
polarisation transfer field (PTF) necessary for SABRE to occur. The second employs a 
handheld shaker consisting of a Halbach array of solid-state magnets providing the 
required PTF.5 The final method is a fully automated flow system where the 
polarisation transfer field is provided by a chamber containing a copper coil which 
can generate controlled magnetic environments between −150 G and 150 G.6 The 
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flow and the shaker methods both afford homogenous magnetic fields essential for 
polarisation transfer. However, as the shake and drop approach relies on the stray 
field of the magnet, the polarisation transfer step may not occur at the optimum  field 
for polarisation transfer.  
2.2 The  Manual Shaking Method 
When SABRE was first published in 2009,3 the phenomenon was observed through 
what was termed the ‘shake and drop’ approach. This is a manual technique whereby 
the SABRE sample is shaken vigorously within the stray field of the magnet (at 
approximately 65 G for 1H) before being dropped into the spectrometer for 
subsequent acquisition (Figure 31). Shaking the sample promotes dissolution of p-H2 
gas in the headspace of the NMR tube to form the SABRE-active species, 
[Ir(H)2(SIMes)(sub)3]Cl (see Figure 26).  





Figure 31 – Schematic diagram describing the manual shaking method. 1) 4 bar pH2 is added to an NMR tube 
fitted with a Young’s tap containing the SABRE active species, 2) The sample is shaken within the stray field of 
the spectrometer to allow for polarisation transfer from the pH2 to the target substrate via the J-coupled 
network, 3) The sample is quickly transferred into the spectrometer for acquisition using the one-shot pulse 
sequence described in Figure 28, 4) Hyperpolarised spectrum is generated and enhancement and polarisation 
can be calculated by comparing to the thermal spectrum and using the calculations shown in Figure 29  
This method is quick and simple to perform. However, the approach is susceptible to 
several variables including: field strength, shake time, shake intensity (usually 
dependent on the user) and transfer time. This means that results produced using 
the shake and drop method are associated with significant  errors. For example, as 
shown in Figure 30, the impact of the polarisation transfer field is significant. In the 
manual shaking method, the stray field of the magnet provides the PTF. Whilst the 
distance from the magnet has been accurately measured using a Gaussmeter it is 
difficult to maintain shaking of the sample within this area. If the sample is not shaken 
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within the required PTF then the calculated signal enhancement may not be 
optimum.   
 Polarisation Transfer Using the Magnetic Stray Field 
In order to observe SABRE hyperpolarisation of a sample, a polarisation transfer field 
is required. In the shake and drop approach this is achieved by shaking the sample 
within the stray field of the NMR spectrometer.  
In order to appreciate the stray field of the magnet, it is necessary to first 
acknowledge the set-up of the hardware in an NMR spectrometer (see Figure 32).  
 
Figure 32 - Schematic diagram of a nuclear magnetic spectrometer adapted with permissions from M. H. 
Levitt et al.16 
As described previously, observation of NMR depends on the splitting of spin states 
in a molecule which is promoted when a magnetic field is applied (see Chapter 1.2). 
Therefore, the most important component of the NMR spectrometer is the 
superconducting coil as it is this that provides the large magnetic field necessary to 
observe magnetic resonance spectroscopy. In order to maintain the homogeneity of 
such large magnetic fields and prevent electrical resistance, the superconducting coil 
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is immersed in liquid helium which is then further insulated via a reservoir of liquid 
nitrogen. Through the centre of the superconducting coil is the bore of the 
spectrometer where the probe is placed containing the sample. The probe is 
designed such that the sample is held at the point of maximum field within the 
superconducting coils.16 Different probes are selected according to the nuclei under 
scrutiny for the NMR experiment or whether imaging is required. 
A superconducting coil or solenoid is depicted in Figure 33. The magnetic field of the 
solenoid can be calculated according to Ampère’s Law: 




Equation 6  
Where B0 is the magnetic field, μ is the magnetic permeability (μ = kμ0 where k = 
permeability of the sample, μ0 = magnetic permeability in free space), N is the 
number of turns in the solenoid, I is the current and l is the length of the solenoid. 
 
Figure 33 - Diagram of a solenoid coil. Arrows are used to show the direction of the magnetic field. As the 
field is more concentrated in the centre, this is where the NMR sample is placed. 
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The design of a solenoid is such that the magnetic field is both concentrated and 
homogenous in the centre of the coil whereas the field outside is weak and 
divergent.17 This explains why there is commonly a stray field outside of the NMR 
magnet. The strength of the stray field depends on the distance from the 
spectrometer and how well the magnet is shielded.  
There are two spectrometers used in York for SABRE experiments, both of which are 
400 MHz. One is a narrow bore instrument and the other is a wide bore instrument. 
The wide bore instrument means that an imaging probe can be inserted for magnetic 
resonance imaging experiments. Due to the differences in bore size, each 
spectrometer has a different stray field profile (see Figure 34).  
 
Figure 34 – Stray field plots for the two spectrometers used for SABRE experiments where A is the narrow 
bore spectrometer and b is the wide bore spectrometer. Reproduced with permission from the NMR magnet 
system folder. 
The stray field plots for both spectrometers (Figure 34) show that the 65 G field 
required for the SABRE hyperpolarisation of 1H nuclei is closer to the spectrometer 
in the narrow bore instrument (a) compared to the wide bore instrument (b). 
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Furthermore, the field lines in spectrometer a are closer together compared to b. The 
implication of this is that when performing SABRE experiments using the  manual 
shaking approach, it is possible to cross these field lines when using instrument a. 
This means that polarisation is not transferred at the correct field and hence SABRE 
enhancements may be lower (see Figure 30). However, transfer of the sample into 
the spectrometer for detection is 1-2 s quicker when using instrument a compared 
to b as shaking occurs closer to the spectrometer.   
 The Impact of Different Experimenters 
As mentioned previously, the manual shaking method is susceptible to a number of 
different variables, including: the experimenter, shake time, shake intensity, transfer 
time and the field at which the sample is shaken (see above). In particular, the shake 
intensity and transfer time can vary between experimenters, thus leading to different 
signal enhancements and associated standard errors. This means that experimenters 
cannot directly compare SABRE results using the manual shaking method as it has 
been reported that a ±20% variation is common between different experimenters 
due to differences in physical height, the rate and angle of shake and transfer times 
into the spectrometer.6 
To illustrate the effect of using different experimenters on SABRE efficiency, a sample 
of [Ir(H)2(SIMes)(sub)3]Cl was shaken by two different experimenters in the stray field 
of the spectrometer at approximately 60 G for 10 seconds. The results of this 
experiment are shown in Figure 35 below. The data shows that the signal 
enhancements calculated for experimenter 2 are larger than for experimenter 1. For 
example for , experimenter 1 achieved an average signal enhancement of −495 ± 22-
fold compared to −767 ± 8-fold for experimenter 2. Furthermore, the enhancements 
calculated for experimenter 2 were more consistent compared to experimenter 1. 
This is indicated by the box plot in Figure 35, where there is a greater variability in 
the data collected for experimenter 1. For example, the minimum and maximum 
enhancements were −465-fold and −548-fold for experimenter 1 compared to −745-
fold and −791-fold for experimenter 2.There are a number of possible reasons for 
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these variations in signal enhancements yielded by the two experimenters. For 
example, experimenter 2 is larger in stature compared to experimenter 1 and 
therefore shaking may be slightly more vigorous allowing for more p-H2 to be 
dissolved into solution. There may be slight differences in transfer times as 
experimenter 2 was able to drop the sample into the spectrometer for detection 
without the use of a step as in the case of experimenter 1. Finally, experimenter 2 
has performed more SABRE experiments using the manual shaking method than 
experimenter 1 and is therefore more comfortable applying this method.  
 
Figure 35 – Box plot showing the enhancement factor as a function of experimenter utilising the manual 
shaking method. The coloured portions indicate the 25% and 75% quartiles, the whiskers the minimum and 
maximum enhancement values, the median line the mid-point of the data and the square the mean. Samples 
contained the SABRE precatalyst [IrCl(COD)(SIMes)] (5 mM), substrate (50 mM) dissolved in methanol-d4 (0.6 
mL) and in the presence of pH2 (4 bar). Samples were shaken for 10 seconds in the stray field of the 
spectrometer at approximately 60 G at 298 K.  
Comparison of Experimental Methods for SABRE Hyperpolarisation 
100 
 
 Effect of Parahydrogen dissolution Time (Shake Time) on Signal 
Enhancement 
Although the manual shaking method garners impressive enhancement factors, a 
crucial problem with this approach is the lack of reproducibility. Enhancement factors 
can also be influenced by shake time, the field strength and the NMR spectrometer 
used for the experiments, especially as each spectrometer has a different field profile 
(Figure 34). 
The impact of shake time using the manual shaking method was assessed using a 
sample of 4-methylpyridine (50 mM) and [IrCl(COD)(SIMes)] (5 mM) in methanol-d4 
(0.6 mL), forming [Ir(COD)(SIMes)(sub)]Cl. The sample was then degassed using a 
freeze-pump-thaw procedure using a dry ice acetone bath. P-H2 (99%) was then 
added to the sample to encourage formation of the SABRE-active species; 
[Ir(H)2(SIMes)(sub)3]Cl. Once formed, the SABRE response of this species was 
measured as a function of shake time. To do this, the sample was shaken within 65 ± 
5 G (measured with a Hirst GM08 series gaussmeter) of the stray field of the 
spectrometer and the shake time was varied from 5-15 seconds. 
The sample was shaken five times for each shake time in order to average the signal 
enhancements effectively assess the reproducibility of each measurement.18 
Although signal enhancements were generated at the ortho, meta and para-proton 
environments, only the ortho enhancements are considered. This is because these 
signal enhancements are the largest as they receive direct polarisation transfer from 
the p-H2. This experiment was repeated on both 400 MHz Bruker AVANCE III NMR 
spectrometers (a & b) to check consistency between spectrometers.  




Figure 36 – Box plots showing the 1H signal enhancement at the ortho proton, plotted as a function of shake 
time for a sample containing [Ir(COD)(SIMes)(sub)]Cl (5 mM) with the substrate 4-methylpyridine (50 mM) 
and pH2 (4 bar) in methanol-d4. Green is used to represent the narrow bore instrument a) and purple the 
wide bore instrument b). The sample was manually shaken at approximately 60 G using the stray field of the 
400 MHz spectrometers at 298 K. The coloured portions indicate the 25% and 75% quartiles, the whiskers the 
minimum and maximum enhancement values, the median line the mid-point of the data, the square the 
mean and the diamonds show any outliers in the data. 
In general, the data in Figure 37 indicates that the average enhancements (indicated 
by the squares) at the ortho-proton position are slightly higher when measured on 
spectrometer a. For example, an average enhancement of −891 ± 18-fold was 
observed on instrument a compared to −842 ± 43-fold on b. However, the whiskers 
show that the highest enhancement was observed using instrument b, where a 10 
second shake time induced an enhancement of −973-fold. This compares to a 
maximum of 935-fold on a. Generally, larger variations were observed using 
instrument b compared to a. This is indicated by the whiskers which illustrate the 
maximum and minimum enhancement values. For example, for a 5 second shake 
time, the minimum enhancement was −74-fold and the largest was −801-fold. The 5 
second shake time also induced a large variation in results on a, this is highlighted by 
the presence of data anomalies at −556-fold and −767-fold. Henceforth it is difficult 
to reproduce enhancements when shaking for such a short period of time.   
There are a number of variables that could be to blame for this increased variance of 
data on b; the field at which the sample is shaken or the transfer time – the time 
between shaking the sample, dropping it into the spectrometer and acquiring the 
NMR signal. Instrument b is a wide bore instrument therefore the field lines are more 
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spaced apart compared to a (Figure 34). This means that maintaining shaking at 65 G 
on b is easier. Practically, b is situated further away from the computer from which 
it is controlled,  therefore the transfer time is a couple of seconds longer compared 
to a. Longer transfer times mean that hyperpolarisation is lost before a spectrum can 
be acquired, therefore this could explain why the average enhancements on 
instrument b are lower than instrument a. Furthermore, the transfer time is more 
likely to be varied across different measurements. 
2.3 The Automated Flow System 
As described in the previous section, the shake and drop method was seen to induce 
large differences  between measurements due its vulnerability to a large number of 
variables,6 an automated polariser and sample delivery system was designed in 
collaboration with Bruker (Figure 38). 
 
Figure 38 – Schematic diagram of the automated flow probe. 1) A sample of [Ir(H)2(SIMes)(sub)3]Cl in 
methanol-d4 is contained in a flow cell where pH2 (4 bar) is bubbled through the solution, 2) The 
hyperpolarised sample is transferred into the spectrometer via a nitrogen flow, 3) The hyperpolarised 
spectrum is acquired using the one-shot pulse sequence described in Figure 28, 4) The sample is transferred 
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from the spectrometer back to the flow cell using a nitrogen flow. Image adapted with permissions from R. E. 
Mewis et al.6 
The flow system briefly comprises of a p-H2 generator which electrolyses water to 
produce hydrogen. The hydrogen is then cooled to 38 K in the presence of an 
activated charcoal catalyst to provide 92% p-H2. The generator is then connected to 
a flow cell containing the sample solution and a porous frit through which p-H2 can 
be bubbled at the base of the chamber. This is surrounded by a copper coil which is 
used to generate a controlled magnetic environment between −150 G and 150 G. 
This sample chamber is then connected to a flow probe located within the 
spectrometer.6 When conducting a SABRE experiment, p-H2 is first bubbled through 
the sample solution and the resulting hyperpolarised solution is pneumatically 
transferred into the spectrometer using a nitrogen flow. A radiofrequency (RF) pulse 
is then applied to the sample in the flow head and an FID is required. Finally the 
sample is shuttled back to the preparation chamber where fresh p-H2 can be bubbled 
through the solution and the process repeated.6  
Results performed on the flow probe are more reproducible as the potential for 
human error has been removed. However, the observed enhancements are generally 
much lower than those gained using the shake and drop method. This occurs because 
the bubbling of p-H2 is generally less vigorous than shaking the sample, therefore less 
p-H2 is dissolved into the solution. Furthermore, transfer times may be slower 
meaning that some of the hyperpolarisation has been lost before the signal has been 
acquired. 
 Effect of Parahydrogen Dissolution Time (Bubble Time) on Signal 
Enhancement 
To assess the magnitude of signal enhancements and the reproducibility of the 
automated flow system (compared to the manual shaking method), the 1H signal 
enhancements were measured for a number of different p-H2 dissolution times 
(bubble time). To do this, a sample containing 4-methylpyridine (50 mM) and 
[IrCl(COD)(SIMes)] (5mM) was dissolved in 3 mL methanol-d4 and placed in the 
sample chamber shown in Figure 38. P-H2 was bubbled through the solution to 
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promote formation of the SABRE-active species; [Ir(H)2(SIMes)(sub)3]Cl. Once 
activated, the SABRE response was measured as a function of bubble time which was 
varied from 5-30 seconds. Each measurement was repeated five times in order to 
assess the reproducibility of the experiment (Figure 39).   
 
Figure 39 – Box plot showing the 1H NMR signal enhancement plotted as a function of bubble time for the 
ortho proton resonance in the free substrate for the SABRE active species [Ir(H)2(SIMes)(sub)3]Cl (5 mM) 
containing the substrate 4-methylpyridine (50 mM). Measurements collected on the 400 MHz narrow bore 
instrument a) are shown in green and those collected on the 400 MHz wide bore instrument b) are shown in 
purple. Hyperpolarised measurements were taken using the flow method shown in Figure 38 at 298 K and the 
pulse sequence shown in Figure 28. The coloured portions indicate the 25% and 75% quartiles, the whiskers 
the minimum and maximum enhancement values, the median line the mid-point of the data, the square the 
mean and the diamonds show any outliers in the data. 
Figure 40 shows the variation in the 1H signal enhancement at the ortho proton as a 
function of the p-H2 bubble time. If we first consider the average signal 
enhancements, the data generally follows the same pattern as the manual shaking 
method whereby larger enhancements were observed on spectrometer a. However, 
the largest average signal enhancement of −264-fold corresponding to a 15 second 
bubble time was observed on instrument b. This compares to −227-fold on 
instrument a which resulted from a 10 second bubble time. Furthermore, the largest 
calculated enhancement of −410-fold was observed on b for a 25 second bubble 
time. In Figure 41, this is shown as an outlier (indicated by the diamond) as the 
remaining data points ranged from −40-fold to −126-fold. Figure 42 clearly shows 
that there is a larger variation in signal enhancements using spectrometer b. This is 
highlighted by the larger box plots, for example a 10 second bubble time induced 
enhancements ranging from −0.6-fold to −399-fold (illustrated by the whiskers). 
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Additionally, more anomalies were observed in the data using NMR b (shown by the 
diamonds). Henceforth, the data collected using spectrometer b is shown to be less 
reproducible compared to a. It was expected that the  signal enhancements 
generated on both instruments would be very reproducible as this SABRE method is 
fully automated and all experimental parameters (e.g. sample transfer time, p-H2 
pressure etc) were constant for both spectrometers. It is possible that the larger 
variation in data is caused by solvent evaporation in the sample. This could be 
induced by the sample being shuttled between the spectrometer and the flow cell a 
number of times via a nitrogen flow. However if this were the case, it would be 
expected that the error would increase with bubble time.  . Interestingly, the 
variation in data across the different bubble times is minimal for a. For example, the 
lowest average enhancement of −193-fold was observed for a 5s bubble time, 
compared to −227-fold for a 10 second bubble time. This suggests that the 
shake/bubble time does not influence the enhancement as much as the field 
strength, transfer time or shake/bubble intensity.  
2.4 Handheld Magnetic Array  
In 2018, Richardson et al.5 designed and implemented a hand-held shaker to be used 
for SABRE experiments on a 43 MHz benchtop spectrometer. As the benchtop 
spectrometer has no stray field, manual shaking experiments had to be performed 
using the stray field of the 400 MHz spectrometer. The implication of this was that a 
large transfer time was involved and hence lower enhancements were observed. To 
combat this, a hand-held magnetic array (shaker) was developed to simulate the PTF 
required for SABRE experiments. Samples were made according to the same 
procedure detailed in section 0. Once p-H2 was added the sample was then placed 
into the shaker and shaken for approximately 10 seconds. The sample was 
subsequently removed and transferred into the spectrometer for acquisition. The 
main advantage of this method is that the PTF remains constant throughout shaking. 
For example, it was noted that a 600% increase in total polarisation was noted 
compared to the flow method and a 25% increase compared to the traditional shake 
and drop approach. The reproducibility of these experiments was also assessed, it 
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was observed that the handheld magnetic array  induced a standard deviation of 5.8 
% compared to 9.1 % for the shake and drop and 4.6 % for the flow. 
 
Figure 43 – Schematic diagram describing the use of the handheld magnetic array. 1) 4 bar pH2 is added to 
SABRE active species in an NMR tube fitted with a young’s tap, 2) The sample is placed inside the handheld 
magnetic array, 3) The handheld magnetic array containing the sample is shaken to allow for polarisation 
transfer into the substrate, 4) the sample is removed from the handheld magnetic array and transferred into 
the spectrometer for detection 
 Design of the Handheld Magnetic Array 
This shaker device is comprised of a number of solid-state magnets arranged in a 
Halbach19 design to generate a homogeneous field of BX (Figure 44).5  
 
Figure 44 – The hand-held shaker adapted with permissions from P. M. Richardson et al.5 
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Figure 44 shows the handheld shaker (a) which is comprised of a number of rings (b). 
A cross section of one of these rings is shown in Figure 44c where magnets (shown in 
green) are placed at a fixed distance from the centre of the ring. The magnets are 
arranged such that they generate a homogenous field of BX transverse to the long 
axis of the cylinder, and thus the NMR sample. This magnetic field is controlled by 
the number of magnets, their distance from the centre of the ring and the spacing 
between the rings shown in Figure 44c.  
A number of these hand-held shakers have been developed, each with different 
magnetic fields of BX. The advantage of this is that experimenters can now perform 
SABRE experiments quickly and easily on nuclei other than proton. For example, 
direct polarisation transfer via SABRE into 13C nuclei occurs at 2.5 mG20 and 15N at 2 
mG.12 Before, these SABRE experiments would have required use of the flow method, 
as the PTF is controlled by the user. Magnetic field profiles for each of the manual 
shakers have been generated, where BX is measured throughout the length of the 
shaker. Figure 45 shows the field profile for the 60 G shaker, where the red line 
demonstrates the average field of 60.6 G.  
 
Figure 45 – Photo of the hand-held shaker and corresponding magnetic field profile measured along the 
central axis of the cylinder. Image taken with permission from P. M. Richardson et al.5 
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 Effect of Parahydrogen Dissolution Time (Shake Time) on Signal 
Enhancement  
The shake time was Shake time was assessed in a similar way to the manual shaking 
approach described in Section 2.2 The Manual Shaking Method. A sample of 4-
methylpyridine and [IrCl(COD)(SIMes)] was dissolved in methanol-d4. P-H2 was then 
added and the sample placed in the shaker. This was then shaken for 5/7/10/15 s 
before being removed and dropped into the spectrometer for acquisition. Again, this 
process was repeated five times to calculate the average enhancement and the 
standard error. 
 
Figure 46 – 1H signal enhancement plotted as a function of shake time for the ortho proton in the free 
substrate for SABRE active species [Ir(H)2(SIMes)(sub)3]Cl containing the substrate 4-methylpyridine. The 
green represent measurements taken on the narrow bore 400 MHz spectrometer a, and the purple are used 
for the wide bore 400 MHz spectrometer b. Hyperpolarised measurements were collected using the 60 G 
handheld magnetic array in Figure 43 at 298 K. The coloured portions indicate the 25% and 75% quartiles, the 
whiskers the minimum and maximum enhancement values, the median line the mid-point of the data, the 
square the mean and the diamonds show any outliers in the data. 
Figure 47 illustrates the variation in 1H signal enhancement at the ortho proton as a 
function of shake time. The largest average enhancement was observed for a shake 
time of 10 seconds. On spectrometer a this shake time induced a signal enhancement 
of −497-fold compared to −339-fold on spectrometer b. Furthermore, larger 
enhancements were observed on instrument a compared to b. If the individual data 
points are considered, the largest enhancement was −564-fold on a compared to 
−410-fold on NMR b (outlieing data point for a 5 second shake time). 
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If the average signal enhancements are considered, there was less variation overall 
in the data using the handheld magnetic array. For example, on NMR a, the minimum 
average enhancement was −442-fold (15 second shake time) compared to the 
maximum of −497-fold (10 second shake time). However, if the individual data points 
are considered, the minimum measurement was −387-fold (15 second shake time) 
compared to −564-fold (10 second shake time). On NMR b, the lowst average signal 
enhancement was −339-fold (7 and 10 second shake times) compared to the 
maximum signal enhancement of −365-fold (5 second shake time). Considering the 
individual measurements, the lowest signal enhancement was −279-fold (10 second 
shake time) and the highest was 396-fold (15 second shake time). This lower variation 
in data suggests that the sample shake time is less important compared to the 
polarisation transfer field and the transfer time. As the field has been kept constant 
at 63 G, this means that it is the difference in transfer time that has contributed to 
the lower enhancements observed on b compared to a.It is clear that this method is 
less reproducible than both the manual shaking method using the stray field of the 
spectrometer and the automated flow system. This can be observed by the number 
of data anomalies shown in Figure 48 for both spectrometers. The lower 
reproducibility can also be attributed to the differences in transfer time between 
measurements as the sample must be removed from the shaker before being 
dropped into the spectrometer for acquisition.  
2.5 Comparison of SABRE Methods 
The effect of p-H2 dissolution time has been compared to the 1H signal enhancements 
for each method. This was observed by plotting the shake time or the bubble time as 
a function of signal enhancement. In order to compare the methods directly, the 1H 
signal enhancements for each method have been plotted for a 10 second shake time 
for spectrometers a and b, this is shown in Figure 49. 




Figure 50 – Signal enhancement plotted as a function of SABRE methodfor the ortho proton in the free 
substrate 4-methylpyridine in the SABRE-active species [Ir(H)2(SIMes)(sub)3]Cl. This is shown for a p-H2 
dissolution time of 10 seconds. Plot a) in green compares the signal enhancements measured on the 400 MHz 
narrow bore instrument a Plot b) compares the signal enhancements measured on the 400 MHz wide bore 
instrument b. The manual shaking method is is labelled ‘M.S’, the handheld magnetic array is labelled 
‘H.M.A’ and the automated flow system is labelled ‘A.F’.  All measurements were collected at 298 K using a 
sample of [Ir(COD)(SIMes)(sub)]Cl (5 mM), 4-methylpyridine (50 mM) and pH2 (4 bar) in methanol-d4. c) 
Enhancement Factor as a function of SABRE method adapted from Richardson et al.5 with permissions. These 
measurements were collected at 298 K using a sample of [Ir(COD)(IMes)(sub)]Cl (5 mM), 4-methylpyridine (50 
mM) and pH2 (4 bar) and a 10 second p-H2 dissolution time. 
Box plots a) and b) in Figure 51 compare the 1H signal enhancements for a 10 second 
shake time for each SABRE methods on spectrometers a (graph a) and b (graph b). 
The manual shaking method using the stray field of the spectrometer is indicated by 
‘M.S’, the handheld magnetic array by ‘H.M.A’ and the automated flow system by 
‘A.F’. Both plots a) and b) show that the largest signal enhancements were measured 
using the manual shaking method. On NMR a, this generated a average enhancement 
of – 891-fold compared to −497-fold using the handheld magneti array and −227-fold 
using the automated flow system. If the individual measurements are considered, 
the largest enhancement was −935-fold using the manual shaking method. Similarly, 
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on NMR b, the largest enhancements were also observed using the manual shaking 
method. This induced an average enhancement of −842-fold, however the largest 
individual measurement was −974-fold which is larger than the maximum observed 
on NMR b. An average enhancement of −339-fold was observed using the handheld 
magnetic array and −135-fold using the automated flow system. A larger variation in 
the data was generated by spectrometer b compared to a. This is clearly observed by 
the large box plot using the automated flow method. Larger variations were also 
observed with the manual shaking method and the handheld magnetic array. For 
example, the data ranged from −714-fold to −974 fold for the manual shaking 
method. On NMR a, the data ranged from −832-fold to −935-fold. This difference in 
reproducibility is attributed to the longer transfer time induced when using 
instrument b. A longer transfer time means that hyperpolarisation can be lost before 
the data can be acquired. Furthermore, as results were found to be more 
reproducible using NMR a compared to b, this was used for all the SABRE 
experiments in the remainder of this thesis.   
The fact that larger enhancements are observed using the manual shaking method is 
interesting because the homogeneous field of the handheld magnetic array has been 
shown to be capable of inducing enhancements 25% larger than using the stray field 
of the spectrometer.5 This compares to a 44% increase using the stray field of the 
spectrometer on NMR a compared to the handheld magnetic array. It is important to 
note that although the handheld magnetic array removes the variability in the 
polarisation transfer field it does not remove other forms of human error such as; 
sample transfer time and shake intensity (which will also be user dependent). In this 
case, it was established that shaking of the sample was less vigorous and therefore 
less p-H2 was dissolved into solution. Furthermore, the transfer time was longer as 
the sample must first be removed from the shaker before being dropped into the 
spectrometer, meaning that some of the polarisation is lost before data acquisition. 
The data in graph c) was adapted from Richardson et al.5 where the three SABRE 
methods were compared for a sample containing [Ir(H)2(IMes)(sub)3]Cl where the 
substrate was 4-methylpyridine. It is important to note that the different NHC means 
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that larger enhancements were observed and so the data is not directly comparable 
to the data in graphs a) and b). Furthermore, a different experimenter conducted the 
measurements in graph c) compared to graphs a) and b). However, it was observed 
that the handheld magnetic array yielded the largest signal enhancements compared 
to the automated flow system and the manual shaking method using the stray field. 
This contrasts with the data in graphs a) and b) where the manual shaking method 
produced the largest enhancements. This may be a consequence of the experimenter 
in c) being more familiar with this method and therefore capable of achieving much 
larger signal enhancements. Personally, I found the handheld magnetic array difficult 
to use and therefore shaking was not as intense as the manual shaking method. 
Furthermore, the transfer times were longer using the handheld magnetic array 
which contributed to the smaller signal enhancements observed using this method. 
This inconsistency is apparent when the error bars are considered. For example, 
whilst the automated flow method induces the smallest error in graphs a) and c), this 
is followed by the handheld magnetic array and the manual shaking method in graph 
c). However in graph a) the manual shaking method was more reliable than when the 
handheld magnetic array was used. The experimenter in graph c) was more 
experienced in using the handheld magnetic array and therefore was more 
comfortable using the device leading to more consistency between results. 
2.6 Summary 
In this chapter we have presented three methods utilised in house for SABRE 
experiments: the manual shaking method using the stray field of the spectrometer,, 
the automated flow system and the handheld magnetic array method. Each method 
has its own advantages and disadvantages, for instance, manual shaking using the 
stray field of the spectrometer produces significant signal enhancements however it 
is susceptible to a number of variables meaning that these results are prone to large 
errors. Conversely, the automated flow and handheld magnetic array methods are 
highly reproducible but do not produce enhancements comparable to the manual 
shaking method. Large enhancements are preferable when analysing mixtures or 
assessing compounds present in low concentrations, such as impurities or reaction 
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intermediates. In MRI terms, this means that small drug quantities are easily 
observable. Furthermore, large enhancements would result in much shorter scan 
times. However, reproducibility is also essential so that different experimenters can 
effectively compare results (within the error). Additionally, in the proceeding 
chapters of this thesis, reproducibility is fundamental when comparing the SABRE 
activity of alternative substrates (see Chapter 3).   
The first method described was the manual shaking method using the stray field of 
the spectrometer. This is a manual technique whereby the sample containing the 
SABRE species [Ir(H)2(SIMes)(sub)3]Cl, and p-H2 is shaken in the stray field of the 
magnet (~65 G) before being dropped into the spectrometer for acquisition. Due to 
the crude nature of this technique, it is susceptible to a number of different variables 
including; field strength, shake time and transfer time. Although efforts were made 
to reduce these variables, the average standard error in these experiments was 29-
fold compared to 18-fold for the handheld magnetic array and 7-fold for the 
automated flow system. Despite this, enhancements were 70% larger compared to 
the flow system and 44% larger compared to the handheld magnetic array.  
The flow system comprises of a mixing chamber containing the SABRE pre-catalyst 
surrounded by a copper coil. P-H2 is then bubbled through the solution whilst the 
copper coil generates a controlled magnetic environment (~65 G) around the sample. 
The hyperpolarised sample is then transferred into the spectrometer via a nitrogen 
flow for NMR detection. The flow system is fully automated, meaning that the field 
strength, bubble time and transfer time are carefully controlled by the user. 
Henceforth, the flow system is highly reproducible compared to the manual 
techniques. Unfortunately, this method is unable to replicate the high enhancements 
of the manual shaking method using the stray field of the spectrometer. For example, 
a 10 second bubble time produced an average signal enhancement of −227 ± 8-fold 
compared to −897 ± 18-fold for the manual shaking method. This has been attributed 
to the fact that shaking the sample promotes more effective dissolution of the p-H2 
into solution compared to bubbling. 
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Finally, a handheld magnetic array was introduced as a solution to the low 
reproducibility of the shake and drop method. In this technique, the sample is shaken 
in a hand-held shaker rather than the stray field of the magnet. The handheld 
magnetic array has been designed such that the field remains constant throughout 
the sample for the duration of the shake. Despite this, the handheld magnetic array 
method is still susceptible to variations in shake and transfer times. Henceforth the 
average standard error for the handheld magnetic array (18-fold) is lower than the 
manual shaking method (29-fold) but higher than the flow system (8-fold). 
Furthermore, whilst the handheld magnetic array has been shown to induce a 25% 
increase in enhancements compared to the manual shaking method using the stray 
field of the spectrometer,5 in these experiments, enhancements were 56% lower. 
Whilst it has been established that reproducibility is an important factor in the 
proceeding chapters of this thesis, most results were generated using the manual 
shaking method using the stray field of the spectrometer. This is because this method 
is much quicker and simple to implement compared to the flow system. For example, 
the comparison of different NHC/substrate combinations (see Chapter 3) involved a 
number of samples which could be analysed in one afternoon using the manual 
shaking method compared to a number of days using the flow where only one-two 
samples could be tested per day. Although the handheld magnetic array displays an 
improvement in the reproducibility, this method was not developed until the 
research in the subsequent chapters was in the later stages.  
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Chapter 3 SABRE Optimisation for a Series of Para-
Substituted Pyridines 
3.1 The Substrates 
In SABRE, substrates are required to reversibly bind to the iridium metal centre as it 
is this association/dissociation that after polarisation transfer allows subsequent 
build-up of a hyperpolarised reagent in solution.1 The most commonly exploited 
substrates for SABRE are N-heterocycles such as pyridine and its derivatives.2 
Pyridine rings contain a lone pair centred on the nitrogen atom which can be involved 
in different interactions including the metal-ligand interaction in organometallic 
chemistry.3 As pyridine is considered a common and relatively strong σ-donor 
ligand,4 it is capable of ‘soft’ binding, meaning it weakly coordinates to a metal 
centre. This makes pyridine an excellent candidate for SABRE as it can associate and 
dissociate from the iridium SABRE catalyst on a suitable timescale to allow 
polarisation transfer. Furthermore, pyridine rings feature heavily throughout nature5, 
6 and play a vital role in drug motifs.7-9 Henceforth, hyperpolarisation of these 
molecules paves the way for their use as MRI contrast agents.  
 Substituent Effects in Pyridine 
As pyridine is an aromatic system, its reactivity can be influenced by substituents 
around the ring. This effect is clear when the resonance structures of pyridine are 
considered (Figure 52). 
 
Figure 52 – Resonance structures for pyridine. 
The resonance structures predict a partial positive charge on positions 2, 4 and 6 and 
a net negative charge on the nitrogen atom.10 This means that substituents in both 
the ortho and para positions have the greatest influence on the behaviour of 
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pyridine. Substituents can be classed as either electron donating or electron 
withdrawing. According to Hęclik and Dobrowolski, substituents are classed as sEDA 
(σ electron donor-acceptor) if they affect the σ orbitals in the plane of the pyridine 
ring which includes the lone pair on the nitrogen. 11, 12  If they affect the π orbitals 
which form the conjugated π electron system they are classed as pEDA (π electron 
donor-acceptor). It was observed that an increase in σ donating ability increases the 
negative charge on the lone pair but decreases the electron population of the π 
valence orbitals on the nitrogen in both the ortho and para positions in pyridine. 
Conversely, an increase in π donation in these positions increases the electron 
population of the π valence orbitals but decreases the σ population at the nitrogen 
lone pair.  
In 2007, Palusiak et al.4 investigated a number of para substituted pyridines and their 
effect on Cr(CO)5-pyridine complexes. It was found that electron withdrawing groups 
stabilised the Cr-N bond whilst electron donating groups weakened the bond. This 
was shown by shorter bond lengths in complexes containing electron withdrawing 
groups (such as aldehydes) due to removal of electron density from the π-system of 
the pyridine ring. Therefore, to stabilise the M-L interaction, π back-donation occurs 
from the metal to the ligand (Figure 53a). Electron donating groups such as methyoxy 
however, increase the electron density within the conjugated system. This 
destabilizes the bond as the metal cannot back-donate into the π-system (see Figure 
53).11, 13  




Figure 53 – comparison of the effect of a) electron withdrawing groups (EWG) and b) electron donating 
groups (EDG) in the para position of pyridine on the metal-ligand interaction. 
Evidently the ligation of pyridine to a metal centre can be influenced by subsitutents 
in the ortho and para positions of the pyridine ring. As SABRE efficiency is heavily 
reliant on the rate of substrate dissociation, if the substrate dissociates too slowly, 
hyperpolarisation can be lost through relaxation effects as the association to the 
metal is too strong.14, 15 This is because binding to the iridium centre promotes 
relaxation. Whereas if substrate ligation is too weak, insufficient polarisation can be 
transferred before dissociation occurs. This means that SABRE efficiency could be 
controlled via substitution at the ortho and/or para positions of pyridine. Shchepin 
et al.16 have briefly compared the effect of methyl substituents  in the ortho and para 
positions on the 15N hyperpolarisation of substituted pyridine. Whilst they observed 
15N enhancements in the para substituted equivalent, the ortho substituted 
derivative resulted in no detectable hyperpolarisation. It was assumed that the steric 
hindrance from the ortho substituent critically altered the timescale of the SABRE 
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exchange process such that magnetism was insufficiently transferred to the nuclei of 
interest.  
In this chapter, a range of para-substituted pyridines were employed to study the 
affect of iridium-substrate ligation on SABRE efficiency. Para-substituted pyridines 
were chosen in order to study the electronic contribution, while minimising the steric 
impact of the functional group change on the SABRE catalyst. In order to directly 
compare the functionality in these substrates, their corresponding pKa values were 
determined. It was anticipated that substrates with high pKa would form strong 
iridium-substrate ligations and those with low pKa values would form weaker 
associations. The substrates selected for this study were 4-chloropyridine, 4-
methylpyridine, 4-methoxypyridine and 4-pyridinecarboxaldehyde (see Figure 54), 
with corresponding literature pKa values of 3.83,17 6.03,17-19 6.5517 and 4.8418, 19. 
 
Figure 54 - The chemical structures of the para-substituted pyridines substrates chosen for this study. 
3.1.1.1 Measuring pKa Values 
The pKa values of each of the substrates displayed in Figure 54 were measured via 
NMR using the method first described by Handloser et al.19 In this method the 
substituted pyridines were dissolved in methanol with added hydrochloric acid (HCl). 
HCl was used to control the pH of the solution and its addition means that two forms 
of the substituted pyridine exist in solution (Figure 55). 




Figure 55 – The two forms of the substituted pyridine in solution with methanol and hydrochloric acid (HCl) 
used to control the pH of the solution 




                                                          
Equation 7 
The pKa can then be written as: 





In NMR, the concentrations of each form can be substituted for the fractional 
populations (𝑥Band 𝑥BH+), therefore Equation 8 becomes:  





The expected chemical shift (δ) for each of the two forms of the substituted pyridine 
would be different due to the proton in the charged case shifting the resonance 
downfield. However, NMR cannot detect chemical change that occurs on a faster 
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timescale than the NMR experiment itself, therefore there is only one observed peak 
which accounts for both forms. The location of this peak reflects the weighted 
average of the relative populations and chemical shift of the pure acidic and pure 
basic forms. If the chemical shift of the protonated form (i.e. in strong acidic 
conditions, δA) and the deprotonated form (i.e. in strong basic conditions, δB) are 
known then the measured chemical shift (δm) can be described by Equation 10. 
δm =  𝑥BH+δBH+ + 𝑥BδB 
Equation 10 
As 𝑥Band 𝑥BH+  are fractional populations, they must sum to 1, therefore the 
proportion of the deprotonated form can be expressed as in Equation 11. 
𝑥B = 1 − 𝑥BH+ 
Equation 11 
The relative population of the protonated form can then be calculated using Equation 






Analogously, the fractional population of the deprotonated form can be expressed 
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Finally, substituting Equation 12 and Equation 13 into Equation 9 and rearranging 
provides an expression for the measured chemical shift as a function of pH in the 
form of Equation 14. 






Therefore, it is possible to measure the chemical shift of a molecule by NMR for 
solutions of different pH levels and fit the data using Equation 14 to determine the 
pKa for the molecule.  
The pKa values of the four target molecules 4-chloropyridine, 4-
pyridinecarboxaldehyde, 4-methylpyridine and 4-methoxypyridine were measured 
in methanol-d4 in order to mimic the conditions of hyperpolarisation experiments. 
For each substrate, two bulk samples were created each containing 10 mL solvent, 
150 mg substrate and 40 μL of trimethylsilanol (TMSO). TMSO was added as a 
reference to ensure there was no drift in chemical shift over time or sample pH. To 
one bulk solution, drops of 1.0 M (and 0.1 M for fine tuning) hydrochloric acid (in 
methanol-d4) were added to obtain low pH levels. Potassium hydroxide (in methanol-
d4) were added to the other bulk solution to reach high pH levels. The pH values of 
the solutions were determined using a benchtop pH sensor (Mettler Toledo) which 
was calibrated prior to each sample using the two-point calibration sequence using 
buffers at pH 4 and pH 7. For each sample, a range of pH values were measured and 
subsequently an aliquot was extracted and placed into NMR tubes for analysis. It 
should be noted that whilst pH is usually only relevant in water, it was measured in 
methanol-d4. This is because all measurements in this chapter were taken in 
methanol-d4.  
The chemical shifts were determined from a simple pulse and acquire using a 90° 
pulse. For each substrate, all the proton resonances present were analysed. The data 
was then fitted with Equation 14 using a least squares regression algorithm where 
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the parameters δA, δB and pKa were permitted to be free in the fitting routine. These 
values were determined for each resonance on the substrate and are shown in Figure 
56 for 4-chloropyridine. The pKa values determined for each substrate are shown in 
Table 1. 
 
Figure 56 – Chemical shift as a function of pH for 4-chloropyridine in methanol-d4. HCl was used to reach low 
pH values and KOH was added to achieve high pH. The data points have been fitted using Equation 14. 
Substrate Literature pKa Measured pKa 
4-Chloropyridine 3.83 2.00 ± 0.02 
4-pyridinecarboxaldehyde 4.84 3.12 ± 0.04 
4-methylpyridine 6.03 4.02 ± 0.02 
4-methoxypyridine 6.55 4.89 ± 0.03 
Table 1 - Table of the literature pKa values17, 18 compared to those measured at the ortho proton resonance 
for each of the substrates. Note that the literature values are in water whilst the measured values were taken 
in methanol-d4. 
Whilst the measured pKa values are slightly lower than the literature values, they 
maintain the same trend where the 4-chloropyridine has the lowest pKa value and 
the 4-methoxypyridine the highest value. The difference here is attributed to the use 
of methanol rather than H2O which was used in the literature values. Methanol-d4 
was used for the measured values as it was important to use the solvent used for all 
the subsequent measurements in this chapter.  
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3.2 Formation of the SABRE Pre-Catalyst: 
[Ir(COD)(SIMes)(sub)]Cl 
The initial step for formation of the active SABRE catalyst involves the reaction of the 
substrate with [IrCl(COD)(NHC)]. Upon this addition, the chloride ligand is displaced 
by the substrate to form the SABRE pre-catalyst [Ir(COD)(NHC)(sub)]Cl. This 16-
electron, square planar species has been seen to form for each of the substrates 
discussed in this chapter. The [Ir(COD)(SIMes)(sub)]Cl complex has been fully 
characterised via 1H, 13C and 15N NMR, full details of which can be found in Appendix 
B, an example characterisation data set for the species formed using 4-
methylpyridine is shown below. 
 
Figure 57 – 1H-NMR spectra showing the SABRE precatalyst [Ir(COD)(SIMes)(sub)]Cl for the substrate 4-
methylpyridine. The sample was prepared by adding [IrCl(COD)(SIMes)] (4 mM) to 4-methylpyridine (40 Mm) 
in methanol-d4. The sample was measured at 235 K and 500 MHz. 
Position 1H-NMR 13C-NMR 15N-NMR 









JHH = 6.1 Hz 
125.4 - 
CH3Free 2.439 19.8 - 
Position 1H-NMR 13C-NMR 15N-NMR 
orthoHsub 
7.593 
JHH = 6.5 Hz 
150.4 232.8 


















CH3Sub 2.528 18.2  







Table 2 – NMR Resonances for [Ir(COD)(SIMes)(4-Methylpyridine)]Cl in methanol-d4. 1H at 500 MHz, 13C at 
125 MHz and 15N at 41 MHz at 235 K. 
 Formation of [Ir(COD)(SIMes)(sub)]Cl with 4-
Pyridinecarboxaldehyde 
Upon addition of 4-pyridinecarboxaldehyde to methanol-d4, the methyl hemiacetal 
forms predominantly in solution (see Appendix B). It is this form that binds to the 
iridium catalyst [IrCl(COD)(SIMes)] in this initial step. However, in the excess solution 
or ‘free substrate’ there is a small quantity of the carboxaldehyde present (seen in 
black in 





Figure 58 - 1H-NMR spectrum for [Ir(COD)(SIMes)(4-pyridinacarboxaldehyde)]Cl in methanol-d4 measured at 
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500 MHz and 263 K. Black indicates the presence of the free aldehyde conformation and the orange 
highlights the bound and free hemiacetal conformation. 
Position 1H-NMR 13C-NMR 15N-NMR 
OrthoHFree 
8.571 




JHH = 6.1 Hz 
121.8 - 
OHCCD3Free - 151.6 - 
Position 1H-NMR 13C-NMR 15N-NMR 
orthoHsub 
7.769 




JHH = 6.5 Hz 
122.8  


























Table 3 - NMR Resonances for [Ir(COD)(SIMes)(4-pyridinecarboxaldehyde)]Cl in methanol-d4. 1H at 500 MHz, 
13C at 125 MHz and 15N at 41 MHz at 235 K. 
The presence of the hemiacetal form is confirmed by the absence of a carbonyl 13C 
resonance which would usually be found at 180 ppm (see following chapter).20 
Instead the 13C resonance at the hemiacetal group is found at 151.9 ppm. This is close 
to the equivalent resonance in the free substrate at 151.6 ppm.  
3.3 Formation of the SABRE-Active Species: 
[Ir(H)2(SIMes)(sub)3]Cl 
Once the complex [Ir(COD)(SIMes)(sub)]Cl has formed, hydrogen is added to 
promote hydrogenation of the COD ligand. As the hydrogen and substrate are both 
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in excess, they both bind into the catalyst to form the SABRE-active complex, 
[Ir(H)2(SIMes)(sub)3]Cl. These species have been characterised for each of the four 
substrates discussed in this chapter. In all cases, the tris-substituted species forms 
where two substrate ligands lie in the equatorial plane of the iridium complex, trans 
to the hydride ligands, and one in the axial position trans to the NHC (SIMes). Full 
NMR characterisation for the SABRE-active species for each of the substrates can be 
found in Appendix B although characterisation for 4-methylpyridine is shown below.  
 
 
Figure 59 – 1H-NMR spectra for the SABRE-active species [Ir(H)2(SIMes)(sub)3]Cl for 4-methylpyridine. The 
sample was prepared using [IrCl(COD)(SIMes)] (4 mM), 4-methylpyridine (40 mM) and p-H2 (4 bar) in 
methanol-d4. The sample was measured at 235 K and 500 MHz. 
Position 1H-NMR 13C-NMR 15N-NMR 









JHH = 6.0 Hz 
125.3 - 
CH3Free 2.439 19.8 - 
Position 1H-NMR 13C-NMR 15N-NMR 
orthoHsub 
(trans to H-) 
8.121 
JHH = 5.9 Hz 
153.6 247.2 
orthoHsub 
(trans to NHC) 
7.799 
JHH = 5.5 Hz 
154.2 233.1 
metaHsub 
(trans to H-) 
6.963 
JHH = 5.9 Hz 
125.9  
metaHsub 
(trans to NHC) 
6.814 
JHH = 5.5 Hz 
125.9  
CHAr,Mes 6.616 128.5  
N-CH2-CH2-N 3.869 50.5  
orthoCH3Mes 2.235 19.83  
CH3Sub 
(trans to H-) 
2.170 17.67  
CH3Sub 
(trans to NHC) 
2.343 19.52  
paraCH3Mes 2.157 19.36  
H- -22.43 -  
Table 4 – NMR resonances for [Ir(H)2(SIMes)(4-Methylpyridine)3]Cl in methanol-d4 at 500 MHz spectrometer 
and 235 K 
 Formation of [Ir(H)2(SIMes)(sub)3]Cl with 4-
Pyridinecarboxaldehyde 
Upon hydrogen addition to the complex [Ir(COD)(SIMes)(sub)]Cl, where sub = 4-
pyridinecarboxaldehyde, it is the hemiacetal form that binds to the iridium catalyst. 
Resonances are observed for the 4-pyridinecarboxaldehyde equivalent which is 
present in small quantities in the free solution (Figure 60).  




Figure 60 - 1H-NMR Spectrum of [Ir(H)2(SIMes)(sub)3]Cl in methanol-d4 at 500 MHz and 263 K. Black indicates 
the presence of the free aldehyde conformation and the orange highlights the bound and free hemiacetal 
conformation. 
Position 1H-NMR 13C-NMR 15N-NMR 
OrthoHFree 
8.563 




JHH = 4.2 Hz 
121.8  
OHCCD3Free - 151.6  
Position 1H-NMR 13C-NMR 15N-NMR 
orthoHsub 
(trans to H-) 
8.28 150.0 254.4 
orthoHsub 
(trans to NHC) 
7.97 150.6 240.1 
metaHsub 
(trans to H-) 
7.18 122.53  
metaHsub 
(trans to NHC) 
7.04 122.59  




(trans to H-) 
- 154.0  
OHCCD3 
(trans to NHC) 
- 154.7  
CHAr,Mes 6.60 128.62  
N-CH2-CH2-N 3.89 50.39  
orthoCH3Mes 2.24 17.86  
paraCH3Mes 2.16 19.69  
H- -22.39 -  
Table 5 - NMR Resonances for [Ir(H)2(SIMes)(4-pyridinecarboxaldehyde)3]Cl in methanol-d4. 1H at 500 MHz, 
13C at 125 MHz and 15N at 41 MHz at 243 K. 
 SABRE Enhancements in [Ir(H)2(SIMes)(sub)3]Cl 
Once the SABRE-active species, [Ir(H)2(SIMes)(sub)3]Cl has been formed, the sample 
is ready for hyperpolarised NMR detection. For SABRE to occur, p-H2 is added to the 
sample resulting in p-H2 derived hydride ligands as a product of chemical exchange. 
Once bound to the iridium, p-H2 can transfer its non-equilibrium spin order to the 
NMR-active nuclei of the substrate via the J-coupling network.21 As the p-H2 and 
substrate are both in excess, they continuously exchange with their bound 
equivalents allowing for the hyperpolarised substrate to be built up into the solution. 
An example of the hyperpolarised spectrum is shown in Figure 61. The largest signals 
in the hyperpolarised spectrum arise from the substrate in solution and the smaller 
signals from the substrate bound trans to hydride. To calculate the enhancement, 
the hyperpolarised spectrum is compared to the thermal (non-hyperpolarised) 
spectrum obtained under identical conditions. In the case below, the hyperpolarised 
spectrum corresponds to an enhancement of −494-fold at the ortho proton for the 
complex [Ir(H)2(SIMes)(4-methylpyridine)3]Cl (Figure 63). 




Figure 61 – Thermal 1H-NMR spectrum under Boltzmann conditions (black) compared to a hyperpolarised 
spectrum where the sample was shaken for 10 s in the stray field (65 G) of the spectrometer (400 MHz) 
(pink). These were measured using a sample containing 4-methylpyridine (40 mM), [IrCl(COD)(SIMes)] (4 
mM) and p-H2 (4 bar) in methanol-d4 (0.6 mL). 
Hyperpolarised signal enhancements similar to that exhibited in Figure 61 were 
detected for each of the four substrates discussed in this chapter. However, it is 
important to note that as the 4-pyridinecarboxaldehyde binds to iridium as the 
hemiacetal form, it is this form that hyperpolarises. Interestingly, the free resonances 
of 4-pyridinecarboxaldehyde, which are present in low quantities, are also seen to 
hyperpolarise (see Figure 62). Furthermore, as the proton in the OH of the hemiacetal 
group is exchangeable, it exchanges with the solvent OH peak, also causing this to 
hyperpolarise under SABRE conditions (Figure 62). This effect appears similar to the 
SABRE-RELAY hyperpolarisation method described in Chapter 1, Section 1.5.2.4 
SABRE-RELAY via Proton Exchange. However, for the purpose of this thesis this 
‘proton exchange’ effect was not explored as it was not relevant to the study in this 
Chapter.  




Figure 62 – Thermal 1H-NMR spectrum under Boltzmann conditions (black) compared to a hyperpolarised 
spectrum where the sample was shaken for 10 s in the stray field (65 G) of the spectrometer (400 MHz) 
(orange). These were measured using a sample containing 4-pyridinecarboxaldehyde (40 mM), 
[IrCl(COD)(SIMes)] (4 mM) and p-H2 (4 bar) in methanol-d4 (0.6 mL). 
The SABRE responses of the four substrates were measured using the manual shaking  
method using the stray field of the spectrometer, described in Chapter 2.2 The 
Manual Shaking Method. 
 




Figure 63 – Enhancements at the ortho proton  resonance in the free substrate as a function of substrate pKa 
for the SABRE-active species; [Ir(H)2(SIMes)(sub)3]Cl for each of the substrates tested. The enhancements 
were observed using the manual shaking method. The experiment was repeated five times and the 1H signal 
enhancements at the ortho proton were averaged. The error bars indicate the standard error of the 
experiment.  
The smallest ortho signal enhancement of −340 ± 2-fold was observed for the SABRE 
complex containing 4-chloropyridine. As this substrate has the lowest (and most 
acidic) pKa value of 2.00 it is assumed that 4-chloropyridine weakly associates to the 
iridium centre. This means that a lesser amount of polarisation is transferred to the 
substrate before it dissociates into solution, allowing a non-hyperpolarised substrate 
from the excess solution to bind for subsequent polarisation transfer. The substrate 
with the highest (most basic) pKa, 4-methoxypyridine  yielded an enhancement of 
−680 ± 11-fold. In this case, it is predicted that 4-methoxypyridine forms much 
stronger associations to the metal centre. Association to iridium promotes 
relaxation, meaning that any hyperpolarisation transferred is lost before the 
substrate ligand dissociated into solution.15 4-Methylpyridine yielded the largest 
enhancement of −767 ± 8-fold. It seems that in this case, the substrate is bound in 
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such a way to allow for sufficient polarisation transfer before dissociation. 
Furthermore, the binding does not allow for the polarisation to be destroyed via 
relaxation. 
3.3.2.1 Effect of Catalyst Deuteration at the NHC 
Deuterating the NHC on the iridium catalyst has been seen to significantly improve 
SABRE enhancements of nicotinamide (and 2H-labelled analogues),15 pyrazinamide 
and isoniazid.22 In 2017, Rayner et al.15 reported a 250% increase in enhancement 
factor for a deuterated isotopologue of nicotinamide (methyl-4,6-d2-nicotnate) when 
d22-IMes was used, corresponding to enhancements of −7712-fold (at H-2) and 
−6368-fold (at H-5). d22-IMes was also seen to extend the T1 value by 21% for each 
proton in methyl-4,6-d2-nicotnate compared to non-deuterated IMes. The fully 
deuterated analogue; d24-IMes was also assessed, however this led to smaller 
increases in both T1 (12% increase at both H-2 and H-5) and enhancement (−5952-
fold for H-2 and −5280-fold for H-5). The difference between these two isotopologues 
is the deuteration of the imidazolydine backbone (Figure 64). This modification to the 
deuterated analogue (d24-IMes) is thought to lead to a much smaller resonance 
condition for polarisation transfer to occur. As the SABRE experiments were 
performed using the manual shaking method using the stray field of the 
spectrometer, it was difficult to maintain an exact polarisation transfer field and 
henceforth magnetism transfer from p-H2 to the substrate was inefficient, leading to 
smaller enhancements. 




Figure 64 – Structures for deuterated isotopologue of IMes. Image adapted from Rayner et al. Proceedings of 
the National Academy of Sciences, 2017. 
Norcott et al.22 also used d22-IMes to improve the SABRE efficiency for a number of 
tuberculosis drug scaffolds. They observed a −4200-fold enhancement for a partially 
deuterated isotopologue of pyrazinamide which corresponds to a 10% increase in 
enhancement factor compared to the non-deuterated form of IMes. Furthermore, 
they noted an 11% increase in the T1 value for d22-IMes compared to IMes. 
Based on this research, it was thought that using the deuterated isotopologue of 
SIMes (d22-SIMes) would also result in larger SABRE enhancements and longer T1 
values (see Section 3.6.2 Relaxation Effects in [Ir(H)2(SIMes)(sub)3]Cl, Deuteration of 
the NHC). 
The SABRE enhancements were measured using the manual shaking method using 
the stray field of the spectrometer described in Chapter 2.2.  




Figure 65 – Enhancements at the ortho proton  resonance in the free substrate  as a function of substrate pKa 
for the SABRE-active species for the four substrates. SIMes is indicated by the darker colour and d22-SIMes by 
the lighter colour. The enhancements were observed using the manual shaking method. The experiment was 
repeated five times and the 1H signal enhancements at the ortho proton were averaged. The error bars 
indicate the standard error of the experiment. 
The SABRE signal enhancements for both the deuterated SIMes and non-deuterated 
SIMes are shown in Figure 65. These data points show that using the d22-SIMes 
catalyst results in much larger enhancements for the 4-chloropyridine, 4-
methylpyridine and 4-pyridinecarboxaldehyde. The largest increase of 50% was 
observed for 4-chloropyridine compared to 29% for 4-pyridinecarboxaldehyde and 
16% for 4-methylpyridine. The enhancements for d22-SIMes follow a similar trend to 
those with SIMes, as the largest enhancement was achieved with 4-methylpyridine 
(−915 ± 18-fold). However, with the deuterated form the next largest enhancement 
was observed for 4-pyridinecarboxaldehyde (−803 ± 14-fold) compared to 4-
methoxypyridine (−677 ± 10-fold). Furthermore, the difference induced by using the 
d22-SIMes was negligible for 4-methoxypyridine.  
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3.4 Chemical Exchange in [Ir(H)2(SIMes)(sub)3]Cl 
In SABRE, the strength of the substrate-iridium association contributes towards how 
much hyperpolarised substrate lies in the solution and therefore the level of signal 
enhancement. The rate at which the substrate dissociates from the metal centre can 
be measured using NMR exchange spectroscopy (EXSY) (see Chapter6, Section 6.2.7 
Exchange Spectroscopy).23 
According to the Arrhenius equation (Equation 15), the exchange rate (k) is 
dependent on temperature. At high temperatures, exchange occurs rapidly whereas 




Equation 15 – The Arrhenius Equation, where k = rate of exchange,  Ea = activation energy, R = universal gas 
constant and T = temperature. 
Because of this, the rate of dissociation (kd) was measured at different temperatures, 
the range of which was dependent on the substrate under investigation. For 
example, observable substrate dissociation can be monitored from 255-295K for 4-
methylpyridine compared to 250-300K for 4-pyridinecarboxaldehyde. Outside of 
these ranges, substrate dissociation was not observed within the timescale of the 
EXSY experiment. The dissociation constant calculated for all substrates has been 
plotted against the temperature (see Figure 66).  




Figure 66 – The dissociation constant (kd) as a function of temperature for the SABRE active species for each 
of the substrates shown. The error bars indicate the error associated with kd calculated using the Jacknife 
method described in Chapter 6, Section 6.2.7.2 Associated errors in the calculation of kd. A table of the 
associated errors can be found in Appendix B.  
Figure 66 illustrates the exchange rates at different temperatures for each of the 
substrates. It clearly shows that the exchange rate increases with temperature 
regardless of the substrate used. 4-chloropyridine has the fastest exchange rate of 
8.88 ± 4.42 × 10-4 s-1 at 285 K, compared to 2.80 ± 2.05 × 10-4  s-1 for 4-
pyridinecarboxaldehyde, 6.69 ± 3.67 × 10-3  s-1 for 4-methylpyridine and 4.46 ± 1.23 
× 10-2  s-1 for 4-methoxypyridine. As 4-chloropyridine has the lowest pKa (2.00) out of 
the three substrates, it was hypothesised that this substrate would form weaker 
associations to the metal centre and therefore exchange on a much faster timescale 
compared to the other three substrates. It was expected that the rate of dissociation 
would become slower as the substrate pKa increased, however 4-
pyridinecarboxaldehyde (pKa = 3.12) has the slowest rate of dissociation. This 
suggests that 4-pyridinecarboxaldehyde has the strongest association to the metal 
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centre in the SABRE-active catalyst out of all the substrates in the series. This theory 
can be explored in more detail if the Gibbs free energy of dissociation is calculated 
which allows us to understand the binding potential between the substrate and the 
metal centre more confidently.  
 Using the Rate of Substrate Dissociation to Determine the Gibbs Free 
Energy 
The Gibbs free energy of dissociation (ΔG≠d) can be used to define the strength of the 
association between the substrate and the metal centre. For example, as 4-
chloropyridine has been shown to dissociate from the metal centre faster than the 
other substrates (Figure 66), it was assumed that its corresponding ΔG≠d value would 
be the lowest.  
In order to determine ΔG≠d, the enthalpy (ΔH≠d) and entropy (ΔS≠d) of dissociation 

















). The results of 
these calculations are shown in Table 6.  




Figure 67 – Eyring-Polanyi plot for the three substrates where ln(kd/T) is plotted against 1/T. The data have 
been fitted according to the equation y = mx + c. These are indicated on the graph alongside the 
corresponding substrate. 
p-substituent Cl CHO CH3 OCH3 




























Table 6 – Calculated enthalpy and entropy of dissociation (ΔH≠ & ΔS≠) for the four substrates. ΔH≠ is 
calculated from the gradient (m) and ΔS≠ is calculated from the intercept (c) using the straight-line equations 
shown in Figure 59 above. ΔH≠ & ΔS≠ weresubsequently used to calculate the Gibbs free energy of 
dissociation. The calculations for the errors in ΔH≠, ΔS≠ & ΔG≠ are explained in Chapter 6, Section 6.2.7.3 
Calculation of Gibbs free energy and associated errors. 
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The enthalpy (ΔH≠) of this process reflects the bond strength of the catalyst. Table 6 
shows that the ΔH≠ value does not link directly to the pKa of the substrate. For 
example, 4-methoxypyridine has the lowest ΔH≠ value of 83.93 ± 4.79 kJmol-1 
compared to 4-pyridinecarboxaldehyde which has the highest value of 92.84 ± 1.06 
kJmol-1. This suggests that 4-pyridinecarboxaldehyde forms the strongest bond to the 
iridium catalyst and 4-methoxypyridine the weakest. The entropy (ΔS≠) indicates the 
level of disorder or freedom on approaching the transition state in the catalyst for 
ligand dissociation. The data for ΔS≠ follows a similar pattern to the ΔH≠ values, where 
4-methoxypyridine has the lowest value of ΔS≠ (70.42 ± 17.93 JK-1mol-1) and 4-
pyridinecarboxaldehyde has the highest ΔS≠ value (95.30 ± 3.86 JK-1mol-1). These 
positive values confirm the dissociative nature of this process but are linked to 
solvation and the original bond length. The longer this bond, the greater the level of 
initial freedom and consequently the smaller the gain on reaching the loss point. This 
implies that 4-pyridinecarboxaldehyde gains the most freedom, compared to the 
other substrates, upon dissociation. 
The Gibbs free energy for ligand loss was calculated at 298 K using the ΔH≠ and ΔS≠ 
values of Table 6 according to Equation 16. 
∆𝐺≠ = ∆𝐻≠ − 𝑇∆𝑆≠ 
Equation 16 
 These ΔG≠ values were then plotted as a function of substrate pKa as detailed in 
Figure 68. It was expected that higher substrate pKa would result in higher values of 
ΔG≠298K as the Ir-N(sub) bond is stronger and therefore more thermodynamic energy 
is required for dissociation to occur. Conversely, the lower the pKa, the weaker the 
Ir-N(sub) bond and therefore the lower the ΔG≠298K. The experimental results are 
shown in Figure 68.  




Figure 68 – Gibbs free energy (ΔG≠298K) as a function of the substrate pKa for the SABRE-active species for the 
substrates shown. 
According to Figure 68 4-chloropyridine has the lowest value of ΔG≠ (62.08 kJ) while 
4-pyridinecarboxaldehyde has the highest (64.44 kJ) but there is no clear link to pKa. 
These data confirm  the rate of exchange is much slower for 4-
pyridinecarboxaldehyde compared to the other substrates. If pKa were the true 
indicator 4-methoxypyridine would have the highest ΔG≠298K value. However, the 
stronger associations observed with 4-pyridinecarboxaldehyde may result from the 
fact that the hemiacetal group is an electron withdrawing group. Consequently, it 
removes electron density from the π-system of the pyridine ring, therefore, to 
stabilise the interaction between the metal and the ligand, π-back donation occurs 
from the metal centre to the pyridine ligand. This is usually observed by short M-L 
bond distances as reported by Palusiak et al.4 and Malecki et al.24 Therefore it is 
important to note that π-effects are an important consideration of bonding which is 
not revealed through pKa. It would appear however that the expected progression in 
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entropy effects confirm that all of these substrates exhibit similar steric behaviour 
and that solvation differences are insignificant.    
3.4.1.1 Optimum Rate of Dissociation for SABRE 
In 2011, Cowley et al.25 investigated the thermodynamic and kinetic behaviour of the 
SABRE-active species [Ir(H)2(IMes)(pyridine)3]Cl. They analysed the SABRE efficiency 
at different temperatures and noted that warming of the sample to 318 K reduced 
the signal enhancement. They measured the exchange rate for pyridine to be ~11.4 
s-1 at 298 K. In 2014, Lloyd et al.26 conducted a study into NHC effects where they also 
explored chemical exchange in the SABRE active species for a number of different 
NHC ligands. As part of this study, they explored the effect of temperature on SABRE 
efficiencies which they correlated to their respective rates of substrate dissociation. 
In 2016, Barskiy et al.27 used computational methods to calculate an optimum 
dissociation rate for SABRE, which they found to be 4.5 s−1 in systems where JAB-JA’B 
= 1 Hz (e.g. N-heterocycles such as pyridine). Furthermore, in 2018 Rayner et al.28 
compared the SABRE efficiency of a range of iridium catalysts with different NHC 
ligands. They found that the best performing catalysts exhibited an exchange rate of 
approximately 4 s-1. 
The rates of substrate dissociation for each of the four substrates have been 
measured at different temperatures (Section 3.4 Exchange in [Ir(H)2(SIMes)(sub)3]Cl). 
If SABRE efficiency is optimal at 4.5 s-1, the enhancements of 4-chloropyridine would 
be larger at 281 K, compared to 288 K for 4-pyridinecarboxaldehyde where their 
respective kd values approach the optimal value. Based on this theory, the optimum 
temperature for SABRE enhancements can be calculated by rearranging the fitting 
for the kd curves shown in Section 3.4, Figure 66 (see Table 7).  
p-
substituent 
Cl CH3 OCH3 CHO 
ΔG≠298K 
(kJmol-1) 
62.08 62.82 62.94 64.44 
SABRE Optimisation for a Series of Para-Substituted Pyridines 
145 
 
pKa 2.00 4.02 4.89 3.12 
y = AeBX y = 4×10-13e0.1069x y = 4×10-17e0.1389x y = 5×10-17e0.1377x y = 4×10-19e0.1522x 
Optimum 
Temp. (K) 
281.1 282.7 285.0 288.2 
Table 7 – Optimum temperature calculated from the exponential equations fitted to the rate data in Figure 
66 using the optimum rate of 4.5 s-1. Substrates are ordered according to their ΔG≠298K values calculated in 
Table 6 
Table 7 compares the optimum temperatures for SABRE catalysis calculated from the 
optimal exchange rate of 4.5 s-1. The substrates are ordered according to their ΔG≠298K 
values calculated in Table 6 to show that the higher the value of Gibbs Free Energy, 
the higher the calculated optimum temperature for SABRE efficiency. 
In previous studies, the effect of temperature has been investigated using the manual 
shaking method using the stray field of the spectrometer.25, 26 However, as previously 
mentioned (Chapter 2, Section 2.2 The Manual Shaking Method), this method is 
susceptible to a large number of variables which results in large errors and low 
reproducibility. Performing a temperature study using this technique involves 
immersing the sample in a water bath, removing to shake for 10 s and then placing 
the sample in the spectrometer which is set to the same temperature as the water 
bath. As the sample is not maintained at the same temperature throughout the 
experiment, this method is associated with a large random error. 
In this experiment, the SABRE efficiency was studied using the highly reproducible, 
automated flow system described in Chapter 2.3.29, 30 The flow cell was modified such 
that the sample chamber was surrounded by a water jacket (Figure 69) connected to 
a variable temperature water bath which is capable of reaching temperatures 
between 277-373 K, although this range could be extended using alternative 
coolants.  




Figure 69 – The modified flow cell used to study the temperature dependence of SABRE 
For this experiment, temperatures were measured in 5 K increments over 280-300 K, 
the data was then empirically fitted using a Gauss distribution curve to predict the 
optimum temperature for SABRE (Figure 70). 




Figure 70 – Enhancement factor plotted as a function of temperature for the SABRE active species for each of 
the substrates shown. 
p-substituent Cl CH3 OCH3 CHO 
ΔG≠ 62.08 62.82 62.94 64.44 
pKa 2.00 4.02 4.89 3.12 
Predicted Temp from 
Table 7 (K) 
281.1 282.7 285.0 288.2 
Predicted Temp from 
Figure 70 (K) 
281.8 ± 1.5 285.0 ± 1.2 284.5 ± 0.4 287.4 ± 0.4 
Corresponding kd 
(s−1) 











Table 8 – The optimal temperature for SABRE predicted using an empirical fit to the data shown in Figure 70 
and the corresponding kd calculated using the exponential equations shown in Table 7. The errors in the 
optimum temperature predicted from Figure 70 are calculated from the gaussian fits shown in Figure 70. The 
error in the corresponding kd is calculated using error propagation. The error in ΔG≠ is calculated using the 
method described in Chapter 6, Section 6.2.7.3 Calculation of Gibbs free energy and associated errors. 




Table 8 shows that the measured temperatures for optimal SABRE efficiency are 
within 1 K of those predicted using an optimal exchange rate of 4.5 s-1 (Table 7) apart 
from 4-methylpyridine. Furthermore, it is clear that the optimal temperature for 
SABRE response increases with pKa. According to the Arrhenius equation (Equation 
15), exchange rate is temperature dependent, therefore the higher the temperature, 
the faster the rate of substrate dissociation. This means that the stronger the iridium-
substrate ligation, the higher the temperature required for optimum SABRE 
efficiency (e.g. 4-pyridinecarboxaldehyde). The optimum temperature could then be 
used to calculate the corresponding rate of dissociation. For example, for 4-
chloropyridine, the maximum enhancement was predicted at occur at 282 K, from 
the fitting in Figure 70, where the expected rate is 4.86 ± 0.79 s-1. For the other 
substrates investigated the corresponding maxima were seen at 286 K for 4-
methylpyridine, 285 K for 4-methoxypyridine and 287 K for 4-
pyridinecarboxaldehyde where the analogous ligand exchange rates are 6.23 ± 1.01 
s-1 (4-methylpyridine), 5.15 ± 0.25 s-1 (4-methoxypyridine) and 3.96 ± 0.25 s-1 (4-
pyridinecarboxaldehyde). This result strengthens the hypothesis that optimum 
SABRE hyperpolarisation transfer occurs when the exchange rate is around 4-5 s-1, 
there is also likely to be other factors which affect this number, such as the spin-
lattice relaxation values. Whilst these values are all close in range to the predicted 
4.5 s-1 they are statistically different from one another. 
If the ΔG≠ values are considered at these temperatures, they can be plotted against 
the associated enhancement values and compared to those at 298 K (see Section 
3.4.1).  




Figure 71 - Enhancement plotted as a function of the ΔG≠ value at 298 K using the manual shaking method 
(left) and the optimum temperature for SABRE using the automated flow system (right) 
Figure 71 shows that the highest SABRE response was detected for 4-chloropyridine 
at the optimal SABRE temperature. The corresponding ΔG≠ value for this substrate is 
63.29 kJ. At 298 K, the largest enhancement is observed for 4-methoxypyridine where 
the associated ΔG≠ value is 62.94 kJ. This suggests that SABRE enhancements are 
largely controlled by the strength of the ligation between the substrate and the 
iridium in the SABRE active catalyst. Furthermore, it appears that, for the substrates 
tested in this chapter, this ligation is optimal when the ΔG≠ value is between 62.94 
and 63.29 kJ. 
3.5 Measuring the Pseudo 4JHH Coupling in 
[Ir(H)2(SIMes)(sub)3]Cl 
A further indication of the strength of the iridium-substrate ligation is the pseudo 
transfer coupling constant. Stronger ligations are usually indicated by stronger 
coupling constants between the p-H2 derived hydride ligands and the substrate 
protons.  
As described previously (Chapter 1, Section 1.5.1.2 Mechanism of Polarisation 
Transfer), polarisation is transferred via the J-coupled network between the hydride 
and substrate ligands within the equatorial plane.31 This occurs in the first instance 
as the H-H scalar coupling between the hydride ligands determines the position of 
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the level anti-crossing (LAC) point.32 This is the magnetic field at which maximum 
polarisation transfer occurs between the hydrides and the substrate protons. In 
SABRE, this transfer occurs at a low magnetic field, typically 60 G.27 Polarisation 
transfer is driven by the long-range hydride-substrate couplings within the iridium 
complex. 
The rate of polarisation transfer is associated with the creation of spin-order on the 
substrate. This is linked to 1/2JHH, which corresponds to the coupling between the 
hydride and the polarisation receptor (substrate). In 2016 Eshuis et al.33 suggested 
that the hydride-substrate 4JHH coupling is 1.2 Hz in pyridine-like substrates. These 
measurements were conducted on complexes containing inequivalent hydrides and 
therefore the spin system is described as AX2. Recently, Barskiy et al.34 proposed that 
this coupling is usually below 1 Hz, whilst the coupling between the two hydrides is 
on the order of 5-10 Hz. For complexes of the type [Ir(H)2(SIMes)(sub)3]Cl as used 
here, the spin system is actually of the [AX2]2 and hence the determination of 4JHH less 
appropriate. Nonetheless, the build-up of polarisation through transfer between the 
hydride and substrate protons can be monitored for these complexes, in this section, 
we will refer to these measurements as the pseudo 4JHH coupling constant.  
The pseudo transfer coupling constants were measured using a series of selective 
1D-COSY experiments conducted at high field and low temperature in order to 
quantify the corresponding oscillation frequency. This method has previously been 
described by Rayner et al.28 where the hydride resonance in the SABRE-active species 
[Ir(H)2(SIMes)(sub)3]Cl is selectively excited using the pulse sequence shown in Figure 
72.  




Figure 72 - Pulse sequence for the selective 1D-COSY experiment. Adapted with permissions from P. J. Rayner 
et al. 28 
The delay constant (d4) was varied over 15 increments between 0.0078 and 0.021 s. 
The relative integral values at the ortho proton in the equatorially bound substrate 
were plotted and fitted according to a sine function to give the delay constant 
maxima. An example of this is shown in Figure 73 for the substrate 4-methylpyridine.  




Figure 73 - the relative integral of the ortho proton in the equatorially bound substrate as a function of the 
delay time (d4). The data has been fitted to a sine function and the oscillation maxima has been indicated. 
The example shown is for [Ir(H)2(SIMes)(4-methylpyridine)3]Cl. 
The pseudo-transfer coupling was then calculated by taking the reciprocal of the 
delay constant maxima and multiplying this by two. For the example shown in in 
Figure 73, this corresponds to a pseudo-transfer coupling of 1.11 Hz. This effective 
coupling has been calculated for each of the substrates discussed in this chapter and 
the values are shown in Table 9. 
p-substituent Cl CH3 OCH3 CHO 
ΔG≠298K (kJmol-1) 62.08 62.82 62.94 64.44 
pKa 2.00 4.02 4.89 3.12 
Pseudo Transfer 
Coupling  (Hz) 
1.05 1.11 1.24 1.38 
Table 9 - Table comparing the 4JHH values to the corresponding ΔG≠298K and pKa values of the substrate 




Figure 74 - The long range hydride-substrate coupling, 4JHH, as a function of the Gibbs free energy (ΔG≠298K) for 
each of the substrates indited 
Figure 74 displays the pseudo-transfer coupling  constants as a function of the ΔG≠298K 
values calculated in the previous section. The stronger the substrate-iridium ligation, 
the larger the value of pseudo-transfer coupling. For example, 4-
pyridinecarboxaldehyde has the largest value of ΔG≠298K at 64.44 kJ and the largest 
corresponding value of 4JHH of 1.38 Hz. The larger this pseudo hydride-substrate 
coupling, the more efficient the polarisation transfer into the substrate. However, 
the enhancements shown in Figure 63, show that whilst 4-pyridinecarboxaldehyde 
has the largest 4JHH value, it yields an enhancement of −571 ± 41-fold. This compares 
to 4-methylpyridine which yields the largest enhancement of −767 ± 8-fold but has a  
transfer coupling constant of 1.11 Hz. This information suggests that another effect 
such as relaxation must be an important consideration of SABRE efficiency.  
These calculated values are comparable to those suggested by Eshuis and Barskiy 
above.33, 34 However, the delay maxima values are similar to those measured by 
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Rayner et al.28 where a maxima of 0.116 s was quoted for the SABRE-active species 
[Ir(H)2(IMes)(methyl-4,6-d2-nicotinate)3]Cl. This corresponds to a 4JHH value of 1.07 
Hz, which is similar to those found in Table 9. 
3.6 Relaxation Effects [Ir(H)2(SIMes)(sub)3]Cl 
As described previously in Chapter 1 (Section 1.5.6 Relaxation Effects in the SABRE-
Active Species), ligation to iridium promotes relaxation. Therefore, the T1 relaxation 
value can indicate the strength of the iridium-substrate ligation. It is hypothesised 
that the stronger the substrate associates to the metal centre, the faster the rate of 
relaxation and therefore smaller the T1 value.  
 T1 and Hyperpolarised T1 Measurements 
T1 and hyperpolarised T1 measurements were collected according to the methods 
described in Chapter 6, Section 6.2.7.2.1 T1 Relaxation Measurements. These values 
were calculated at both the ortho and meta protons for each of the three substrates 
previously discussed in this section at 298 K. However, only the T1 values at the ortho 
protons are discussed as this resonance exhibits higher enhancement levels and 
receives more direct polarisation. In order to prove that ligation to the metal 
promotes relaxation, the T1s for the free substrate in solution have been compared 
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to those bound trans to the NHC and trans to the hydride in the SABRE-active 
complex (Figure 75). 
 
Figure 75 – T1 as a function of ΔG≠298K for the SABRE active species for the substrates shown. The graph shows 
the T1 at the ortho-proton in the free material (dark colour) compared to the ortho-proton in the substrate 
bound trans to the hydride (medium colour) and the ortho-proton in the substrate bound trans to the NHC 
(light colour). The error bars indicate the fitting error for the T1 curves shown in Appendix B. 
p-substituent Cl CH3 OCH3 CHO 
ΔG≠298K 62.08 62.82 62.94 64.44 
pKa 2.00 4.02 4.89 3.12 
HyperT1 (s) 8.86 7.70 5.60 4.85 
Free(cat) T1(s) 8.49 ± 0.26 6.50 ± 0.04 5.35 ± 0.16  3.54 ± 0.02 
Trans to H- T1 (s) 6.49 ± 2.08 6.42 ± 0.10 5.09 3.43 ± 1.58 
Trans to NHC T1 (s) 3.04 ± 1.58 1.95 ± 0.04 1.76 ± 0.07 1.81 ± 0.03 
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Table 10 – Comparison of the T1 and Hyperpolarised T1 values at the ortho proton for each of the four 
substrates. The errors in the T1 values are calculated from fitting the T1 curves shown in Appendix B. 
As predicted, Figure 75 demonstrates that as the substrate ΔG≠298K increases, the T1 
value decreases due to longer residence times on the catalyst. This contributes to the 
lower 1H enhancements shown in Figure 63 for 4-pyridinecarboxaldehyde compared 
to 4-methylpyridine and 4-methoxypyridine. The T1 values of the substrate bound 
trans to the NHC are shown to be shorter than those of the equatorially bound 
substrate (trans to hydride). This is due to the strong iridium-substrate ligation with 
does not exchange on the timescale of the T1 NMR experiment.14, 15 The T1 values of 
the equatorial substrate bound trans to hydride are similar to those of the free 
substrate as they exchange with one another, meaning they are a weighted 
average.26, 29, 35 
 Effect of Catalyst Deuteration atthe NHC 
The use of deuterated NHCs has been shown to decrease the rate of relaxation, and 
thus increase the T1 value (see Section 3.3.2.1 SABRE Enhancements in 
[Ir(H)2(SIMes)(sub)3]Cl, Effect of Catalyst Deuteration at the NHC),15, 22 therefore the 
T1 values for d22-SIMes were also measured and compared to the non-deuterated 
NHC.  




Figure 76 – T1 as a function of ΔG≠298K for the SABRE active species, [Ir(H)2(SIMes)(sub)3]Cl, for the substrates 
shown. The graph compares the T1 at the ortho-proton when SIMes is used as the NHC (darker colour) to the 
ortho-proton in the substrate when d22-SIMes is used as the NHC (lighter colour). The errors in the T1 values 
are calculated from fitting the T1 curves shown in Appendix B. 
p-substituent Cl CH3 OCH3 CHO 
ΔG≠298K (kJmol-1) 62.08 62.82 62.94 64.44 
pKa 2.00 4.02 4.89 3.12 
T1 SIMes (s) 8.49 ± 0.26 6.50 ± 0.04  5.35 ± 0.16 3.54 ± 0.02 
T1 d22-SIMes (s) 8.76 ± 0.39 8.27 ± 0.06 6.77 ± 0.03 3.95 ± 0.02 
Table 11 – T1 values at the ortho proton in the free substrate for d22-SIMes and SIMes for each of the four 
substrates. The errors in the T1 values are calculated from fitting the T1 curves shown in Appendix B. 
As predicted, the data shows that the deuterated analogue of SIMes extends the T1 
value for the substrate in the SABRE mixture (Table 11). d22-SIMes significantly 
increases the T1 value for both 4-methylpyridine and 4-methoxypyridine. For these 
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substrates, a 21% increase is induced in the T1 which is comparable to the increases 
observed by Rayner et al.15 with d22-IMes for a deuterated form of nicotinamide (21% 
increase). The T1 values of 4-pyridinecarboxaldehyde and 4-chloropyridine are also 
lengthened, but to a lesser extent to the other substrates as a 10% increase is noted 
for the former compared to 3% for the latter. These smaller increases in T1 lifetimes 
may be a result of their respective rates of substrate dissociation. 
 Optimum Rate of Dissociation for SABRE 
Binding to iridium is known to promote relaxation of the substrate protons and so 
this may contribute to the differences in kd predicted in Table 8 (see Section 3.4.1.1 
Exchange in [Ir(H)2(SIMes)(sub)3]Cl, Optimum Rate of Dissociation for SABRE). To test 
this, the effective T1 values for the four substrates were measured at the optimal 
temperatures of 281.8 K (4-chloropyridine), 285 K (4-methylpyridine), 284.5 K (4-
methoxypyridine) and 287.4 K (4-pyridinecarboxaldehyde) shown in Table 8. For 4-
chloropyridine, the T1 was measured to be 5.63 ± 0.07s, compared to 4.07 ± 0.07s (4-
methylpyridine), 3.3 ± 0.3s (4-methoxypyridine) and 2.6 ± 0.2s (4-
pyridinecarboxaldehyde). If the T1 values are plotted against the enhancement factor 
both determined at their respective optimum temperatures (Figure 77), it is clear 
that once the rate of dissociation is removed from consideration, the T1 becomes the 
dominant factor dictating the level of enhancement. For example, larger 
enhancements are observed for longer T1 values (4-chloropyridine). These data 
points can be fitted using a single exponential; therefore, beyond this point (4-
chloropyridine) the level of enhancement will be less sensitive to changes in the T1 
value. This would suggest that beyond this point the enhancement could be 
controlled by a number of different variables including: p-H2 concentration or the 
rate of hydrogen exchange. 




Figure 77 – T1 values at the ortho-proton in the free substrate for the substrates shown as a function of the 
optimum SABRE temperatures shown in Table 8. 
3.7 Exploring the Effect of Catalyst Modifications on Iridium-
Substrate Ligation 
Modifications at the NHC in the SABRE catalyst have been shown to influence the 
SABRE efficiency of a number of substrates.26, 28, 36 In 2013, van Weerdenburg et al.36 
investigated the impact of different functionalities on the arms of the central 
imidazole ring (Figure 78).  
 
Figure 78 – Basic structure for the NHC ligand 
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They quantified the steric and electronic effects of various aliphatic and aromatic R-
groups on the buried volume (%Vbur) and the Tolman Electronic Parameter (TEP). 
They reported that aromatic R-groups provided better SABRE enhancements. 
Additionally, they found that unsaturated ligands have less steric bulk compared to 
their respective saturated counterparts and yield much higher signal enhancements. 
The following year, Lloyd et al.26 expanded on this research and reported that the 
larger the R-group (and the larger the steric bulk), the faster the rate of substrate 
dissociation. Consequently, they identified that the more sterically-encumbered 
NHCs cause elongation of the Ir-py bonds, resulting in smaller Ir-py bond energies 
(ΔH≠) and a smaller release in entropy (ΔS≠) on reaching the transition state required 
for substrate dissociation. Both groups found that optimum rates of substrate 
dissociation are achieved when mesityl groups are attached to the imidazole (1,3-
bis(2,4,6-trimethyl phenyl)imidazole - IMes and 1,3-bis(2,4,6-trimethylphenyl)-4,5-
dihydroimidazol-2-ylidene – SIMes), however the largest enhancements were 
observed for the unsaturated analogue, IMes.  
In 2018, Rayner et al.28 further expanded this research area by modifying the 
functionality at the ortho, meta and para positions on the mesityl ring along with 
altering the substituents on the imidazolium backbone and comparing them to IMes 
for the substrate methyl-4,6-d2-nicotinate. They found that introducing strongly 
electron donating groups (such as tert-butyl) in the para position of the mesityl ring 
resulted in a higher rate of substrate dissociation. They suggested that these groups 
increase the electron density on the metal centre, stabilizing the intermediate 
complex leading to faster iridium-substrate dissociation (Figure 79). Furthermore, 
the addition of chloro-containing substituents on the imidazole ring significantly 
slows ligand association as they pull electron density away from the metal centre 
(Figure 79). 




Figure 79 – Structures of the NHCs; SIMes, ITBXy and IMesCl, including the TEP and %Vbur values. 
In this section, the effect of changing the NHC was explored in order to identify 
whether similar behaviours were observed in terms of enhancement, kd and T1. The 
NHCs chosen for this investigation were 1,3-bis(4-tert-butyl-2,6-
dimethylphenyl)imidazole-2-ylidine (ITBXy) and 1,3-bis(2,4,6-trimethylphenyl)-4,5-
dichloroimidazol-2-ylidine (IMesCl) (see Figure 79). 
It was hypothesised that ITBXy would promote faster rates of substrate dissociation 
compared to SIMes as the tert-butyl groups in the para position on the phenyl ring 
contribute towards the increased electron density on the iridium centre, resulting in 
weaker iridium-substrate associations and hence, faster substrate dissociation. This 
is demonstrated via the TEP values for SIMes (2051.5 cm−1) and ITBXy (2049.6 cm−1) 
shown in Figure 79. Conversely, it was predicted that IMesCl would strengthen the 
iridium-substrate interaction compared to SIMes as the chlorides on the imidazole 
pull electron density away from the iridium centre resulting in slow substrate 
dissociation. This is also shown in Figure 79 where the TEP value for IMesCl is 2052.8 
cm−1 compared to 2051.5cm−1 for SIMes. 
 Gibbs Free Energy in [Ir(H)2(NHC)(sub)3]Cl 
The rates of substrate dissociation at different temperatures were used to determine 
the Gibbs free energy of dissociation for each of the catalyst/substrate combinations 
(Figure 80). 
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Figure 80 – The Gibbs free energy ΔG≠298K as a function of the NHC in the SABRE active species, 




Cl CH3 OCH3 CHO 
ΔG≠(298) 
(kJmol-1) 
pKa 2.00 4.02 4.89 3.12 
SIMes  62.08 62.82 62.94 64.44 
ITBXy  65.64 65.43 65.56 66.86 
IMesCl  68.14 68.46 68.51 69.90 
Table 12 – ΔG≠(298) values for each of the substrate/catalyst combinations. The errors in the ΔG≠ values were 
calculated using the method described in in Chapter 6, Section 6.2.7.3 Calculation of Gibbs free energy and 
associated errors. As the errors are very small they are not listed in this table but they can be found in 
Appendix B. 
Figure 80 compares the ΔG≠298K values calculated for each substrate/NHC 
combination. Similar trends are observed for SIMes and IMesCl where 4-
chloropyridine has the lowest value of ΔG≠298K followed by 4-methylpyridine, 4-
methoxypyridine and 4-pyridinecarboxaldehyde. If the NHC ITBXy is employed, 4-
methylpyridine has the lowest value of ΔG≠298K (65.43 kJmol-1) followed by 4-
methoxypyridine (65.56 kJmol-1), 4-chloropyridine (65.64 kJmol-1) and 4-
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pyridinecarboxaldehyde (66.86 kJmol-1). 4-pyridinecarboxaldehyde consistently has 
the highest value of ΔG≠298K regardless of the NHC used. This contradicts the 
hypothesis that the lower the pKa, the weaker the iridium-substrate association and 
therefore the lower the value of ΔG≠298K . This stronger interaction has been 
attributed to the increased π-backdonation that occurs from the metal centre to the 
ligand as a consequence of the electron withdrawing hemiacetal group which 
removes electron density from the pyridine ring.  
As predicted, IMesCl encourages stronger iridium-substrate associations in all the 
substrates as the ΔG≠(298) value increased from 62.08 kJmol-1 to 68.14 kJmol-1 for 4-
chloropyridine and 64.44 kJmol-1 to 69.90 kJmol-1 for 4-pyridinecarboxaldehyde. It 
was anticipated that the catalyst modification ITBXy would encourage weaker 
iridium-substrate associations as the tert-butyl groups in the para position on the 
mesityl group increase the electron density on the iridium resulting in faster 
substrate dissociation. This is demonstrated in Figure 79 by the TEP values for SIMes 
(2051.5 cm-1) and ITBXy (2049.6 cm-1). However, Figure 80 shows that ITBXy instead 
favours the formation of stronger associations as the ΔG≠(298) values are higher than 
those of SIMes. For example, the ΔG≠(298) value increased from 62.08 kJ to 65.64 kJ 
for 4-chloropyridine. If the steric contribution for each of the catalyst modifications 
are considered, the buried volume for ITBXy (31.7%) is smaller than for SIMes 
(36.9%), meaning it is less sterically encumbered (Figure 79). As SIMes is bulkier, it 
pushes the substrate further away from the iridium centre weakening this 
association and culminating in faster substrate dissociation. Therefore, when SIMes 
is compared to ITBXy, sterics are a vital aspect when considering iridium-substrate 
ligation. 
 Relaxation Effects in [Ir(H)2(NHC)(sub)3]Cl 
The T1 relaxation data was measured using the process described in Chapter 6 
(Section 6.2.7.2.1 T1 Relaxation Measurements), for each of the substrate/catalyst 
combinations. As binding to iridium promotes relaxation, it was predicted that the T1 
values measured for ITBXy and IMesCl would be shorter compared to SIMes. 




Figure 81 – T1 as a function of the NHC in the SABRE active species, [Ir(H)2(NHC)(sub)3]Cl for the substrates 
shown. The T1 is for the ortho-proton in the free substrate. The errors in the T1 values are calculated from 
fitting the T1 curves shown in Appendix B. 
Figure 81 shows that as the T1 decreases with the substrate  ΔG≠(298)  irrespective of 
the NHC used. For example, for SIMes the T1 values vary from 8.49 s (4-
chloropyridine) to 3.54 s (4-pyridinecarboxaldehyde), for ITBXy they range from 9.31 
s to 4.31 s, finally for IMesCl they vary from 9.45 s to 5.25 s. As the catalyst 
modifications ITBXy and IMesCl encouraged stronger iridium-substrate associations 
and it is well established that binding to iridium promotes relaxation, it was expected 
that the corresponding T1 values would be shorter compared to SIMes. Whilst this is 
the case for 4-methoxypyridine and 4-pyridinecarboxaldehyde combined with ITBXy, 
longer T1 values are observed for 4-chloropyridine and 4-methylpyridine. When 
IMesCl is considered, longer T1 values are observed for all four of the substrates. In 
this catalyst modification, the replacement of the hydrogens on the imidazolydine 
backbone with chlorides is thought to remove a scalar coupling route to relaxation, 
hence T1 values are longer. 28 
SABRE Optimisation for a Series of Para-Substituted Pyridines 
165 
 
 Enhancement in [Ir(H)2(NHC)(sub)3]Cl 
All enhancements were measured with the manual shaking method using the stray 
field of the spectrometer, using 4 bar (absolute) pressure of 99.9% p-H2. However, 
when ITBXy was used with 4-methylpyridine, antiphase peaks were observed (Figure 
82) which are characteristic of radiation damping. Radiation damping is typically 
observed at high field and in the presence of protonated solvents. As these samples 
are highly concentrated (proton rich), when a pulse is applied, placing the protons in 
the transverse (xy plane), a rotating electromotive force is induced in the RF coil. This 
produces an additional magnetic field in the sample, leading to peak broadening, 
peak asymmetry, phase shifting and residual signals.37-39 In some SABRE experiments, 
the intensity of the hyperpolarised signals has been seen to induce similar affects.40  
 
Figure 82 - Radiation dampening observed during repeating manual shaking using the stray field of the 
spectrometer, with 4-methylpyridine, ITBXy and 99% p-H2 
In Figure 82 it was observed that with continued shaking without refreshing the p-
H2, the hyperpolarised signals eventually became in-phase once the signal reaches a 
certain level (see Shakes 4 and 5). In 2018, Richardson et al.40 measured the level of 
substrate enhancement as a function of p-H2 enrichment. It was found that there was 
a linear relationship between these variables for a range of molecules, catalysts and 
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NMR detection fields. It was thought that using a lower level of enrichment here 
could also be employed to overcome the radiation damping problem presented in 
Figure 82 where the enhancements could be calculated at different concentrations 
of p-H2 in order to predict the enhancement at 99.9 %. The concentrations selected 
were 40, 50 and 60 % p-H2 and once these had been plotted against the relative 
enhancements, the enhancement at 99.9 % could be calculated using a linear model 
(Figure 83).40  
 
Figure 83 - Plot of enhancements against p-H2 percentage 
Predicting the enhancement in this way gave rise to the largest signal enhancement 
out of all the substrate/catalyst combinations (−980 ± 10-fold for 4-methylpyridine 
and ITBXy). The largest measured enhancement was −756 ± 18-fold for 4-
methoxypyridine and IMesCl (Figure 84). As the NHC influences the iridium-substrate 
association, each substrate produced the largest enhancement for different NHCs. 
For example, 4-pyridinecarboxaldehyde has been seen to form strong associations 
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with SIMes, therefore when these associations are further strengthened via the NHC 
modifications ITBXy and IMesCl, substrate dissociation is even slower and relaxation 
effects are stronger, resulting in lower enhancements. It seems that the largest 
enhancements are observed when the ΔG≠(298) value lies between 64.44 kJ (4-
pyridinecarboxaldehyde + SIMes) and 65.56 kJ (4-methoxypyridine + ITBXy). 
 
Figure 84 – Enhancement factor as a function of the NHC in the SABRE active species, [Ir(H)2(NHC)(sub)3]Cl for 
the substrates shown. The enhancements were observed using the manual shaking method. The experiment 
was repeated five times and the 1H signal enhancements at the ortho proton were averaged. The error bars 
indicate the standard error of the experiment. 
3.7.3.1 NHC Deuteration 
As the combination of 4-methylpyridine and catalyst ITBXy yielded the largest 
enhancement of −980 ± 10-fold, the deuterated analogue of the NHC was also tested. 
Instead of using the traditional manual shaking method involving the stray field of 
spectrometer, this was tested using the 65 G shaker. Furthermore, five [p-H2] 
concentrations were chosen rather than three in order to accurately predict the 
enhancement level at 99.9% p-H2. 




Figure 85 - Variation in enhancement factor with [p-H2] for ITBXy and its deuterated isotopologue d34-ITBXy 
Enhancement levels with d34-ITBXy were larger compared to the non-deuterated 
analogue. For example, at 70% p-H2, the signal enhancement was −619 ± 56-fold for 
ITBXy compared to −839 ± 22-fold for d34-ITBXy which corresponds to a 36% increase. 
By using the straight-line equations, it was predicted that enhancements of −990 ± 
65-fold would be observed for ITBXy and −1411 ± 40-fold for d34-ITBXy at 99% p-H2.  
3.8 Summary 
In this chapter, the strength of the iridium-substrate ligation in the SABRE-active 
species and consequently the SABRE response was investigated. The strength of this 
ligation was probed by a range of para substituted pyridines. This topic is of high 
importance in the optimisation of the SABRE approach as a lot of work goes into the 
optimisation of each individual system, therefore this work could lead to some insight 
into predicting substrate-catalyst behaviour.  
SABRE Optimisation for a Series of Para-Substituted Pyridines 
169 
 
Substitution at the para position is known to have the greatest effect on the activity 
of pyridine which can be expressed in terms of pKa. The substrates selected for this 
study were 4-chloropyridine, 4-pyridinecarboxaldehyde, 4-methylpyridine and 4-
methoxypyridine which have corresponding pKa values of 2.00, 3.12, 4.02 and 4.89. 
It was predicted that the higher the substrate pKa, the stronger the substrate would 
associate to the metal centre. This hypothesis was validated using the rate of 
substrate dissociation and the rate of relaxation. It was postulated that strong 
substrate-iridium ligations would result in slow substrate dissociation and shorter T1 
values. Conversely, weak ligations would be demonstrated by fast rates of substrate 
dissociation and longer T1 values. 
The SABRE enhancements of the SABRE-active species for the four substrates were 
determined. 4-Methylpyridine yielded the largest enhancement of −767 ± 8-fold 
compared to −340 ± 2-fold (4-chloropyridine), −571 ± 41-fold (4-
pyridinecarboxaldehyde) and −680 ± 11-fold (4-methoxypyridine). This means that 4-
methylpyridine binds to iridium such that relaxation effects are not induced whilst 
sufficient polarisation is transferred from the hydrides before substrate dissociation 
occurs. 
The rate of substrate dissociation was determined over a range of different 
temperatures for each of the substrates. It was observed that 4-chloropyridine had 
the fastest rate of dissociation followed by 4-methylpyridine, 4-methoxypyridine and 
4-pyridinecarboxaldehyde. It was expected that the rate of dissociation would 
become slower as the substrate pKa increased. It was observed that 4-
pyridinecarboxaldehyde had the slowest rate of dissociation compared to the other 
substrates, suggesting it forms stronger associations to the metal centre. Previous 
works have suggested that the optimum dissociation rate for SABRE is 4.5 s-1.27, 28 
According to the Arrhenius equation, the rate of dissociation is temperature 
dependent and therefore SABRE efficiency must also vary with temperature. It was 
predicted that the optimum temperatures for SABRE (where kd = 4.5 s-1) were 281.1 
K, 282.7 K, 285.0 K and 288.2 K across the substrate series. The effect of temperature 
on SABRE efficiency was measured using a variable temperature flow system. The 
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SABRE enhancements were then plotted as a function of the temperature and fitted 
with a gauss curve to determine the precise temperature for optimum SABRE 
catalysis. These were 281.8 K (4-chloropyridine), 285 K (4-methylpyridine), 284.5 K 
(4-methoxypyridine) and 287.4 K (4-pyridinecarboxaldehyde), confirming that the 
stronger the iridium-substrate association, the higher the temperature required for 
optimum SABRE efficiency. The corresponding rates of dissociation were also 
calculated as 4.86 ± 0.79 s-1, 6.23 ± 1.01 s-1, 5.15 ± 0.25 s-1 and 3.96 ± 0.25 s-1 which 
whilst statistically different from one another, are all comparable to the predicted 
optimum of 4.5 s-1. 
Further analysis of the rate of dissociation via the Eyring-Polanyi equation allowed 
for the Gibbs free energy of dissociation to be calculated. The Gibbs free energy 
describes the stability of the iridium-substrate ligation.  4-Chloropyridine had the 
highest value of ΔG≠298K  at 62.08 kJmol-1 compared to 62.82 kJmol-1 (4-
methylpyridine),  62.94 kJmol-1 (4-methoxypyridine) and 64.44 kJmol-1 (4-
pyridinecarboxaldehyde).  It was expected that ΔG≠298K would increase with the 
substrate pKa, however the strongest iridium-substrate interaction was observed for 
4-pyridinecarboxaldehyde (pKa = 3.12) as it exhibits the highest ΔG≠298K value of the 
series. This stronger association explains why 4-pyridinecarboxaldehyde has the 
slowest rate of dissociation compared to the other three substrates. As 4-
pyridinecarboxaldehyde contains an electron withdrawing group, π-backdonation 
occurs from the metal centre to the pyridine to stabilise the metal-ligand interaction. 
This means that this interaction is more stable compared to those observed with 4-
chloropyridine, 4-methlypyridine and 4-methoxypyridine. The ΔG≠298K values were 
also determined at the optimum SABRE temperatures. Comparison of these values 
with the corresponding enhancements at 298 K and the optimum SABRE 
temperature suggested that for optimum SABRE the ΔG≠ value must lie between 
62.94 kJmol-1 and 63.29 kJmol-1. 
The pseudo transfer couplings (4JHH) between the hydride and the substrate protons 
were also determined. Whilst there was no clear relationship to substrate pKa, it was 
observed that this coupling increased with the strength of the substrate-iridium 
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ligation, as observed via ΔG≠298K. For example, 4-pyridinecarboxaldehyde had the 
largest value of value of ΔG≠298K (64.44 kJ) and the largest corresponding pseudo 
transfer coupling of 1.38 Hz. This compares to 4-chloropyridine that formed the 
weakest ligations to iridium (ΔG≠298K =) and exhibited the smallest value of 4JHH (Hz). 
It was assumed that the larger the pseudo coupling, the more efficient the 
polarisation transfer into the substrate. However, the largest enhancements were 
observed with 4-methylpyridine (−767 ± 8-fold) which has a transfer coupling of 1.11 
Hz. 4-pyridinecarboxaldehyde however, yielded a smaller enhancement of −571 ± 41-
fold, suggesting that relaxation effects are another important consideration of SABRE 
efficiency.  
The T1 values were also measured at 298 K for the free and bound substrate in the 
SABRE active species [Ir(H)2(SIMes)(sub)3]Cl for the four substrates. Ligation to the 
metal centre promotes relaxation of the substrate resulting in shorter T1 values. This 
was observed when the effective T1 values were compared to axial substrate bound 
trans to the NHC which doesn’t exchange on the timescale of the NMR experiment. 
For instance, the free ortho T1 of 4-chloropyridine was 8.49 s compared to 3.04 s in 
the axial bound substrate. This also meant that 4-pyridinecarboxaldehyde which 
forms the strongest associations to iridium had the shortest T1 values from the series 
(3.54 s in the free substrate and 1.81 s in the axially bound substrate). The effective 
T1 values were also measured for the free substrate at the SABRE optimum 
temperatures of 281.8 K (4-chloropyridine), 285 K (4-methylpyridine), 284.5 K (4-
methoxypyridine) and 287.4 K (4-pyridinecarboxaldehyde). These were measured as 
5.63 ± 0.07 s, 4.07 ± 0.07 s 3.3 ± 0.3 s and 2.6 ± 0.2 s, respectively. When these data 
points are plotted against the corresponding enhancement maxima it seems that 
once the rate of substrate dissociation is removed from consideration, the T1 
becomes the dominant factor controlling the level of SABRE enhancement. 
Furthermore, the data points can be fitted to a single exponential suggesting that 
there is a limit to this T1 effect.  
To compliment previous works, these measurements were expanded to include two 
additional NHCs; 1,3-bis(4-tert-butyl-2,6-dimethylphenyl)imidazole-2-ylidine (ITBXy) 
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and 1,3-bis(2,4,6-trimethylphenyl)-4,5-dichloroimidazol-2-ylidine (IMesCl). It was 
predicted that ITBXy would encourage formation of weaker substrate associations 
whilst IMesCl would favour stronger associations. However, analysis of the ΔG≠298K 
data showed that ITBXy stronger substrate-iridium associations existed. The buried 
ligand volumes showed that SIMes is more sterically hindered; hence it promotes 
weaker substrate associations. The ΔG≠298K values for ITBXy and IMesCl followed a 
similar trend to those of SIMes where 4-chloropyridine had the smaller value of 
ΔG≠298K and 4-pyridinecarboxaldehyde had the highest.  Furthermore, the T1 value of 
the substrate decreased with substrate ΔG≠298K . The NHC was seen to critically 
influence the level of 1H SABRE enhancement observed. The largest enhancement of 
−980 ± 10-fold was detected for 4-methylpyridine and the NHC; ITBXy. As 4-
pyridinecarboxaldehyde had been shown to form strong associations with SIMes, 
further strengthening these associations via the ITBXy and IMesCl modifications lead 
to smaller enhancements.  
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Chapter 4 SABRE Optimisation for Oxygen-Bound 
Pyridines 
4.1 The Substrates 
The previous chapter compared the SABRE efficiency of a series of para-substituted 
pyridine derivatives. 4-hydroxypyridine and isoniazid were originally selected for this 
study as they also reflect readily available para-substituted pyridines with low pKa 
values (3.20 and 1.82 respectively). However, upon reaction with H2 and 
[IrCl(COD)(SIMes)], rather than form a tris-substituted SABRE-active species typically 
observed (see previous chapter), they each formed a bis-substituted complex. These 
complexes proved to contain a substrate ligand bound to iridium via the secondary 
functional group rather than the pyridine nitrogen. Both complexes have been shown 
to enhance under SABRE conditions.  
These structures have been fully characterised by 1H, 13C and 15N-NMR methods. 
Furthermore, their SABRE suitability has also been explored. These results are now 
discussed. 
 4-Hydroxypyridine 
At first glance, 4-hydroxypyridine presents itself as a simple alcohol derivative of 
pyridine where the functional group is located in the para-position. However, the 
proton of the alcohol functional group is acidic meaning that tautomerism results in 
both enol (4-hydroxypyridine) and keto equivalent forms (4-pyridone).1 This 
tautomerism has been studied extensively as it is of considerable importance in both 
chemical and biochemical processes.2 For example, this tautomeric equilibria can 
provide a rationale for the structure-function relationships exhibited by nucleotides, 
the mechanism of enzyme catalysis and substrate-receptor interactions.3  




The tautomeric equilibria between 4-hydroxypyridine and 4-pyridone is shown in 
Figure 86. This interaction has been heavily scrutinised and can be influenced by the 
phase, solvent, temperature and substitution around the pyridine ring. 
 
Figure 86 - Tautomerism of 4-hydroxpyridine to 4-pyridone 
In 1999, Murguly et al.4 studied the tautomerism of 4-hydroxyterpyridine in the solid, 
solution and gas phases via infrared (IR) and nuclear magnetic resonance (NMR) 
spectroscopy. They established that in the gaseous phase, 4-hydroxypyridine exists 
exclusively in the enol form. This was evident by IR spectroscopy, where an isolated 
O-H stretch was observed at 3640 cm-1. In the solid phase, the keto form is 
predominant. This is indicated by the presence of an N-H IR stretch at 3280 cm-1. In 
polar solvents, such as chloroform or methanol, 4-pyridone is favoured as the IR 
spectrum now shows an N-H stretching band at 3310 cm-1 and a C=O stretch at 1635 
cm-1. In solution with dichloromethane, however, a mixture of both tautomers is 
indicated according to 1H-NMR spectroscopy at 25°C, in a ratio of 6:1 (keto/enol). The 
proportion of the enol tautomer was shown to increase at lower temperatures. This 
result was surprising as the dielectric constant of CD2Cl2 increases upon cooling5 and 
larger dielectric constants favour polar tautomers,6 hence it was assumed that the 
more polar keto tautomer would exist exclusively at these temperatures.  
The predominance of the keto tautomer; 4-pyridone in the crystalline form and in 
solution with polar solvents was also supported by Albert et al.1 who used Raman 
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and IR spectroscopy to analyse this tautomerism. Vogeli et al.7 also observed similar 
findings using 13C and 1H NMR techniques.   
Katritzky et al.8-10 has investigated the effect of substituents on 4-hydroxypyridine/4-
pyridone tautomerism in a number of papers. He found that placing electron 
withdrawing groups, such as chlorine, α (ortho) to the pyridine nitrogen atom favours 
the enol form, 4-hydroxy-2-chloro-pyridine. This is because the chlorine increases the 
acidity of the amine group in the pyridine form and decreases the basicity of the 
nitrogen in the hydroxy form thereby pushing the equilibrium to favour 4-
hydroxypyridine.9 In contrast, electron donating groups in the ortho-position were 
shown to favour the keto form, 4-pyridone.8 Placing either group in the β-position 
(meta) had little effect on the equilibrium position. 
Before 4-hydroxypyridine was used in SABRE experiments, it was first characterised 
by FTIR and NMR methods.  
4.1.1.1.1 Fourier Transform Infra-Red Spectroscopy 
Due to the tautomerism of 4-hydroxypyridine to 4-pyridone, a number of samples of 
4-hydroxypyridine were analysed via FTIR. First the solid, then a solution of 4-
hydroxypyridine in dichloromethane-d2 and a second solution in methanol-d4. 
Deuterated solvents were used as the same samples were used for the NMR 
experiments. The FTIR spectra were measured using a Bruker Tensor 37 FTIR 
spectrometer, the solid sample was placed directly onto the diamond crystal whereas 
the solution FTIR samples were measured using the diamond fibre optic probe 
submersed in < 1 mL solution in a sample vial. 




Figure 87 - FTIR spectra of 4-hydroxypyridine solid (black), dissolved in dichloromethane-d2 (red) and 
dissolved in methanol-d4 (blue). Solid FTIR was measured where a <1 mg of substrate was placed directly 
onto the diamond crystal. Solution FTIR was measured using the diamond fibre optic probe submersed into a 
vial containing the sample. 
Figure 87 shows the FTIR spectra for the solid sample (black) compared to the two 
solutions in methanol-d4 (blue) and dichloromethane-d2 (red). The solid sample 
shows an absorbance at 3035 cm-1 which is indicative of an N-H stretch. The N-H 
bending mode is observed at 1504 cm-1. A C=O stretch is observed at 1629 cm-1. An 
O-H stretch which spans a wide range of absorbance frequencies (3300-2250 cm-1) is 
due to intermolecular H-bonding via the carbonyl group. This confirms that the solid 
form exists exclusively as the keto tautomer. In methanol-d4, the keto tautomer is 
also observed via absorbances at 3267 cm-1 and 1632 cm-1 which indicate the N-H 
and C=O stretching modes respectively. 4-Pyridone is shown to form in d2-
dichloromethane by the presence of the N-H stretch at 3172 cm-1 and the C=O stretch 
at 1629 cm-1. 
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4.1.1.1.2 Temperature Dependence 
In 1999 Murguly et al.4 discovered that the keto/enol tautomerism of 4-
hydroxypyridine in dichloromethane-d2 was affected by temperature. They found 
that as they lowered the temperature from 25°C to -80°C, the proportion of the enol 
tautomer increased.  
To investigate the effect of temperature on the keto/enol tautomerism, 4-
hydroxypyridine (< 1 mg) was dissolved in dichloromethane-d2 (0.6 mL). The sample 
was then cooled to 203 K in a 500 MHz Bruker Spectrometer before the spectrum 
was acquired. The temperature was then increased in 10 K increments up to 303 K 
and a 1H spectra was acquired at each temperature (see Figure 88). 
 
Figure 88 - 1H NMR spectra as a function of temperature for a solution of 4-hydroxypyridine in 
dichloromethane-d2. The enol tautomer is represented by the resonances highlighted in teal and the keto 
tautomer is indicated by the purple resonances. The darker colour represents the ortho 1H resonance and the 
lighter colour the meta 1H resonance. The samples were measured on the 500 MHz spectrometer. 
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Table 13 - Table of the enol:keto ratio in the 4-hydroxypyridine/4-pyridone tautomerism as a function of 
sample temperature for the resonances shown in Figure 88 
Figure 88 shows the corresponding 1H-NMR spectra as a function of temperature for 
4-hydroxypyridine. The teal colour is used to indicate the presence of the enol 
tautomer whilst the purple highlights the keto tautomer; 4-pyridone. The darker 
colours are used to represent the ortho 1H resonance and the lighter colour the meta 
resonance. From 203 K to 243 K (not shown), the enol tautomer is predominant as 
no peaks from the keto tautomer are observed. At 253 K, small peaks at 7.90 and 
6.72 ppm reveal the ortho and meta resonances of the keto tautomer. At this 
temperature the ratio of enol:keto is 2:1, at 263 K, the abundance of the enol 
tautomer is equal to that of the keto tautomer. As the temperature increases, the 
resonances for the keto tautomer increase as the tautomerism shifts to favour 4-
pyridone, for example at 303 K, the ratio of enol:keto becomes 1:27 (Table 13).  
According to the Van’t Hoff equation, the equilibrium constant, Keq of a chemical 
transformation is related to the change in temperature.11 For a reversible reaction, 
the linear form of the Van’t Hoff equation (Equation 17) can be used to find the 














Equation 17, where Keq is the equilibrium constant, ΔHθ is the enthalpy, ΔSθ is the entropy. T is the 
temperature and R is the gas constant  
The enthalpy can then be calculated from the gradient (−
Δ𝐻𝜃
𝑅𝑇





Using the ratio of the ketone tautomer from Table 15 as Keq, the natural log of these 
values can be plotted against the reciprocal of the temperature 
This equation can be applied to the data in Table 15, where the ratio of the pyridone 
tautomer is used as Keq.  
 
Figure 89 - plot of ln(keto/enol) as a function of 1/T according to the linear form of the Van't Hoff equation in 
Equation 17 
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The plot in Figure 89 shows that the formation of the pyridone tautomer is an 
endothermic reaction. This is why this tautomer is favoured at higher temperatures, 
as heat is absorbed, meaning that the net enthalpy change is positive. The enthalpy 
of this transformation is 887 Jmol-1 and the entropy is 3.34 JK-1mol-1. 
 Isoniazid 
Isoniazid, also known as isonicotinylhydrazide, is a derivative of pyridine containing 
a hydrazide functional group in the para position of the aromatic ring. It has received 
significant attention in the scientific community due to its use as an antibiotic in the 
treatment of tuberculosis (TB). It has also been included on the World Health 
Organisation’s list of essential medicines since 1977.13-15 The reactivity of isoniazid is 
also of interest as they can form stable complexes with transition metals behaving as 
mono-, bi- and even poly-dentate ligands,16, 17 a number of which also possess anti-
TB activity.18 
In 2000, Bottari et al.18 investigated and characterised a number of isoniazid-related 
transition metal complexes. They found that copper (II) and nickel (II) formed 
octahedral complexes where the four equatorial coordination sites were occupied by 
two molecules of isonicotinylhydrazone enolate (see Figure 90a)). The formation of 
this complex was detected using infrared spectroscopy where the most significant 
absorbances were observed at 1060 cm-1 and 1545 cm-1. The former indicates the C-
O stretch in enolate coordination and the latter represents the isonicotinic skeleton 
ring stretch which illustrates that the pyridine nitrogen does not participate in 
coordination to the metal centre. Similar complexes where the isoniazid coordinates 
via the oxygen and nitrogen in the hydrazide group have been observed by Stringer 
et al.19 and Akinyele et al.20, these complexes are shown in Figure 90. 




Figure 90 - Metal complexes formed with isoniazid. a) adapted with permissions from B. Bottari et al. 18 b) 
adapted with permissions from T. Stringer et al. 19 c) adapted with permissions from O. Akinyele et al. 20 
Isoniazid has previously been assessed as a SABRE candidate, first in 2013 by Zeng et 
al.21 and again in 2017 by Norcott et al.22 In the first paper, Zeng et al.21 investigated 
the SABRE hyperpolarisation of isoniazid and its suitability for in vivo applications. 
They found that the maximum enhancement was −220-fold at the ortho proton at 
46.1°C and 65 G using the iridium catalyst [IrCl(COD)(IMes)]. In 2017, Norcott et al.22 
explored a number of different TB drug scaffolds, including their deuterated 
analogues, and compared their SABRE enhancements and lifetimes. It was 
discovered that polarisation levels of 20% were possible using a deuterated analogue 
of isoniazid combined with the deuterated form of IMes (d24-IMes). In both studies, 
it was assumed that isoniazid bound into the iridium metal centre via the pyridine 
nitrogen. However, this structure was never confirmed via characterisation.  
4.2 Formation of the SABRE pre-catalyst 
In the first step of SABRE, the substrate is added to [IrCl(COD)(NHC)]. Typically this 
induces the displacement of the chloride ligand to form the 16 electron, square 
planar species; [Ir(COD)(NHC)(sub)]Cl which is termed the ‘SABRE pre-catalyst’. 
Examples of this complex can be found in the previous chapter (see Figure 57). The 
complexes that form upon reaction of [IrCl(COD)(SIMes)] with 4-hydroxypyridine and 
isoniazid have been fully characterised by 1H, 13C and 15N-NMR, full details of which 
can be found below. 
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  [Ir(COD)(SIMes)(4-Hydroxypyridine)]Cl 
Despite tautomerism of 4-hydroxypyridine to 4-pyridone, upon reaction with 
[IrCl(COD)(SIMes], the precatalyst [Ir(COD)(SIMes)(4-hydroxypyridine)]Cl forms.  
 
Figure 91 - Schematic diagram of the formation of the SABRE precatalyst [Ir(COD)(SIMes)(sub)]Cl with the 
substrate 4-hydroxypyridine 




Figure 92 - 1H NMR spectra of the SABRE precatalyst; [Ir(COD)(SIMes)(4-hydroxypyridine)]Cl. The sample 
contained [IrCl(COD)(SIMes)] (5 mM) and 4-hydroxypyridine (50 mM) dissolved in methanol-d4 (0.6 mL). The 
NMR spectrum was acquired at 235 K and 500 MHz. 
Position 1H-NMR 13C-NMR 15N-NMR 
FreeorthoH 
7.910 




JHH = 7.2 Hz 
116.5  
FreeparaC=O - 180.2  
Position 1H-NMR 13C-NMR 15N-NMR 
orthoHsub 
7.389 
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Table 14 - NMR resonances for the product formed by reaction of [IrCl(COD)(SIMes)] (5 mM) and 4-
hydroxypyridine (50 mM) in methanol-d4. 1H at 500 MHz, 13C at 125 MHz and 15N at 51 MHz at 235 K. 
Confirmation of the binding of 4-hydroxypyridine via the pyridine nitrogen is clearly 
evident in the 15N-NMR spectrum (Figure 93). The free substrate 15N resonance for 
the pyridine nitrogen can be found at 152.8 ppm. This resonance is shifted upfield 
compared to the free pyridine 15N resonance in 4-methylpyridine because in the free 
solution, 4-hydroxypyridine exists predominantly in the keto form as 4-pyridone. 
Upon ligation to the iridium centre, this resonance shifts to 207.9 ppm. Further 
confirmation can be found in the 13C-NMR spectrum where the 13C resonance that 
corresponds to C-OH in 4-hydroxypyridine or C=O in 4-pyridone can be readily 
differentiated. In the free solution, this can be found at 180.2 ppm, indicating the 
presence of 4-pyridone. In the bound substrate, this shifts to 152 ppm corresponding 
to C-OH in 4-hydroxypyridine.   
 
Figure 93 - 15N/1H HMQC NMR spectrum of a solution containing [IrCl(COD)(SIMes)] (5 mM) and 15N-labelled 
4-hydroxypyridine (50 mM) in methanol-d4 at 9.4 T and 253 K. The purple highlighted resonance indicates the 
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15N-labelled pyridine nitrogen in the bound 4-hydroxypyridine in the SABRE precatalyst; 
[Ir(COD)(SIMes)(sub)]Cl. 
4.2.1.1 In dichloromethane-d2 
It was previously observed that upon dissolution of 4-hydroxypyridine in 
dichloromethane-d2, a mixture of both enol/keto tautomers are present in solution 
(see Section 4.1.1.1.2). The ratio of these tautomers has been shown to be 
temperature dependent (Figure 88). To observe this effect on the SABRE-precatalyst, 
4-hydroxypyridine (50 mM) was added to [IrCl(COD)(SIMes)] (5 mM) in 
dichloromethane-d2. This reaction produced a mixture of species in solution. The first 
species contained the enol tautomer bound to iridium through the pyridine nitrogen 
and the second the keto tautomer bound via the oxygen. The ratio of these species 
was also temperature dependent (Figure 94). 
 
Figure 94 - 1H NMR spectra as a function of temperature for a solution of 4-hydroxypyridine (40 mM) and 
[IrCl(COD)(SIMes)]Cl (4 mM) in dichloromethane-d2. The enol tautomer is represented by the resonances 
highlighted in teal and the keto tautomer is indicated by the purple resonances. Only the resonances at the 
ortho proton are shown. These spectra were measured on a 500 MHz spectrometer. 
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Table 15 - Table of the enol:keto ratio in the 4-hydroxypyridine/4-pyridone tautomerism as a function of 
sample temperature for the resonances shown in Figure 94 
Figure 94 shows a very similar trend to that of Figure 88 where at temperatures 
below 253 K (not shown) the enol isomer is predominant. At 253 K, the keto tautomer 
emerges as a broad resonance at 7.72 ppm. At 263 K the enol and keto tautomer are 
equally present in solution. From 273 – 303 K, the keto tautomer becomes the 
predominant species in solution. This form has been characterised by 13C NMR where 
the keto carbon can be observed at 198 ppm. This compares to the free substrate (4-
pyridone) where this carbon is detected at 208.8 ppm. The shift in the pre-catalyst 
[Ir(COD)(SIMes)(4-pyridone)] is due to ligation to iridium. 
The ratio of the keto tautomer in Table 15 can be used to generate a Van’t Hoff plot 
where ln(keto/enol) is plotted as a function of 
1
𝑇
. The enthalpy (ΔHθ) and entropy 
(ΔSθ) can then be calculated using the gradient and the intercept. 




Figure 95 - plot of ln(keto/enol) as a function of 1/T according to the linear form of the Van't Hoff equation in 
Equation 1 
Similarly to Figure 89, the plot in Figure 95 also shows that the formation of the 
pyridone tautomer is an endothermic reaction. The enthalpy in this case is 624 Jmol-
1 and the entropy is 2.39 JK-1mol-1 which are smaller than the corresponding values 
in the substrate; 887 Jmol-1 and 3.34 JK-1mol-1 respectively (Figure 89). This means 
that formation of the pyridone tautomer is more favourable with [Ir(COD)(SIMes)(4-
hydroxypyridine)]Cl. 
 [Ir(COD)(SIMes)(Isoniazid)]Cl 
Upon addition of isoniazid to [IrCl(COD)(SIMes)],  two products form in a 2:1 ratio. In 
the major species ligation occurs via the oxygen atom of the hydrazide group. In the 
minor species, isoniazid binds in the traditional way, via the pyridine nitrogen atom.  




Figure 96 - Schematic diagram for the formation of the SABRE precatalst [Ir(COD)(SIMes)(sub)]Cl for the 
substrate isonaizid showing the major and minor forms. The major species binds to the iridium via the oxygen 
in the hydrazide group and the minor binds via the pyridine nitrogen. 




Figure 97 - 1H NMR spectrum of the SABRE precatalyst [Ir(COD)(SIMes)(isoniazid)]Cl. Sample initially 
contained [IrCl(COD)(SIMes)(sub)] (5 mM) and isoniazid (50 mM) in methanol-d4 (0.6 mL) and was measured 
at 500 MHz and 235 K. 
Position 1H-NMR 13C-NMR 15N-NMR 
FreeorthoH 
8.730 




JHH = 5.3 Hz 
121.7  
FreeC-CONHNH2 - 165.6  
MAJOR SPECIES 
Oxygen Bound Isoniazid 
Position 1H-NMR 13C-NMR 15N-NMR 
orthoHsub 
8.812 





































Pyridine Bound Isoniazid 
orthoHsub 
7.945 

































Table 16 - Table of NMR Resonances for the SABRE precatalyst [Ir(H)2(SIMes)(Isoniazid)2Cl] in methanol-d4. 1H 
resonances measured at 500 MHz, 13C at 125 MHz and 15N at 51 MHz at 235 K. 
Confirmation of these structures comes from the 15N-NMR data. In the major species, 
the pyridine nitrogen can be found at 311 ppm which is close to the 15N resonance of 
the free substrate in solution (308.2 ppm). In the minor species, this shifts to 248 
ppm due to ligation to the iridium centre.  




Figure 98 - 1H/15N HMQC NMR spectrum of a solution of [IrCl(COD)(SIMes)] (5 mM) and isoniazid (50 mM) in 
methanol-d4 at 9.4 T and 263 K. 
To confirm that binding to iridium in isoniazid does not occur via the hydrazide 
nitrogen atom, the 15N resonances for this functional group were also measured. 
These were shown to be very similar to the 15N chemical shifts of the free substrate 
and therefore show that ligation must occur via the lone pair on the oxygen atom.  




Figure 99 - 15N NMR spectrum of the SABRE precatalyst [Ir(COD)(SIMes)(isoniazid)]Cl with i15N-labelled 
labelled isoniazid. 15N NMR spectrum measured at 40.56 MHz and 263 K. The strong signals are due to the 
free ligand 
15N-NMR Free Substrate Oxygen Bound 
Npy 308.2 311.0 
Na 130.7 124.9 
Nb 51.8 52.5 
Table 17 - Table of 15N NMR hydrazide functional group resonances for the SABRE precatalyst 
[Ir(COD)(SIMes)(isoniazid)]Cl in methanol-d4  measured at 40.56 MHz and 263 K.  
4.3 Formation of the SABRE-Active Catalyst 
A SABRE-active catalyst is formed upon addition of p-H2 to the precatalyst. Typically 
this forms an octahedral complex of the form [Ir(H)2(SIMes)(sub)3]Cl where two 
substrate ligands lie in the equatorial plane trans to two hydride ligands. The third 
substrate is bound trans to the NHC in the axial position. Examples of this tris-
substituted species can be found in the previous chapter (see Figure 26).  
The complexes that form with 4-hydroxypyridine and isoniazid have been fully 
characterised by 1H, 13C and 15N-NMR, full details of which can be found below. 
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 [IrCl(H)2(SIMes)(κ-O-4-pyridone)(κ-N-4-hydroxypyridine)]  
When 4-hydroxypyridine is used as the substrate of interest, a neutral bis-substituted 
complex [IrCl(H)2(SIMes)(κ-O-4-pyridone)(κ-N-4-hydroxypyridine)] forms (NMR data 
Table 18). 
 
Figure 100 - Schematic diagram showing the formation of the SABRE-active species [IrCl(H)2(SIMes)(κ-O-4-
pyridone)(κ-N-4-hydroxypyridine)] from the precatalyst [Ir(COD)(SIMes)(4-hydroxypyridine)]Cl 
 
Figure 101 - 1H NMR spectrum of the SABRE-active species [IrCl(H)2(SIMes)(κ-O-4-pyridone)(κ-N-4-
hydroxypyridine)] . Sample contains [IrCl(COD)(SIMes)] (5 mM), 4-hydroxpyridine (50 mM) and p-H2 (4 bar) 
dissolved in methanol-d4 (0.6 mL) in a young's tap NMR tube. Sample was measured at 500 MHz and 235 K. 
Position 1H-NMR 13C-NMR 15N-NMR 
FreeorthoH 
7.912 




JHH = 7.3 Hz 
116.5  
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FreeparaC=O  180.3  
Position 1H-NMR 13C-NMR 15N-NMR 
orthoHsub (trans to H-) 7.348 136.1 148.8 
orthoHsub (trans to 
NHC) 
7.688 
JHH = 6.5 Hz 
154.5 215 
metaHsub (trans to H-) 6.418 117.8  
metaHsub (trans to 
NHC) 
6.251 
















Table 18 - Table of NMR Resonances for  [IrCl(H)2(SIMes)(κ-O-4-pyridone)(κ-N-4-hydroxypyridine)] in 
methanol-d4. 1H at 400 MHz and 253 K, 13C at 125 MHz and 235 K and 15N at 41 MHz at 253 K. 
These NMR data suggest that the SABRE-active species for 4-hydroxypyridine is of 
the form [IrCl(H)2(SIMes)(sub)2] where the chloride ligands lies trans to hydride. This 
hydride resonance is observed at −21.24 ppm. Iali et al.23 and Tickener et al.24 have 
both reported similar hydrides which are bound trans to chloride at -21.53. The 
second hydride is bound trans to the keto tautomer of 4-hydroxypyridine, 4-
pyridone, which ligates to iridium via the oxygen in the ketone group. This hydride 
resonance is found at −27.24 ppm. SABRE complexes involving an oxygen bound 
substrate have been described by Iali et al.23 using pyruvate. They observed hydride 
resonances trans to oxygen at −27 and −29 ppm. In 2019, Tickener et al.25, 26 also 
characterised hydride ligands trans to oxygen using an α-carboxyimine coligand. 
These were found at −28.5 ppm. The second substrate binds in the axial position 
trans to the NHC. This ligand binds in the traditional way, through the pyridine 
nitrogen lone pair.  
Confirmation of this structure can also be found in the 13C-NMR resonances of the 
keto/enol carbon. The carbon for the oxygen bound, keto substrate (trans to hydride) 
is located at 180 ppm. The substrate trans to SIMes is observed at 164 ppm which is 
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indicative of the enol tautomer which is bound through the pyridine nitrogen lone 
pair (Figure 102).  
 
Figure 102 - 1H/13C -HMQC NMR spectrum of [IrCl(H)2(SIMes)(κ-O-4-pyridone)(κ-N-4-hydroxypyridine)]. 
Sample containing [IrCl(COD)(SIMes)] (5 mM), 4-hydroxypyridine (50 mM) and p-H2 (4 bar) dissolved in 
methanol-d4 measured at 11.74 T at 235 K. Resonance for the keto carbon shown at 180 ppm (13C)/7.35 ppm 
(1H) is highlighted in lilac and resonance for the enol carbon shown at 164 ppm (13C)/7.69 ppm (1H) 
highlighted in purple. 
The 15N isotopologues of 4-hydroxypyridine were used to confirm the binding modes 
of the two substrate ligands in the SABRE-active species via 1H/15N-HMQC (Figure 
103). The 15N resonance for the substrate bound trans to the NHC is observed at 215 
ppm. This suggests the enol tautomer is binding via the pyridine nitrogen. This 
compares to the substrate trans to the hydride where the pyridine nitrogen is 
detected at 148 ppm. This indicates an amino-nitrogen and suggests binding via the 
ketone oxygen atom in 4-pyridone.27 




Figure 103 –1H/15N -HMQC of [IrCl(H)2(SIMes)(κ-O-4-pyridone)(κ-N-4-hydroxypyridine)]. Sample containing 
[IrCl(COD)(SIMes)] (5 mM), 4-hydroxypyridine (50 mM) and p-H2 (4 bar) dissolved in methanol-d4 measured at 
500 MHz (1H) and 51 MHz (15N) at 235 K. Resonance for the nitrogen in the keto tautomer  shown at 215 ppm 
(15N)/7.35 ppm (1H) is highlighted in lilac and the resonance for the nitrogen in the enol form is shown at 
148.8 ppm (15N)/7.69 ppm (1H) highlighted in purple.  
Whilst the pre-catalyst was also characterised in d2-dichloromethane (Section 
4.2.1.1), addition of p-H2 did not promote the formation of a SABRE-active species.  
 [Ir(H)2(SIMes)(κ-N-isonicotinylhydrazide)(isonicotinyl-κ-O-κ-N-
hydrazide]Cl 
When isoniazid reacts with [IrCl(COD)(SIMes)] a major and minor species form in 
solution; in the major species isoniazid binds via the oxygen in the hydrazide group, 
while in the minor species it binds through the pyridine nitrogen atom. Upon reaction 
with p-H2, a bis-substituted complex forms whereby one isoniazid chelates to the 
iridium via the oxygen and nitrogen in the hydrazide group and a second ligates 
through the pyridine nitrogen. This complex has been fully characterised by 1H, 13C 
and 15N-NMR methods. 




Figure 104 - Schematic diagram showing the formation of the SABRE-active species [Ir(H)2(SIMes)(κ-N-
isonicotinylhydrazide)(isonicotinyl-κ-O-κ-N-hydrazide]Cl from the pre-catalyst [Ir(COD)(SIMes)(sub)]Cl. 
 
Figure 105 - 1H NMR spectra of the SABRE-active catalyst formed upon the reaction of [IrCl(COD)(SIMes)] (5 
mM) with isoniazid (50 mM) and p-H2 (4 bar) in methanol-d4 (0.6 mL). Spectra measured at 500 MHz and 235 
K.  
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Position 1H-NMR 13C-NMR 15N-NMR 
FreeorthoH 8.698 149.5 308.6 
FreemetaH 7.783 121.6  
FreeparaCONHNH2 - 141.3  
FreeCONHNH2 - 165.4  
Position 1H-NMR 13C-NMR 15N-NMR 
orthoH (chelate bound) 8.81 149.87 311.7 
orthoH (Npy -bound) 8.07 154.04 261.1 
metaH (chelate bound) 7.70 121.86  
metaH (Npy -bound) 7.46 123.83  
paraCONHNH2 (chelate bound) - 140.3  
paraCONHNH2 (Npy-bound)  139.9  
CONHNH2 (chelate bound) - 169.9  

















Table 19 - Table of NMR Resonances for [Ir(H)2(SIMes)(κ-N-isonicotinylhydrazide)(isonicotinyl-κ-O-κ-N-
hydrazide]Cl in methanol-d4. 1H measured at 400 MHz and 253 K, 13C at 125 MHz and 235 K and 15N at 41 MHz 
at 253 K. 
The hydride ligand signals observed in the 1H NMR spectrum of the product formed 
upon reaction of isoniazid and [IrCl(COD)(SIMes)] with H2 are similar to those 
detected for 4-hydroxypyridine. The hydride resonance observed at -28.52 ppm is 
indicative of being trans to an Ir-O binding mode.23-26, 28, 29 Isoniazid contains three 
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different sites capable of ligation to iridium; the nitrogen within the pyridine ring and 
the oxygen and nitrogen in the hydrazide group. The presence of two binding sites 
within the hydrazide group means that isoniazid can chelate to the iridium with the 
oxygen binding trans to the hydride at −28.52 ppm. The second hydride signal at 
−22.57 ppm is similar in chemical shift to those of the tris-substituted species 
produced with 4-methylpyridine, 4-methoxypyridine and 4-pyridinecarboxaldehyde 
(see previous chapter).30 Therefore, the second substrate ligand binds to iridium 
through the nitrogen within the pyridine ring trans to the hydride at −22.57 ppm.  
Further evidence for these two ligation motifs is observed through the 13C chemical 
shift of the carbon resonances in the hydrazide group. The signal giving a 13C NMR 
shift at 164.65 ppm is very close to that of the free substrate in solution (165.45 ppm) 
whereas the second peak at 169.96 ppm is shifted, suggesting chelation between the 
hydrazide oxygen and iridium (Figure 107). A similar complex was characterised by 
Stringer et al.19 (Figure 90b), where the same carbon atom in the chelated isoniazid 
was detected at 158.91 ppm.  
 
Figure 106 – 1H/15N-HMQC NMR spectrum of the product formed when [IrCl(COD)(SIMes)] (5 mM), isoniazid 
(50 mM) and p-H2 (4 bar) react together in methanol-d4 (0.6 mL), measured at 500 MHz (1H) and 51 MHz (15N) 
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and 235 K. The 15N resonance of the pyridine bound isoniazid ligand is highlighted at 261.1 ppm (15N)/8.07 
ppm (1H) in light blue and the resonance for the chelate bound isoniazid is shown at 311 ppm (15N)/8.81 ppm 
(1H) in dark blue.   
The 15N-HMQC data revealed a distinct difference in chemical shift of the two 
pyridine-based nitrogen atoms. The resonance at 311 ppm is very close to the 
resonance of the free substrate in solution (306.9 ppm), justifying that this pyridine 
nitrogen does not ligate to the iridium in the SABRE-active species. The second 
resonance appears at 261 ppm which is distinctive of Ir-N(pyridine) coordination. This 
shift is similar to the 15N chemical shift observed for the tris-substituted SABRE-active 
species formed by 4-methylpyridine where the pyridine nitrogen is observed at 247 
ppm (see previous chapter for more details).  
 
Figure 107 – 1H/13C-HMQC NMR spectrum of the product formed when [IrCl(COD)(SIMes)] (5 mM), isoniazid 
(50 mM) and p-H2 (4 bar) react in methanol-d4 (0.6 mL). Measured at 500 MHz (1H) and 125 MHz (13C) and 235 
K. The 13C resonance of pyridine bound isoniazid is highlighted at 165 ppm (13C)/8.07 ppm (1H) in light blue 
and the resonance for the chelate bound isoniazid is shown at 170 ppm (13C)/8.81 ppm (1H) in dark blue.   
The 1H/15N-HMQC NMR spectrum of Figure 106 does not show signals for the 
nitrogen atoms in the hydrazide functional group for either isoniazid ligand in the 
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product. To observe these resonances, isoniazid was 15N-isotopically labelled at these 
sites. The SABRE-active species was then analysed by 15N-NMR spectroscopy (Figure 
108).  
 
Figure 108 – 15N NMR spectrum of 15N labelled isoniazid measured at 41 MHz and 298 K for a sample 
containing [IrCl(COD)(SIMes) (5 mM), isoniazid (50 mM) and p-H2 (4 bar) in methanol-d4 (0.6 mL). 15N 
resonances for the pyridine bound hydrazide nitrogen atoms are highlighted in light blue while those for the 
chelate bound form are shown in dark blue. 
15N-NMR Free Substrate Npy-Bound Chelate-Bound 
Npy 309.6 265.3 315.1 
Na 
131.5 




JNN = 5.6 Hz 
54.1 29.3 
Table 20 - Table of 15N resonances for [Ir(H)2(SIMes)(κ-N-isonicotinylhydrazide)(isonicotinyl-κ-O-κ-N-
hydrazide]Cl containing 15N-labelled isoniazid measured at 41 MHz and 298 K. 
The NMR spectrum of [Ir(H)2(SIMes)(κ-N-isonicotinylhydrazide)(isonicotinyl-κ-O-κ-N-
hydrazide]Cl shown in Figure 108, depicts the 15N resonances of the two hydrazide 
nitrogen atoms, labelled as Na and Nb for each of the ligands bound to iridium. It has 
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been suggested that the chelated substrate ligates to iridium through the terminal 
N-atom of the hydrazide functional group (Nb) and the oxygen atom. In the free 
substrate, the signal for this nitrogen is observed at 53.7 ppm and overlaps with a 
signal from the pyridine bound isoniazid ligand. The corresponding signal the 
proposed chelated form appears at 29.3 ppm, this shift to a lower ppm is due to the 
nitrogen environment becoming more shielded due to ligation to the iridium.  
 SABRE Enhancements in the SABRE-Active Catalyst 
Once the SABRE-active species has been formed with both 4-hydroxypyridine and 
isoniazid, the sample is ready for hyperpolarisation measurements. To do these, p-
H2 is added to the sample and the sample is shaken within the stray field of the 
spectrometer (65 G) to promote dissolution of the gas. Magnetism transfer then 
ensues from the p-H2 derived hydrides to the substrate before the sample is quickly 
‘dropped’ into the spectrometer for detection. Examples of these hyperpolarised 
spectra are shown in Figure 109. The thermal, non-hyperpolarised control NMR 
spectra are shown in black and have been magnified 32 times so that they can be 
viewed alongside the hyperpolarised spectra. The hyperpolarised NMR spectra for 4-
hydroxypyridine (dominant in methanol) is depicted in purple and that of isoniazid in 
blue. Whilst these spectra are shown on similar scales alongside one another, the 
enhancement yielded for isoniazid is −183-fold compared to −34-fold at the ortho-
proton resonance. At the meta-proton resonance the enhancements are −40-fold 
and −6-fold respectively. 




Figure 109 - Thermal 1H-NMR spectrum under Boltzmann conditions (black) compared to a hyperpolarised 
spectrum where the sample was shaken for 10 s in the stray field (65 G) of the spectrometer (400 MHz) 
(purple = 4-hydroxypyridine, blue = isoniazid). These spectra were measured using a sample containing the 
substrate (40 mM), [IrCl(COD)(SIMes)] (4 mM) and p-H2 (4 bar) in methanol-d4 (0.6 mL). The thermal spectrum 
has been magnified 8 times for 4-hydroxypyridine and 16 times for isoniazid in the stacked spectra. The 
enhancements at the ortho and meta resonances have been calculated. 
The NMR signal enhancements exhibited by 4-hydroxypyridine proved to be much 
lower than those for isoniazid (and the substrates investigated in the previous 
chapter). SABRE enhancements are known to be concentration dependent,30 
therefore the amount of SABRE-active species for both isoniazid and 4-
hydroxypyridine were optimised in order to improve the corresponding 
enhancements. 4-methylpyridine was also included in this study for comparison. 
To do this a number of samples were formulated, each containing different 
concentrations of substrate. These concentrations were varied from 20-100 mM, 
whilst the concentration of [IrCl(COD)(SIMes)] was maintained at 4 mM. The same 
pressure of p-H2 (4-bar) was used and the samples were each shaken for 10 seconds 
at 65 G using the stray field of the spectrometer (400 MHz). This method of manual 
shaking was repeated five times to allow an average result to be recorded and the 
corresponding standard error was calculated. The results of this investigation are 
shown in Figure 110.  




Figure 110 – 1H NMR signal Enhancement factor as a function of substrate enhancement for the SABRE-Active 
species containing 4-methylpyridine, 4-hydroxypyridine and isoniazid in methanol-d4 measured at 400 MHz 
and 298 K. 
Figure 110 compares the SABRE enhancements of isoniazid, 4-hydroxypyridine and 
4-methylpyridine as a function of substrate concentration. It is clear that 4-
hydroxypyridine consistently yields very low SABRE enhancements when compared 
to the other two substrates. The highest enhancement level is −31 ± 1-fold and was 
observed when a concentration of 50 mM of substrate was used. This compares to 
isoniazid which produced the largest signal enhancement of −696 ± 17-fold when the 
substrate excess was 30 mM. 4-Methylpyridine yielded the largest enhancements 
compared to the other substrates. The optimum concentration of this substrate was 
shown to be 40 mM where an enhancement of −891 ± 18-fold was calculated. This 
trend must link to the ligand binding mode and will be discussed later. 
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4.4 Diffusion Ordered Spectroscopy in the SABRE-Active 
Catalyst 
The substrates 4-hydroxypyridine and isoniazid have been shown to form atypical 
SABRE-active species. As both of these complexes contain a ‘free’ pyridine nitrogen, 
it is possible that another equivalent of the SABRE catalyst could ligate via this atom. 
An example of such dimers can be found in Figure 111. Diffusion ordered 
spectroscopy (DOSY) can be used to observe whether such species form via the 
diffusion constant that can be used to estimate the size of a molecular species.   
 
Figure 111 - Suggested dimer structures for the SABRE active species for (a) 4-hydroxypyridine and (b) 
isoniazid 
Self-diffusion describes the random translational (often called Brownian) motion of 
molecules that is driven by internal thermal energy.31 This motion is a fundamental 
form of mass transport and underpins almost all chemical processes as reacting 
species must collide for the reaction to occur.32 Additionally, diffusion coefficients 
can provide information on the size and shape of these molecular species. The 
connection between diffusion and structural properties arises as the diffusion 
coefficient (D) depends on friction factors (fT) and electrophoretic mobilities (μ).33 
This is observed through the Debye-Einstein theory: 








Where kB is the Boltzmann constant, T is the absolute temperature and fT is the 
friction factor. 
For an idealised case of a diffusing sphere of hydrodynamic radius (rH) and solvent 
viscosity (η), the friction factor is provided by:34 
𝑓𝑇 = 6𝜋𝜂𝑟𝐻 
Equation 19 






The Stokes-Einstein equation (Equation 20) demonstrates that the diffusion 
coefficient is inversely related to the radius of the diffusing species. This means that 
larger molecules or complexes exhibit smaller diffusion coefficients. However, it is 
important to note that the Stokes-Einstein equation is limited to how well the shape 
of the molecule can be approximated to that of a sphere. More realistic models for 
the friction factor represent ellipsoids of revolution or collections of spherical 
subunits and are described by Perrin’s ellipsoid expressions.35-37 
Pulsed-field gradient NMR (PFG-NMR) is an excellent method to determine the self-
diffusion coefficient of a molecule in solution. Often referred to as diffusion-ordered 
spectroscopy (DOSY), it can also be used to identify different molecular components 
of mixtures, including any impurities and characterise the size of aggregates or the 
degree of polymerisation.38 DOSY is particularly useful for the analysis of mixtures, 
where NMR signals can be overlapped, however, can be separated according to the 
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translational diffusion coefficients of the corresponding molecules. The resulting 2D 
spectra where chemical shift is displayed along the x-axis and the relative self-
diffusion coefficient on the y-axis, appears as a virtual form of chromatography.39 The 
spectra allows correlation of signals lacking mutual couplings which are difficult to 
identify as originating from the same molecule via other NMR experiments.40  
DOSY is achieved by combining radiofrequency pulses with magnetic field gradients 
that encode spatial information. By using magnetic field gradients, molecules can be 
spatially labelled according to their position in the sample tube. After a short 
diffusion time, typically on the order of 10 ms, a second magnetic field gradient pulse 
is applied to remove the spatial encoding. If the molecules move after the initial 
encoding step during the diffusion time, the signal will have attenuated. There are 
four main PFG-NMR pulse sequences for measuring a DOSY spectrum: pulsed 
gradient spin echo (PFG-SE), pulse field gradient stimulated spin echo (PFG-SSE), 
bipolar pulse longitudinal eddy current delay (BPP-LED) and asymmetric bipolar PFG-
SSE or ‘one shot’ experiment.33, 34, 41  In this chapter, we have used the BPP-LED pulse 
sequence. 
The simplest of these methods is the pulsed field gradient spin echo (PFG-SE) which 
was first proposed by Stejskal and Tanner in 1965.41 During this sequence, the 
magnetisation is excited into the xy plane using a 90° pulse which is then dispersed 
using a magnetic field gradient pulse of duration, δ. After a time period of 
∆
2
, a 180° 
radiofrequency pulse is applied which inverts the dispersed magnetisation such that 
the after a period of Δ, the magnetisation is the inverse direction of what it was 
following the gradient pulse. Finally, a second gradient pulse is applied to remove the 
spatial encoding (see Figure 112). 




Figure 112 - The PFG-SE pulse sequence 
The pulse sequence is iterated, each time incrementing the gradient strength (G) 
whilst keeping the delays (δ and Δ) constant. The intensity (I) can then be plotted 
against the gradient strength and the diffusion constant extracted using a non-linear 







Equation 21 – The Stejskal Tanner Equation, where γ is the gyromagnetic ratio, G is the gradient strength, δ 
and Δ are delays and D is the diffusion constant.41,42 




Figure 113 - Signal intensity as a function of the gradient strength. The data has been plotted according to 
Equation 21. The delays used for δ and Δ have been indicated alongside the calculated diffusion coefficient 
(D) 
The PFG-SE pulse is limited by relaxation as the magnetisation is present in the xy 
plane during the diffusion period, therefore signal relaxation is dominated by 
transverse relaxation (T2). Transverse magnetisation can also be subject to J-
modulation (coupling evolution) which causes undesirable signal distortion, 
particularly in strongly-coupled systems.34 The PFG-STE pulse sequence contains two 
90° pulses, rather than the 180° pulse in Figure 112.43 This means that magnetisation 
is transverse during the short gradient encoding periods (δ) but longitudinal for the 
remainder of the diffusion time. Consequently, any signal losses are caused by the 
slower T1 relaxation rate. After the diffusion period, the magnetisation is returned to 
the transverse place by the third 90° pulse for refocusing and subsequent detection. 
The BPP-LED approach uses bipolar gradient pulse pairs. These replace the single 
gradient pulses in the SE (Figure 112) and STE approach with two pulses of half the 
duration and opposing signs separated by a non-selective (hard) 180° pulse. This 
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imposes a net additive dephasing effect and mirrors the effect of a single pulse and 
has the purpose of removing any background magnetic field gradients arising from 
imperfections in the hardware. This pulse sequence also employs an eddy current 
delay period in which the magnetisation is stored longitudinally prior to detection 
which allows any eddy currents to decay.44-46 
Here DOSY has been employed to determine whether dimers have also been formed 
in these studies for the atypical SABRE-active species for 4-hydroxypyridine and 
isoniazid. In these cases, dimers can form due to ligation from the lone pair situated 
on the pyridine nitrogen to iridium (Figure 111). In order to compare these 
structures, the SABRE active species for 4-methylpyridine was also considered.  
 [Ir(H)2(SIMes)(4-methylpyridine)3]Cl 
The tris-substituted SABRE active species for 4-methylpyridine was assessed as a 
control for this experiment. 4-methylpyridine is incapable of dimerization upon 
complexation with iridium as it contains no other coordination site to the pyridine 
nitrogen. Therefore, this complex serves as a good comparison against the SABRE-
active species for the other substrates.  
The diffusion coefficients were measured at 298 K and 273 K. The DOSY experiment 
was conducted at two different temperatures as from the Stokes-Einstein equation 
(Equation 20) it is clear that diffusion is temperature dependent.31 Whilst Figure 114 
shows the 2D-DOSY plot from topspin, the diffusion constants were not extracted 
from this plot. Instead the raw data (peak intensity and the gradient strength) was 
plotted in origin and fitted using equation 21 to calculate the diffusion constant for 
each of the 1H resonances in Table 21. These plots can be found in Appendix C. This 
method was also used to calculate the diffusion constants for [IrCl(H)2(SIMes)(κ-O-4-
pyridone)(κ-N-4-hydroxypyridine)] and [Ir(H)2(SIMes)(κ-N-
isonicotinylhydrazide)(isonicotinyl-κ-O-κ-N-hydrazide]Cl in sections 4.2.2 and 4.2.3.  




Figure 114 - 2D DOSY spectra of [Ir(H)2(SIMes)(4-methylpyridine)3]Cl. Sample contained [IrCl(COD)(SIMes)] (5 
mM), 4-methylpyridine (50 mM)), p-H2 (4 bar absolute) dissolved in methanol-d4 (0.6 mL) measured at 400 
MHz and 298 K. This figure is used for illustrative purposes only. 
 
Diffusion Constant  
(m2s-1) 
Hydrodynamic Radius  
(m) 
Free 1.46 × 10-9 2.47 × 10-10 
Trans to H- 7.38 × 10-10 4.88 × 10-10 
Trans to NHC 6.20 × 10-10 5.81 × 10-10 
SIMes 6.27 × 10-10 5.74 × 10-10 
Average on the 
catalyst 
6.24 × 10-10 ± 3.65 × 10-12 5.77 × 10-10 ± 3.38 × 10-12 
Table 21 - Table of the diffusion constant for [Ir(H)2(SIMes)(4-methylpyridine)3]Cl at 298 K. The diffusion 
constants were extracted from the raw data plots in Appendix C. The Spherical radius was then calculated 
using the Stokes-Einstein equation in Equation 20 
Figure 114 shows a 2D DOSY plot where the diffusion coefficients correspond to 
those displayed in Table 21. The plot in Figure 114 compares the diffusion coefficients 
for the free substrate (black), the substrate bound trans to the hydride (pink), the 
substrate trans to SIMes (dark pink) and the catalyst (green). The diffusion coefficient 
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for the free substrate is larger than the SABRE-active complex. This is expected as the 
free substrate is smaller than the complex and therefore can diffuse faster than the 
complex. The diffusion coefficients for SIMes and the slow exchanging substrate 
ligand trans to it are very similar in magnitude. The substrate trans to hydride 
however undergoes exchange on the timescale of these measurements with the free 
material. Consequently, the diffusion coefficient for these ligands moves towards 
that of the smaller free material.  
The diffusion coefficient can be used to calculate molecular size by rearranging the 
Stokes-Einstein equation (Equation 20) to make the Van der Waals or hydrodynamic  
radius, r, the subject. To do this, the viscosity (η) and temperature must also be 
known. Whilst the temperature was known to be 298 K for this experiment, the 
viscosity was not measured. Instead a value of 6.06 × 10-4 Pa S was taken from the 
literature.37 The spherical radius was calculated to be 2.47 × 10-10 m for the free 
substrate compared to 5.77 × 10-10 m for the iridium complex. As expected, the free 
substrate is smaller than the complex. It must be noted that the Stokes-Einstein 
equation assumes a perfect diffusing sphere, furthermore, the viscosity of the 
solution has not been measured. Therefore these values for the hydrodynamic radii 
are estimated and henceforth they should not be used quantitatively but could be 
used comparatively.  
 
Figure 115 - 2D DOSY 1H NMR spectra of [Ir(H)2(SIMes)(4-methylpyridine)3]Cl. Sample contained 
[IrCl(COD)(SIMes)] (5 mM), 4-methylpyridine (50 mM)), p-H2 (4 bar) dissolved in methanol-d4 (0.6 mL) 
measured at 400 MHz and 273 K. This figure is used for illustrative purposes only. 




Diffusion Constant  
(m2s-1) 
Spherical Radius  
(m) 
Free 1.53 × 10-9 1.68 × 10-10 
Trans to H- 6.44 × 10-10 3.98 × 10-10 
Trans to NHC 6.20 × 10-10 4.14 × 10-10 
SIMes 6.22 × 10-9 4.12 × 10-10 
Average on the catalyst 6.21 × 10-10 ± 1.00 × 10-12 
4.13 × 10-10 ± 6.53 × 
10-13 
Table 22 - Table of the diffusion constant for [Ir(H)2(SIMes)(4-methylpyridine)3]Cl at 273 K. The diffusion 
constants were extracted from the raw data plots in Appendix C. The Spherical radius was then calculated 
using the Stokes-Einstein equation in Equation 20 
Figure 115 shows the 2D DOSY plot for [Ir(H)2(SIMes)(4-methylpyridine)3]Cl at 273 
K. The corresponding diffusion coefficients and calculated spherical radii are shown 
in Table 22. Similarly to Figure 114, the diffusion coefficient for the free substrate is 
faster than the bound species. However, now as the rate of ligand exchange is 
slowed, the coefficients for the bound ligands and SIMes group as much closer in size. 
The spherical radii for the free substrate are smaller than the SABRE-active complex 
and therefore can translate a larger distance than the bound species during the delay 
time, Δ. The diffusion coefficients at 273 K are slightly slower than at 298 K. This is 
observed as the diffusion coefficient for the SABRE-active complex at 298 K is 6.24 × 
10-10 m2s-1 compared to 6.21 × 10-10 m2s-1 at 273 K. This is to be expected as according 
to the Stokes-Einstein equation (Equation 20), diffusion is inversely proportional to 
the temperature. For example, at higher temperatures, molecules have more energy 
and can therefore they diffuse faster as the movement of the molecules in solution 
increases. 
The hydride region is also visible on the 2D DOSY plot, however, the signals for this 
resonance are very weak and therefore extracting the corresponding diffusion 
coefficient was very difficult. However, as they are bound to the iridium complex, 
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they are similar to those of the bound ligands in the iridium complex (average = 6.21 
× 10-10 m2s-1). 
 [IrCl(H)2(SIMes)(κ-O-4-pyridone)(κ-N-4-hydroxypyridine)]   
The SABRE active species containing 4-hydroxypyridine has been shown to form a 
bis-substituted complex of the form; [IrCl(H)2(SIMes)(κ-O-4-pyridone)(κ-N-4-
hydroxypyridine)]. This species contains one substrate bound via the terminal oxygen 
as 4-pyridone and another bound through the pyridine nitrogen. The equatorial 
plane contains two inequivalent hydrides, one bound trans to chloride and the other 
trans to the oxygen bound substrate. As 4-hydroxypyridine clearly contains two 
binding sites, it may have the ability to form dimers to iridium, as shown in Figure 
111. DOSY can be used to characterise the formation of aggregates including dimers 
and trimers in solution.32, 37  Similarly to [Ir(H)2(SIMes)(4-methylpyridine)3]Cl, the 
experiment was repeated at two temperatures; 298 K and 253 K. The DOSY 
experiment was attempted at 273 K, however, the signal was too weak for the 
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complex to be fully analysed at this temperature.
 
Figure 116 - 2D DOSY 1H NMR spectra of [IrCl(H)2(SIMes)(κ-O-4-pyridone)(κ-N-4-hydroxypyridine)] . Sample 
contained [IrCl(COD)(SIMes)] (5 mM), 4-hydroxypyridine (50 mM) and p-H2 (4 bar) dissolved in methanol-d4 






Free 1.12 × 10-9 3.21 × 10-10 
SIMes 6.27 × 10-10 5.75 × 10-10 
Table 23 - Table of the diffusion constant calculated from Equation 4 for [IrCl(H)2(SIMes)(4-hydroxypyridine)2] 
at 298 K. The diffusion constants were extracted from the raw data plots in Appendix C. The Spherical radius 
was then calculated using the Stokes-Einstein equation in Equation 3 
Figure 116 shows the 2D DOSY plot for  [IrCl(H)2(SIMes)(κ-O-4-pyridone)(κ-N-4-
hydroxypyridine)]. The corresponding diffusion values and calculated spherical radii 
are shown in Table 23. The bound substrate forms could not be observed at this 
temperature, however the SIMes ligand is visible and therefore this is used to 
represent the complex form. 4-Hydroxypyridine/4-pyridone exchanges rapidly at 298 
K and therefore this could explain why it could not be observed at this temperature.  
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The diffusion constant for the free form is very similar to the free form of 4-
methylpyridine. The diffusion coefficient for free 4-hydroxypyridine is 1.12 × 10-9 m2s-
1 compared to 1.46 × 10-9 m2s-1 for 4-methylpyridine. Both substrates are simple para 
substituted derivatives of pyridine and therefore it was expected that they would 
diffuse at a similar rate. The SABRE-active species for both 4-hydroxypyridine and 4-
methylpyridine are also very similar. [Ir(H)2(SIMes)(4-methylpyridine)3]Cl has a 
diffusion coefficient of 6.24 × 10-10 m2s-1 compared to 6.27 × 10-10 m2s-1 for  
[IrCl(H)2(SIMes)(κ-O-4-pyridone)(κ-N-4-hydroxypyridine)]. The calculated spherical 
radii are also similar, 5.77 × 10-10 m for [Ir(H)2(SIMes)(4-methylpyridine)3]Cl and 5.75 
× 10-10 m for the SABRE-active complex containing 4-hydroxypyridine. As 4-
methylpyridine is unable to dimerise and exhibits a similar diffusion coefficient, and 
spherical radii, to 4-hydroxypyridine, it could be assumed that [IrCl(H)2(SIMes)(4-
hydroxypyridine)2]Cl also does not form dimers at this temperature. 
 
Figure 117 – 2D DOSY 1H NMR spectra of [IrCl(H)2(SIMes)(κ-O-4-pyridone)(κ-N-4-hydroxypyridine)]. Sample 
contained [IrCl(COD)(SIMes)] (5 mM), 4-hydroxypyridine (50 mM) and p-H2 (4 bar) dissolved in methanol-d4 
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Free 4.81 × 10-10 3.47 × 10-10 
N-bound 2.40 × 10-10 6.94 × 10-10 
O-bound 2.58 × 10-10 6.46 × 10-10 
SIMes 2.52 × 10-10 6.63 × 10-10 
SIMes 2.67 × 10-10 2.25 × 10-10 
Average on the catalyst 2.53 × 10-10 ± 7.74 × 10-12 6.61 × 10
-10 ± 2.01 × 
10-11 
Table 24 - Table of the diffusion constant calculated from Equation 4 for [IrCl(H)2(SIMes)(κ-O-4-pyridone)(κ-N-
4-hydroxypyridine)] at 253 K. The diffusion constants were extracted from the raw data plots in Appendix C. 
The Spherical radius was then calculated using the Stokes-Einstein equation in Equation 3 
Figure 117 shows the 2D DOSY plot for [IrCl(H)2(SIMes)(κ-O-4-pyridone)(κ-N-4-
hydroxypyridine)] at 253 K. The corresponding diffusion coefficients and calculated 
values for the spherical radii are shown in Table 24. Lowering the temperature to 253 
K means that the diffusion for the bound forms of the substrate are also visible on 
the 2D DOSY plot. The slow exchanging pyridine bound ligand has been averaged 
with those of the SIMes ligand to give the overall complex diffusion of 2.53 × 10-10 




The SABRE-active species containing isoniazid also forms a bis-substituted species of 
the form; [Ir(H)2(SIMes)(κ-N-isonicotinylhydrazide)(isonicotinyl-κ-O-κ-N-
hydrazide]Cl. This complex contains one isoniazid ligand bound via the pyridine 
nitrogen in the equatorial plane trans to hydride. The other isoniazid ligand chelates 
to iridium through the oxygen and nitrogen in the hydrazide group. This means that 
the pyridine nitrogen in this substrate is free to coordinate to iridium as the dimer 
suggested in Figure 111. 
The DOSY experiment was conducted at 298 K and 273 K. The results were then 
compared to [Ir(H)2(SIMes)(4-methylpyridine)3]Cl which is known not to form dimers. 




Figure 118 - 2D DOSY 1H NMR spectra of  [Ir(H)2(SIMes)(κ-N-isonicotinylhydrazide)(isonicotinyl-κ-O-κ-N-
hydrazide]Cl Sample contained [IrCl(COD)(SIMes)] (5 mM), isoniazid (50 mM) and p-H2 (4 bar) dissolved in 






Free 1.33 × 10-9 2.72 × 10-10 
Chelate 7.27 × 10-10 4.95 × 10-10 
Pyridine bound 7.06 × 10-10 5.10 × 10-10 
SIMes 6.73 × 10-10 5.35 × 10-10 
SIMes 5.87 × 10-10 6.13 × 10-10 
Average on the catalyst 6.62 × 10-10 ± 4.08 × 10-11 
5.48 × 10-10 ± 3.48 × 
10-11 
Table 25 – Table of the diffusion constant calculated from Equation 4 for [Ir(H)2(SIMes)(κ-N-
isonicotinylhydrazide)(isonicotinyl-κ-O-κ-N-hydrazide]Cl at 298 K. The diffusion constants were extracted 
from the raw data plots in Appendix C. The Spherical radius was then calculated using the Stokes-Einstein 
equation in Equation 3 
Figure 118 shows the 2D DOSY plot for [Ir(H)2(SIMes)(κ-N-
isonicotinylhydrazide)(isonicotinyl-κ-O-κ-N-hydrazide]Cl at 298 K. The corresponding 
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diffusion coefficients and calculated spherical radii are shown in Table 25. The 
diffusion coefficient for the SABRE-active species is very similar to those containing 
4-methylpyridine and 4-hydroxypyridine. When isoniazid is used as the substrate the 
diffusion coefficient is 6.62 × 10-10 m2s-1 compared to 6.24 × 10-10 m2s-1 for 4-
methylpyridine and 6.27 × 10-10 m2s-1 for 4-hydroxypyridine. This suggests that 
isoniazid does not form dimers upon complexation with iridium. [Ir(H)2(SIMes)(κ-N-
isonicotinylhydrazide)(isonicotinyl-κ-O-κ-N-hydrazide]Cl  has a slightly larger 
diffusion coefficient and therefore a smaller spherical radius (5.48 × 10-10 m) 
compared to the other two substrates. This is followed by  [IrCl(H)2(SIMes)(κ-O-4-
pyridone)(κ-N-4-hydroxypyridine)] which has a spherical radius of 5.75 × 10-10 m and 
finally, [Ir(H)2(SIMes)(4-methylpyridine)3]Cl which has a spherical radius of 5.77 × 10-
10 m. 4-Methylpyridine forms a slightly larger SABRE-active species as it forms a tris-
substituted complex compared to 4-hydroxypyridine and isoniazid which form 
complexes containing only two substrate ligands. 
 
Figure 119 – 2D DOSY 1H NMR spectra of [Ir(H)2(SIMes)(κ-N-isonicotinylhydrazide)(isonicotinyl-κ-O-κ-N-
hydrazide]Cl. Sample contained [IrCl(COD)(SIMes)] (5 Mm), isoniazid (50 Mm) and p-H2 (4 bar) dissolved in 






Free 8.19 × 10-10 3.13 × 10-10 
Chelate 4.88 × 10-10 5.26 × 10-10 
Pyridine bound 4.54 × 10-10 5.65 × 10-10 
SIMes 3.89 × 10-10 6.60 × 10-10 
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SIMes 3.91 × 10-10 6.56 × 10-10 
Average on the catalyst 4.22 × 10-10 ± 3.26 × 10-11 6.14 × 10
-10 ± 4.40 × 
10-11 
Table 26 - Table of the diffusion constant calculated from Equation 4 for [Ir(H)2(SIMes)(κ-N-
isonicotinylhydrazide)(isonicotinyl-κ-O-κ-N-hydrazide]Cl at 273 K. The diffusion constants were extracted 
from the raw data plots in Appendix C.  The Spherical radius was then calculated using the Stokes-Einstein 
equation in Equation 3 
Figure 119 shows the diffusion of [Ir(H)2(SIMes)(κ-N-
isonicotinylhydrazide)(isonicotinyl-κ-O-κ-N-hydrazide]Cl at 273 K. The 2D DOSY plot 
also shows the diffusion of the hydrides which appears on the same level as the rest 
of the SABRE-active species. The diffusion of the SABRE complex is 4.22 × 10-10 m2s-1 
at 273 K which is slower than the diffusion at 298 K (6.62 × 10-10 m2s-1). It is also much 
slower than the diffusion constant of [Ir(H)2(SIMes)(4-methylpyridine)3]Cl which was 
6.21 × 10-10 m2s-1. 
4.5 Ligand exchange within these SABRE-active catalysts 
Despite 4-hydroxypyridine and isoniazid forming alternative octahedral complexes 
(Figure 100 and Figure 104) to the typical tris-substituted SABRE-active species 
(Figure 26), both these complexes enhance under SABRE conditions (Figure 109). This 
means that both [IrCl(H)2(SIMes)(κ-O-4-pyridone)(κ-N-4-hydroxypyridine)] and 
[Ir(H)2(SIMes)(κ-N-isonicotinylhydrazide)(isonicotinyl-κ-O-κ-N-hydrazide]Cl must 
undergo exchange. These hyperpolarised signals result from dissociation of the 
hyperpolarised bound substrate into bulk solution (Figure 14). When a sample 
containing the SABRE-active complex and p-H2 is shaken in the stray field of the 
spectrometer (65 G), p-H2 binds to the metal as two hydrides. Magnetism is then 
transferred from these p-H2 derived hydrides to the substrate protons via the J-
coupled network (Figure 16). The now hyperpolarised substrate then dissociates into 
the free solution leaving a vacant site on the metal centre, allowing for a new 
substrate from the bulk solution to bind for magnetism transfer. This cycle of 
hyperpolarisation and dissociation continues until all of the p-H2 has been used. 
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Substrate dissociation was observed in these species using the EXSY technique 
described in Chapter 6, Section 6.2.7 Exchange Spectroscopy. 
The rates of dissociation have been plotted as a function of temperature for the 
substrates 4-hydroxypyridine and 4-isoniazid and are shown in Figure 120. The 
exchange rate of 4-methylpyridine has also been shown in order to compare the 
behaviour of the tris-species to the active species for 4-hydroxypyridine and 
isoniazid. 
 
Figure 120 – Rate of ligand dissociation (kd) as a function of temperature for the complexes form when 
[IrCl(COD)(SIMes)]Cl (5 mM), the indicated substrate (50 Mm) and p-H2 (4 bar) are probed in methanol-d4 (0.6 
mL) at 500 MHz. Data points corresponding to isoniazid are shown in blue squares, 4-hydroxypyridine are 
represented by purple circles and 4-methylpyridine are shown by pink triangles. The error bars indicate the 
error associated with kd calculated using the Jacknife method described in Chapter 6, Section 6.2.7.2 
Associated errors in the calculation of kd. A table of the associated errors can be found in Appendix C. 
The data in Figure 120 shows that the exchange of 4-hydroxypyridine (kd = 18.31 ± 
0.19 s-1 at 270 K) occurs on a faster timescale compared to isoniazid (kd = 0.04 ± 1.79 
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× 10-4 s-1 at 280 K) and 4-methylpyridine (kd = 0.75 ± 1.53 × 10-3 s-1 at 270 K and 2.61 
± 2.71 × 10-3 s-1 at 280 K). Exchange is observed in the substrate bound trans to 
hydride. In the SABRE-active species containing 4-hydroxypyridine, this substrate 
ligand is bound through the oxygen as its 4-pyridone tautomer. Ligand association is 
clearly weaker when compared to the other substrates which bind through the 
pyridine nitrogen. The exchange of isoniazid is very slow by comparison. In this case, 
the substrate bound trans to the hydrides is bound through the pyridine nitrogen. 
This slower exchange (compared to 4-methylpyridine) must therefore be a 
consequence of the electronic effect of the chelate (Table 19). Exchange was not 
observed in the chelated isoniazid ligand in [Ir(H)2(SIMes)(κ-N-
isonicotinylhydrazide)(isonicotinyl-κ-O-κ-N-hydrazide]Cl or in the pyridine bound 4-
hydroxypyridine ligand in [IrCl(H)2(SIMes)(κ-O-4-pyridone)(κ-N-4-hydroxypyridine)]. 
 Gibbs Free Energy  
To further understand the interaction between the substrate and the metal centre, 
the activation parameters for ligand loss (ΔG≠d) can be calculated. As isoniazid loss is 
much slower, compared to both 4-hydroxypyridine and 4-methylpyridine, it was 
assumed that this substrate would exhibit the highest barrier.  
These data were calculated using an Eyring plot where ln
k
T














). The results of these calculations 
are shown in Table 27.  










ΔH≠ (kJmol-1) 84.6  ± 3.6 69.7 ± 2.7  91.6 ± 2.9 
ΔS≠ (JK-1mol-1) 73.2  ± 13.1 44.1  ± 10.6 62.0  ± 9.8 
ΔG≠298K (kJmol-1) 62.82  ± 0.01 56.58  ± 0.14 73.10  ± 3.13 
Table 27 - Table of values calculated for the enthalpy and entropy of dissociation (ΔH≠ & ΔS≠) for the SABRE-
active species containing isoniazid and 4-hydroxypyridine, which have then been used to calculate the Gibbs 
free energy of dissociation at 298 K. Data for 4-methylpyridine has been displayed for comparison.  ΔH≠ is 
calculated from the gradient (m) and ΔS≠ is calculated from the intercept (c) using the straight-line equations 
shown in Figure 121 above. ΔH≠ & ΔS≠ were subsequently used to calculate the Gibbs free energy of 
dissociation. The calculations for the errors in ΔH≠, ΔS≠ & ΔG≠ are explained in Chapter 6, Section 6.2.7.3 
Calculation of Gibbs free energy and associated errors. 
The entropy (ΔS≠) is positive which is consistent with a dissociative pathway. 4-
Hydroxypyridine has the smallest entropy value of 44.1 JK-1mol-1 which reflects the 
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weaker bond between the oxygen bound pyridone tautomer and the metal complex. 
This means this complex has the most freedom out of the series. The enthalpy (ΔH≠) 
indicates the bond strength for dissociative change. Isoniazid has the highest 
enthalpy value of 91.6 kJmol-1 which reflects the stronger bond between the pyridine 
bound ligand and the metal. This is induced by the chelate bound isoniazid ligand 
which donates electron density into the metal complex, rendering the metal electron 
rich. The entropy and enthalpy can be used to calculate the Gibbs free energy of 
dissociation which have been plotted as a function of the substrate below. 
 
Figure 122 – Gibbs free energy as a function of substrate in the SABRE-active species.  
The Gibbs free energy shown in Table 27 and Figure 122  illustrates that, as predicted, 
the ligation between isoniazid and the metal centre is stronger than the other two 
examples. Interestingly, the Gibbs free energy of isoniazid (73.1 kJmol-1) is also much 
larger than that seen for 4-pyridinecarboxaldehyde (64.4 kJmol-1) in the previous 
chapter. It is thought that the substrate ligand that chelates to the metal centre 
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donates a large amount of electron density to the iridium. As the iridium centre is 
now incredibly electron rich, ligation to the pyridine bound isoniazid is much 
stronger. The Gibbs free energy for 4-hydroxypyridine (56.6 kJ mol-1) is much smaller 
compared to all of the substrates tested previously, including 4-chloropyridine (62.08 
kJ mol-1). This proves that ligation between the oxygen bound pyridone species is far 
weaker compared to substrates which bind through the pyridine nitrogen atom. 
4.6 Relaxation Effects in the SABRE-Active Catalyst 
 T1 Relaxation Measurements 
The relaxation (T1) of the associated resonances in these systems were measured 
according to the procedure described in Chapter 6, Section 6.2.7.2.1 T1 Relaxation 
Measurements. These resonances are due to the free substrate, the chelate bound 
substrate and the pyridine bound substrate (trans to H-) in isoniazid and for the 
oxygen-bound and nitrogen bound substrate in 4-hydroxypyridine. It was postulated 
that as isoniazid requires the most energy to dissociate from the metal centre, the T1 
of the substrate trans to the hydride would be much shorter compared to the free 
substrate. The results of this investigation are shown in Figure 123. 




Figure 123 – Comparison of the OrthoH T1 values for 4-hydroxypyridine (purple) and isoniazid (blue). The T1 
for the substrate without catalyst was measured using at 40 mM in methanol-d4. The T1 in the presence of 
catalyst was measured using a sample containing [IrCl(COD)(SIMes)] (4 mM), substrate (40 mM) and p-H2 (4 
bar) in methanol-d4. All measurements were taken at 298 K and 400 MHz. The error bars indicate the fitting 
error for the T1 curves shown in Appendix C. 
T1 (s) 4-Hydroxypyridine Isoniazid 
Free 8.11 ± 0.03 8.84 ± 0.01 
FreeCat 5.04 ± 0.05 7.12 ± 0.03 
N-boundCat 2.90 ± 0.16 3.08 ± 0.29 
O-bound/chelate 
boundCat 
3.60 ± 0.18 3.45 ± 0.09 
Table 28 - Table of T1 values at the ortho proton resonance in the substrate of interest corresponding to 
Figure 123. The errors in the T1 values are calculated from fitting the T1 curves shown in Appendix C. 
Figure 123 shows the T1 at the ortho proton resonance in the free substrate both in 
the presence of catalyst and without compared to the bound substrate in the SABRE-
active species for 4-hydroxypyridine and isoniazid. The corresponding values are 
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shown in Table 28. The free substrate T1 without catalyst is 8.11 ± 0.03 s for 4-
hydroxypyridine compared to 8.84 ± 0.01 s for isoniazid. Binding to iridium is known 
to decrease substrate T1. This effect is observed in the free substrate in the presence 
of the SABRE catalyst which reduces the T1 by almost three seconds to 5.04 ± 0.05 s 
for 4-hydroxypyridine. The presence of the catalyst has a lesser effect on isoniazid 
where the T1 is reduced to 7.12 ± 0.03 s. This effect is more pronounced in the bound 
species, where the pyridine nitrogen bound substrate has a T1 of 2.90 ± 0.16 s in  
[IrCl(H)2(SIMes)(κ-O-4-pyridone)(κ-N-4-hydroxypyridine)] compared to 3.08 ± 0.29 s 
for [Ir(H)2(SIMes)(κ-N-isonicotinylhydrazide)(isonicotinyl-κ-O-κ-N-hydrazide]Cl. The 
oxygen bound tautomer in [IrCl(H)2(SIMes)(κ-O-4-pyridone)(κ-N-4-hydroxypyridine)] 
has a T1 of 3.60 ± 0.18s. This substrate undergoes rapid dissociation with the free 
material. In the previous chapter it was observed that due to dissociation, the 
substrate ligand trans to hydride has a T1 value close to that of the free substrate 
compared to the substrate trans to SIMes which has a much lower T1.  
The chelate bound substrate in [Ir(H)2(SIMes)(κ-N-
isonicotinylhydrazide)(isonicotinyl-κ-O-κ-N-hydrazide]Cl has a larger T1 (3.45 ± 0.09 
s) than the pyridine bound ligand (3.08 ± 0.29s). This could be attributed to the fact 
that the ortho proton is situated further away from the binding site and therefore is 
closer to the free T1. 
As the free T1 in isoniazid is much higher than 4-hydroxypyridine and 4-
methylpyridine (6.50 ± 0.04 s for the free substrate in presence of catalyst) it can 
yield larger enhancements. Hyperpolarisation is lost via relaxation effects, therefore 
as the T1 of 4-hydroxypyridine is very small, this effect will reduce the detected signal 
enhancements.   
4.7 Summary 
4-Hydroxypyridine and isoniazid were initially selected for SABRE as they are simple 
para-substituted pyridines with low pKa values. These substrates were to be included 
as part of the study in Chapter 3, however, 4-hydroxypyridine readily tautomerizes 
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to 4-pyridone in solution and isoniazid has been seen to form chelated metal species. 
This causes them to form atypical SABRE-active species. 
In the crystalline form, 4-hydroxypyridine is predominantly found as its 4-pyridone 
tautomer. It is also the dominant tautomer in polar solvents, the enol tautomer (4-
hydroxypyridine) is predominant in the gaseous phase and non-polar solvents. In d2-
dichloromethane, a mixture of both tautomers was found in solution. The ratio of 
this was found to be temperature dependent. At low temperatures (below 253 K), 
the enol tautomer was the dominant form. At temperatures above 253 K, the keto 
tautomer rapidly became the favoured form. A Van’t Hoff plot showed the formation 
of the 4-pyridone tautomer to be an endothermic reaction. The enthalpy was 
calculated as 886.85 Jmol-1 and the entropy was 3.34 JK-1mol-1. 
The SABRE efficiency of isoniazid has previously been published; however the 
structure of this complex has been overlooked. It was assumed that this substrate 
formed the tris-substituted complex ([Ir(H)2(SIMes)(sub)3]Cl), typical in SABRE 
experiments (see previous chapter). However, analysis in the literature showed that 
can chelate to metal centres via the oxygen and terminal nitrogen in the hydrazide 
group.  
Reaction of 4-hydroxypyridine with [IrCl(COD)(SIMes)] formed [Ir(COD)(SIMes)(κ-N-
4-hydroxypyridine)]Cl, where the substrate ligates to iridium via the pyridine 
nitrogen as the enol tautomer. This was characterised in the 15N-NMR spectrum 
where the free pyridine nitrogen is observed at 152.8 ppm compared to 207.9 ppm 
in the bound form. This upfield shift is similar to those observed for the free and 
bound forms of 4-methylpyridine in the previous chapter. In d2-dichloromethane, the 
keto tautomer was also found to bind to iridium in [Ir(COD)(SIMes)(κ-O-4-
pyridone)]Cl. The ratio of the enol:keto tautomers was again shown to be 
temperature dependent. Below 253 K, the enol form was the predominant tautomer 
compared to higher temperatures where the keto tautomer dominated. The 
enthalpy and entropy were calculated from a Van’t Hoff plot. The enthalpy in this 
case is 623.61 Jmol-1 and the entropy is 2.39 JK-1mol-1 which are smaller than the 
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corresponding values in the substrate, meaning that formation of the pyridone 
tautomer is more favourable with [Ir(COD)(SIMes)(4-hydroxypyridine)]Cl. 
Reaction of isoniazid with [IrCl(COD)(SIMes)] formed a mixture of species in solution. 
The major species formed where the substrate bound to iridium via the oxygen in the 
hydrazide group. This formed in a 2:1 ratio with the minor species where the 
substrate bound to iridium via the pyridine nitrogen. The 15N-NMR chemical shift 
showed that the pyridine nitrogen in the major species (311.0 ppm) was close to the 
15N chemical shift of the free substrate (308.2 ppm). The equivalent chemical shift in 
the minor species was 248.5 ppm, this upfield shift is characteristic of a pyridine 
nitrogen bound to metal (see previous chapter). 
The SABRE-active catalyst is typically a tris-substituted species of the form: 
[Ir(H)2(SIMes)(substrate)3]Cl. Upon reaction with the iridium pre-catalyst, 4-
hydroxypyridine and isoniazid each form a bis-substituted species. When 4-
hydroxypyridine is used as the catalyst this takes the form[IrCl(H)2(SIMes)(κ-O-4-
pyridone)(κ-N-4-hydroxypyridine)]. This species contains two inequivalent hydrides 
in the equatorial plane, one trans to chloride and the other trans to the 4-pyridone 
tautomer of 4-hydroxypyridine which binds via the oxygen in the keto functional 
group. The second substrate ligand lies trans to SIMes in the axial position. This 
substrate binds to iridium via the pyridine nitrogen as the enol tautomer (4-
hydroxypyridine). When isoniazid is used as the SABRE target, the SABRE-active 
species takes the form [Ir(H)2(SIMes)(κ-N-isonicotinylhydrazide)(isonicotinyl-κ-O-κ-
N-hydrazide]Cl . One substrate ligates to iridium in the traditional way, via the 
pyridine nitrogen, the other binds as a chelate via the nitrogen and oxygen in the 
hydrazide group. This results in two inequivalent hydrides as one is trans to the 
pyridine bound isoniazid ligand and the other trans to the oxygen binding site of the 
chelate. These structures have been confirmed via 1H, 13C and 15N-NMR 
characterisation techniques. Despite forming these unusual SABRE-active species, 
both structures have been shown to be SABRE-active as they exhibit enhancements 
under SABRE-conditions of 4 bar p-H2. [IrCl(H)2(SIMes)(κ-O-4-pyridone)(κ-N-4-
hydroxypyridine)]exhibits the lowest enhancements of −31 ± 1-fold when a substrate 
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concentration of 50 mM is used. [Ir(H)2(SIMes)(κ-N-
isonicotinylhydrazide)(isonicotinyl-κ-O-κ-N-hydrazide]Cl  yields much larger 
enhancements compared to 4-hydroxypyridine. The largest enhancement yielded 
was −696 ± 17-fold when a substrate concentration of 30 mM was used. 
4-Hydroxypyridine and isoniazid form unusual SABRE-active species, each containing 
a substrate ligand which binds through the functional group in the para-position of 
the pyridine ring, either as a chelate (isoniazid) or via the oxygen as 4-pyridone (4-
hydroxypyridine). This means that the lone pair on the nitrogen is free and could 
potentially bind to iridium, forming dimers in solution. To establish the formation of 
aggregates in solution, diffusion ordered spectroscopy (DOSY) can be employed. The 
results for 4-hydroxypyridine and isoniazid were compared to [Ir(H)2(SIMes)(4-
methylpyridine)3]Cl which is known to not form dimers in solution. The diffusion 
coefficients for each of the SABRE-active species were found to be very similar. For 
[Ir(H)2(SIMes)(4-methylpyridine)3]Cl the diffusion coefficient was 6.24 × 10-10 m2s-1 
compared to 6.27 × 10-10 m2s-1 for [IrCl(H)2(SIMes)(κ-O-4-pyridone)(κ-N-4-
hydroxypyridine)]  and 6.62 × 10-10 m2s-1 for [Ir(H)2(SIMes)(κ-N-
isonicotinylhydrazide)(isonicotinyl-κ-O-κ-N-hydrazide]Cl . This suggests that reaction 
of 4-hydroxypyridine and isoniazid does not encourage the formation of dimers or 
any other aggregates in solution. The diffusion coefficient can be used to calculate 
the spherical radii using the Stokes-Einstein equation. However, this assumes a 
perfect spherical molecule, furthermore the calculation requires the viscosity of the 
solution is known. This was not measured and therefore a value from the literature 
was used, therefore these values cannot be used quantitatively but can be used for 
comparative purposes. [Ir(H)2(SIMes)(4-methylpyridine)3]Cl was shown to have the 
largest spherical radius, followed by [IrCl(H)2(SIMes)(κ-O-4-pyridone)(κ-N-4-
hydroxypyridine)]  and [Ir(H)2(SIMes)(κ-N-isonicotinylhydrazide)(isonicotinyl-κ-O-κ-
N-hydrazide]Cl . This is because the SABRE-active species containing 4-
methylpyridine is a tris-substituted complex whereas [IrCl(H)2(SIMes)(κ-O-4-
pyridone)(κ-N-4-hydroxypyridine)] and [Ir(H)2(SIMes)(isoniazid)2]Cl contain two 
substrate ligands. 
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Exchange between the bound and free substrate is a critical feature of the SABRE 
process as it allows for the hyperpolarised substrate to build up in the bulk solution. 
Hyperpolarisation is transferred from the p-H2 derived hydrides to the substrate 
nuclei via the scalar coupling. The substrate then dissociates from the complex 
leaving a vacant site. A substrate from the bulk solution then binds to the catalyst for 
hyperpolarisation transfer. As 4-hydroxypyridine and isoniazid yield SABRE 
enhancements, they must undergo substrate dissociation.  
The fastest exchange rate was observed for [IrCl(H)2(SIMes)(κ-O-4-pyridone)(κ-N-4-
hydroxypyridine)]  . Substrate dissociation was observed between 240 K and 270 K 
where kd was 0.31 s-1 and 18.31 s-1 respectively. This rate of dissociation was too rapid 
for efficient SABRE, hence why [IrCl(H)2(SIMes)(κ-O-4-pyridone)(κ-N-4-
hydroxypyridine)] yields small enhancements. 
[Ir(H)2(SIMes)(κ-N-isonicotinylhydrazide)(isonicotinyl-κ-O-κ-N-hydrazide]Cl  
exhibited much slower substrate dissociation between 280 K and 300 K. Where the 
kd value ranged from 0.04 s-1 and 0.61 s-1 respectively. These substrate dissociation 
for these complexes was compared to [Ir(H)2(SIMes)(4-methylpyridine)3]Cl which 
had a substrate dissociation of 0.08 s-1 at 255 K and 21.46 s-1 at 295 K. Exchange is 
observed in the substrate that lies trans to the hydride. In [IrCl(H)2(SIMes)(κ-O-4-
pyridone)(κ-N-4-hydroxypyridine)]  this is the oxygen bound 4-pyridone tautomer. As 
binding to iridium via oxygen is assumed to be weaker than binding via the pyridine 
nitrogen, this will result in rapid substrate exchange. In [Ir(H)2(SIMes)(κ-N-
isonicotinylhydrazide)(isonicotinyl-κ-O-κ-N-hydrazide]Cl , the substrate trans to 
hydride is bound via the pyridine nitrogen. Therefore, the slower exchange must be 
a consequence of the chelated substrate.  




plotted as a function of 
1
T
. The enthalpy (ΔH≠) can then be extracted from the gradient 
and the entropy (ΔS≠) from the intercept. The entropy for [IrCl(H)2(SIMes)(κ-O-4-
pyridone)(κ-N-4-hydroxypyridine)] and [Ir(H)2(SIMes)(κ-N-
isonicotinylhydrazide)(isonicotinyl-κ-O-κ-N-hydrazide]Cl is positive which is 
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consistent with a dissociative pathway. 4-hydroxypyridine had the smallest entropy 
and enthalpy values of 44.1 JK-1mol-1 and 69.7 kJmol-1 which reflected the weaker 
bond between the oxygen bound pyridone tautomer and the metal complex. 
Isoniazid had higher entropy and enthalpy values of 62 JK-1mol-1 and 91.6 kJmol-1 
which reflects the stronger bond between the pyridine bound ligand and the metal.  
ΔG≠ can calculated from ΔS≠ and ΔH≠ and be used to quantify the strength of iridium-
substrate ligation. As 4-hydroxypyridine demonstrated the fastest substrate 
dissociation, it was shown to have the weakest ligation to iridium. The ΔG≠ (298 K) value 
was 56.58 kJmol-1, which was smaller than 4-chloropyridine which had the weakest 
iridium-substrate ligation in the previous chapter (ΔG≠(298 K) = 62.08 kJ mol-1). Isoniazid 
displayed the highest ΔG≠ value of all of the substrates discussed in this thesis. The 
ΔG≠(298 K) value was 73.10 kJmol-1 compared to 4-pyridinecarboxaldehyde which had 
a ΔG≠(298 K) of 64.44 kJmol-1 in the previous chapter. This is attributed to the chelate 
ligand which donates electron density to the iridium metal centre. As the iridium is 
now very electron rich, ligation to the pyridine bound isoniazid is much stronger.  
Relaxation (T1) is another limiting factor of SABRE efficiency as hyperpolarisation can 
be lost via relaxation effects. This is because binding to iridium promotes relaxation, 
this is observed when the free substrate ortho T1 in the absence of catalyst is 
compared to the free substrate in the presence in catalyst. For example, 4-
hydroxypyridine has an ortho T1 of 8.11 s which is reduced to 5.04 s in the presence 
of the SABRE-active species. This effect is much weaker when isoniazid is considered. 
In the absence of catalyst, the ortho T1 is 8.84 s which is lowered to 7.12 s in the 
presence of catalyst. As the T1 of isoniazid is larger than 4-hydroxypyridine, less 
hyperpolarisation is lost before substrate dissociation occurs. This means that larger 
signal enhancements can be yielded using isoniazid. This is unexpected as isoniazid 
has a higher ΔG≠ value and therefore it was assumed that it would experience a larger 
T1 effect from ligation to iridium compared to 4-hydroxypyridine. 
4.8 References 
1. A. Albert and E. Spinner, J. Chem. Soc., 1960, 1221-1226. 
SABRE Optimisation for Oxygen-Bound Pyridines 
235 
 
2. M. T. Chenon, R. J. Pugmire, D. M. Grant, R. P. Panzica and L. B. Townsend, J. 
Am. Chem. Soc., 1975, 97, 4636-4642. 
3. H. B. Schlegel, P. Gund and E. M. Fluder, J. Am. Chem. Soc., 1982, 104, 5347-
5351. 
4. E. Murguly, T. B. Norsten and N. Branda, J. Chem. Soc., Perkin Trans. 2, 1999, 
DOI: DOI 10.1039/a904323c, 2789-2794. 
5. R. Diguet, R. Deul and E. U. Franck, Berichte der Bunsengesellschaft für 
physikalische Chemie, 1985, 89, 800-804. 
6. J. Wang and R. J. Boyd, J. Phys. Chem., 1996, 100, 16141-16146. 
7. U. Vögeli and W. von Philipsborn, Org. Magn. Reson., 1973, 5, 551-559. 
8. A. Gordon, A. Katritzky and S. Roy, Journal of the Chemical Society B: Physical 
Organic, 1968, 556-561. 
9. A. Katritzky, J. Rowe and S. Roy, Journal of the Chemical Society B: Physical 
Organic, 1967, 758-761. 
10. A. R. Katritzky and J. M. Lagowski, in Adv. Heterocycl. Chem., ed. A. R. 
Katritzky, Academic Press, 1963, vol. 1, pp. 311-338. 
11. H. Kemp, J. Chem. Educ., 1987, 64, 482. 
12. H. Naghibi, A. Tamura and J. M. Sturtevant, Proc. Natl. Acad. Sci., 1995, 92, 
5597. 
13. W. H. Organization, 2020. 
14. W. H. Organization, World Health Organization model list of essential 
medicines: 21st list 2019, World Health Organization, 2019. 
15. N. Persaud, M. Jiang, R. Shaikh, A. Bali, E. Oronsaye, H. Woods, G. Drozdzal, 
Y. Rajakulasingam, D. Maraj, S. Wadhawan, N. Umali, R. Wang, M. McCall, J. 
K. Aronson, A. Plüddemann, L. Moja, N. Magrini and C. Heneghan, Bull World 
Health Organ, 2019, 97, 394-404C. 
16. P. S. S. J. Sastry, R. K. Lonibala and T. R. Rao, Synth. React. Inorg. Met. Org. 
Chem., 1995, 25, 1261-1278. 
17. K. K. Narang, M. K. Singh, M. R. Goyle and K. Bhuvaneshwari, Synth. React. 
Inorg. Met.-Org. Chem., 1991, 21, 1569-1585. 
18. B. Bottari, R. Maccari, F. Monforte, R. Ottana, E. Rotondo and M. G. Vigorita, 
Bioorg. Med. Chem. Lett., 2000, 10, 657-660. 
19. T. Stringer, R. Seldon, N. Liu, D. F. Warner, C. Tam, L. W. Cheng, K. M. Land, P. 
J. Smith, K. Chibale and G. S. Smith, Dalton Trans., 2017, 46, 9875-9885. 
20. O. Akinyele, E. Fakola, L. Durosinmi, T. Ajayeoba and A. Ayeni, Ife Journal of 
Science, 2019, 21, 184-192. 
21. H. Zeng, J. Xu, J. Gillen, M. T. McMahon, D. Artemov, J. M. Tyburn, J. A. 
Lohman, R. E. Mewis, K. D. Atkinson, G. G. Green, S. B. Duckett and P. C. van 
Zijl, J. Magn. Reson., 2013, 237, 73-78. 
22. P. Norcott, P. J. Rayner, G. G. R. Green and S. B. Duckett, Chemistry, 2017, 23, 
16990-16997. 
23. W. Iali, S. S. Roy, B. J. Tickner, F. Ahwal, A. J. Kennerley and S. B. Duckett, 
Angew. Chem. Int. Ed., 2019, 58, 10271-10275. 
24. B. J. Tickner, J. S. Lewis, R. O. John, A. C. Whitwood and S. B. Duckett, Dalton 
Trans., 2019, 48, 15198-15206. 
25. B. J. Tickner, W. Iali, S. S. Roy, A. C. Whitwood and S. B. Duckett, Chem. Phys. 
Chem., 2019, 20, 241-245. 
SABRE Optimisation for Oxygen-Bound Pyridines 
236 
 
26. B. J. Tickner, R. O. John, S. S. Roy, S. J. Hart, A. C. Whitwood and S. B. Duckett, 
Chem. Sci., 2019, 10, 5235-5245. 
27. P. Beltrame, E. Cadoni, C. Floris, G. Gelli and A. Lai, Spectrochimica Acta Part 
A: Molecular and Biomolecular Spectroscopy, 2002, 58, 2693-2697. 
28. A. J. Ruddlesden, R. E. Mewis, G. G. Green, A. C. Whitwood and S. B. Duckett, 
Organometallics, 2015, 34, 2997-3006. 
29. A. J. Ruddlesden and S. B. Duckett, Chem. Commun., 2016, 52, 8467-8470. 
30. L. S. Lloyd, A. Asghar, M. J. Burns, A. Charlton, S. Coombes, M. J. Cowley, G. J. 
Dear, S. B. Duckett, G. R. Genov, G. G. R. Green, L. A. R. Highton, A. J. J. Hooper, 
M. Khan, I. G. Khazal, R. J. Lewis, R. E. Mewis, A. D. Roberts and A. J. 
Ruddlesden, Catal. Sci. Technol., 2014, 4, 3544-3554. 
31. K. Nicolay, K. P. J. Braun, R. A. d. Graaf, R. M. Dijkhuizen and M. J. Kruiskamp, 
NMR Biomed., 2001, 14, 94-111. 
32. R. Evans, Prog. Nucl. Magn. Reson. Spec., 2019, DOI: 
https://doi.org/10.1016/j.pnmrs.2019.11.002. 
33. C. S. Johnson, Prog. Nucl. Magn. Reson. Spec., 1999, 34, 203-256. 
34. T. D. W. Claridge, High-Resolution NMR Techniques in Organic Chemistry, 
Elsevier Science, 2016. 
35. C. R. Cantor and P. R. Schimmel, Biophysical chemistry: Part II: Techniques for 
the study of biological structure and function, Macmillan, 1980. 
36. W. A. Wegener, V. J. Koester and R. M. Dowben, Proc. Natl. Acad. Sci., 1979, 
76, 6356-6360. 
37. R. Evans, G. Dal Poggetto, M. Nilsson and G. A. Morris, Anal. Chem., 2018, 90, 
3987-3994. 
38. K. F. Morris and C. S. Johnson, J. Am. Chem. Soc., 1992, 114, 3139-3141. 
39. L. Guduff, D. Kurzbach, C. van Heijenoort, D. Abergel and J. N. Dumez, 
Chemistry, 2017, 23, 16722-16727. 
40. I. Reile, R. Aspers, J. M. Tyburn, J. G. Kempf, M. C. Feiters, F. Rutjes and M. 
Tessari, Angew. Chem. Int. Ed., 2017, 56, 9174-9177. 
41. E. O. Stejskal and J. E. Tanner, J. Chem. Phys., 1965, 42, 288-292. 
42. D. Sinnaeve, Concepts in Magnetic Resonance Part A, 2012, 40A, 39-65. 
43. R. M. Cotts, M. J. R. Hoch, T. Sun and J. T. Markert, Journal of Magnetic 
Resonance (1969), 1989, 83, 252-266. 
44. R. F. Karlicek and I. J. Lowe, Journal of Magnetic Resonance (1969), 1980, 37, 
75-91. 
45. S. J. Gibbs and C. S. Johnson, J. Magn. Reson., 1991, 93, 395-402. 
46. D. Wu, A. Chen and C. S. Johnson, J. Magn. Reson., 1995, 115, 260-264. 
47. J. D. Isdale, A. J. Easteal and L. A. Woolf, Int. J. Thermophys., 1985, 6, 439-450. 
  
Conclusions and Further Work 
237 
 
Chapter 5 Conclusions and Further Work 
As illustrated in this work, signal amplification by reversible exchange (SABRE) is a 
hyperpolarisation technique that dramatically increases the sensitivity of the nuclear 
magnetic resonance (NMR) experiment. SABRE employs an inorganic, iridium catalyst 
and p-H2 for the enhanced detection of a target molecule (substrate). In the SABRE 
experiment, an iridium complex catalyses the polarisation transfer from p-H2 to the 
substrate. Polarisation is then transferred via the J-coupled network within the 
iridium complex. However, whilst the catalyst facilitates polarisation transfer, it also 
provides a route to depolarisation via relaxation processes and the oscillatory nature 
of the transfer. Substrate dissociation and association mechanisms then allow for net 
polarisation to build up (equilibrate) in the bulk solution, generating large signal 
enhancements. Typically, SABRE targets are pyridine derivatives as coordination via 
the ring nitrogen to the iridium centre allows for substrate exchange to occur on a 
suitable timescale to allow polarisation transfer. Additionally, pyridine rings are 
heavily prevalent in biological processes making them excellent candidates for 
SABRE-MRI.  
Three different SABRE methods for polarisation transfer experiments were 
investigated in this thesis: manual shaking using the stray field of the spectrometer, 
manual shaking using a handheld magnetic array and an automated flow system. It 
was established that the automated flow system was the most reproducible method, 
but the manual shaking methods yielded larger signal enhancements. The manual 
shaking method using the stray field approach yielded the largest signal 
enhancements and smallest errors compared to the other two methods. This was 
surprising at it contradicted the findings of Richardson et al.1 who established that 
using the handheld magnetic array provided larger signal enhancements coupled 
with much smaller errors. The differences between the literature and the results of 
Chapter 2 were attributed to longer sample transfer times, and the clear challenge in 
using this method. Differences were established between two 400 MHz 
spectrometers, one of which was a narrow bore instrument (a) whilst the other was 
a wide bore instrument (b) to allow for imaging capabilities. It was found that 
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instrument A produced the largest and most reproducible signal enhancements. The 
differences between these two spectrometers were assumed to result from the 
longer sample transfer times associated with the utilisation of spectrometer b as a 
consequence of the instrument being situated further away from the computer 
compared to spectrometer a.  Therefore this spectrometer was utilised for all 
subsequent SABRE experiments. This observation is itself illuminating as it details 
how careful an operator needs to be if optimum polarisation levels are to be 
achieved. 
A number of para-substituted pyridine rings were selected for SABRE scrutiny: 
4-chloropyridine, 4-methylpyridine, 4-methoxypyridine and 
4-pyridinecarboxaldehyde. These substrates were shown to form tris-substituted 
SABRE active complexes of the form [Ir(H)2(SIMes)(substrate)3]Cl. Initially, the 
properties of these systems were classed according to their pKa and it was 
hypothesised that substrates with high pKa values would form strong associations to 
the iridium SABRE-active catalyst due to the increased basicity at the pyridine 
nitrogen. The effective pKa values were then measured in methanol solution such 
that 4-chloropyridine had the lowest pKa value of 2.00, followed by 4-
pyridinecarboxaldehyde (3.12), 4-methylpyridine (4.02) and finally 4-
methoxypyridine (4.89). Therefore, it was predicted that 4-methoxypyridine would 
form the strongest substrate-iridium ligations. Instead, 4-pyridinecarboxaldehyde 
was shown to form the strongest associations to the metal complex. This was 
observed by slow substrate dissociation rates and high values of enthalpy of 
activation of ligand loss (92.84 kJ mol-1) and related Gibbs free energy values (64.44 
kJ mol-1), which indicate strong and stable bonds. As a consequence of these strong 
bonds and longer catalyst residence times, 4-pyridinecarboxaldehyde proved to 
exhibit the shortest 1H T1 values in solution due to contributions from the strongly 
ligations to the iridium centre. Conversely, 4-chloropyridine was found to undergo 
rapid substrate dissociation and therefore formed the weakest iridium-substrate 
associations this resulted in a reduced reduction in 1H T1 values. 4-Chloropyridine 
proved to yield the smallest signal enhancements of (−340-fold) compared to the 
other substrates. Therefore, in this case, substrate dissociation occurs too rapidly for 
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efficient polarisation transfer prior to its dissociation. Similar trends in SABRE 
behaviour to those observed with [IrCl(COD)(SIMes)] were also observed when 
related investigations were performed in conjunction with the catalyst precursors 
[IrCl(COD)(ITBXy)] and [IrCl(COD)(IMesCl)]. The optimum rate of substrate 
dissociation has been suggested to be 4.5 s-1 according to the literature in such 
systems.2 This meant that is was possible to define the temperature for optimum 
SABRE performance in theses [Ir(H)2(SIMes)(substrate)3]Cl catalysts. Unsurprisingly, 
it was established that the stronger the iridium-substrate associations, the higher the 
temperature required for optimal SABRE performance. In this idealised scenario, 
where the rate of substrate dissociation on SABRE efficiency was removed from 
consideration, the T1 became the dominant factor controlling the level of signal 
enhancement. These findings were published in Catalysis Science and Technology in 
2019.3 
When the substrates isoniazid and 4-hydroxypyridine were investigated for their 
SABRE hyperpolarisation, both proved to form bis-substituted species where one 
substrate ligand binds to iridium via the pyridine nitrogen and the second ligates via 
an alternative binding mode according to the functional group that is located in the 
para position. Analysis by diffusion ordered spectroscopy (DOSY) showed that 
despite both complexes containing free pyridine nitrogen atoms available for 
binding, no dimers were formed in solution. Furthermore, the SABRE-active 
complexes of 4-hydroxypyridine and isoniazid were found to hyperpolarise under 
SABRE conditions. 4-Hydroxypyridine readily tautomerises to 4-pyridone and both 
tautomers were found to bind to iridium in the SABRE-active complex which takes 
the form: [IrCl(H)2(SIMes)(κ-O-4-pyridone)(κ-N-4-hydroxypyridine)]. The 4-pyridone 
tautomer binds to iridium via the oxygen in the ketone functional group and is 
located trans to hydride. It is this substrate ligand that receives optimal polarisation 
during transfer from the parahydrogen derived hydride ligands. This ligand also 
undergoes fast substrate dissociation which, coupled with the 5JHH propagator results 
in small signal enhancements when compared to the other substrates discussed in 
this thesis. Small values of enthalpy of activation (69.7 kJ mol-1) and Gibbs free energy 
of activation (56.58 kJ mol-1) are characteristic of dissociation and illustrate the 
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weaker ligation between the oxygen-bound 4-pyridone tautomer and iridium. In 
contrast, isoniazid forms the SABRE-active species [Ir(H)2(SIMes)(κ-N-
isonicotinylhydrazide)(isonicotinyl-κ-O-κ-N-hydrazide]Cl upon reaction with 
[IrCl(COD)(SIMes)] and parahydrogen. This species contains one substrate ligand that 
chelates to the iridium via the terminal nitrogen and oxygen in the hydrazide 
functional group. The pyridine-bound isoniazid ligand lies trans to hydride and 
undergoes slow substrate dissociation and was found to form strong associations to 
the metal centre. This was evidenced by high values of enthalpy of activation (91.6 
kJ mol-1) and Gibbs free energy of activation (73.1 kJ mol-1). Despite the slower 
substrate dissociation rate, the signal enhancements yielded for isoniazid (−696-fold) 
were comparable to those observed for 4-methylpyridine (−891-fold). Whilst these 
novel complexes have not yet been published, previous literature has overlooked the 
formation of these bis-substituted species.4, 5 
5.1 Further Work 
The effect of para-substituents on the iridium-substrate binding modes were 
thoroughly investigated. This included the initial study comparing the binding 
potential of 4-chloropyridine, 4-pyridinecarboxaldehyde, 4-methylpyridine and 
4-methoxypyridine. It was established that the optimal conditions for SABRE occur 
when the iridium-substrate ligations allow for sufficient polarisation transfer before 
relaxation mechanisms begin to take effect, thus limiting the observed signal 
enhancement. As an extension of this study, it would be interesting to analyse 
mixtures of these substrates in solution and observe which substrate preferentially 
binds to the iridium complex. Studies of SABRE hyperpolarised mixtures of substrates 
have been published using single-scan DOSY NMR.6 Furthermore, it would be 
interesting to understand whether specific substrate combinations could be used to 
enhance the signal enhancements of the least SABRE efficient substrates (eg 4-
chloropyridine). 
In the second investigation, it was observed that 4-hydroxypyridine and isoniazid 
form the following bis-substituted SABRE-active species: [IrCl(H)2(SIMes)(κ-O-4-




isonicotinylhydrazide)(isonicotinyl-κ-O-κ-N-hydrazide]Cl. Although these complexes 
were fully characterised by 13C, 15N and 1H-NMR methods, analysing these via x-ray 
crystallography would provide a clear picture of the complex structures. To do this, 
crystals of the SABRE-active species would need to be grown in a controlled 
environment. Although similar oxygen-bound and chelated iridium SABRE species 
have been published,7-9 the species associated with 4-hydroxypyridine and isoniazid 
have not yet been scrutinised. Furthermore, the data presented in Chapter 4 
demonstrates a full and comprehensive study of the SABRE efficiency of these 
catalysts. [Ir(H)2(SIMes)(κ-N-isonicotinylhydrazide)(isonicotinyl-κ-O-κ-N-hydrazide]Cl 
was shown to yield larger signal enhancements, comparable to 4-methylpyridine and 
4-methoxypyridine. Therefore, isoniazid could potentially be used as a co-ligand to 
enhance the detection of less efficient SABRE substrate (e.g. 4-chloropyridine or 4-
hydroxypyridine). Co-ligands such as acetonitrile and dimethoxy sulfoxide have 
previously been reported for the enhanced SABRE hyperpolarisation of a number of 
substrates including [1-13C]-pyruvate.8, 10-12 Finally, as [IrCl(H)2(SIMes)(κ-O-4-
pyridone)(κ-N-4-hydroxypyridine)] contains oxygen-bound 4-pyridone it may be 
possible to observe signal enhancements using 13C-NMR. Hyperpolarisation of 13C 
nuclei via SABRE is beneficial as this nucleus has been shown to exhibit longer 
hyperpolarisation lifetimes compared to 1H.13, 14   
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Chapter 6 Experimental 
6.1 Instrumentation 
 Nuclear Magnetic Resonance 
NMR characterisation was conducted on Bruker Avance III 400 and 500 MHz 
spectrometers, where the 1H NMR frequency was 400.1 or 500.1 MHz respectively. 
The 13C frequency was 100.6 or 125.8 MHz and the 15N frequency at 40.5 or 50.7 
MHz. The hyperpolarisation measurements were conducted on Bruker Avance III 400 
MHz spectrometers, where the 1H NMR frequency was 400.1 MHz. Bruker Topspin 
3.5 was used for data acquisition and processing. 
Chemical shifts are provided in parts per million (ppm) with respect to the associated 
residual solvent signal. The NMR solvents used were: methanol-d4, methanol-d2 and 
dichloromethane-d2. These have been specified in the figure and table captions 
throughout the results chapters. Couplings are given in Hz. 
6.1.1.1 Pulse Sequences/Experiments 
A number of advanced NMR methods were used in this work.  
1H/13C-HMQC and 1H/15N-HMQC spectra were used for the characterisation of the 
SABRE precatalyst and the SABRE-active species described in Chapters 3 and 4. These 
were collected using the hmqcgpqf pulse sequence (see Figure 1). The delay, d2, is 
set according to the reciprocal of the coupling between the proton and 
heteronucleus. Couplings constants of 145 Hz and 12 Hz were chosen for 13C as these 
correspond to the typical 2JCH ≈ 12 Hz and 1JCH ≈120-160 Hz.1 A value of 8 Hz was used 





Figure 124 - hmqcgpqf pulse sequence 
The 15N characterisation spectra in Chapter 4 were collected using the zgig pulse 
sequence of Figure 2. 
 
Figure 125 - zgig pulse sequence 
Hyperpolarised NMR data was collected using standard 1D pulse sequence (Figure 3) 
involving a single scan with receiver gain 1 and a π/4 pulse. This pulse sequence was 





Figure 126 - standard zg pulse sequence 
The rate and nOe data were collected using the EXSY sequence (Figure 4) which 
involves selective excitation. D8 is the mixing time used to encode exchange or build-
up nOe transfer. This sequence was used for the exchange measurements described 
in Chapters 3 and 4. 
 
Figure 127 - selnogp pulse sequence 
The 4JHH couplings measured in Chapter 3 that are reported were determined using 
a measured using a selective 1D COSY pulse program (Figure 5). This pulse sequence 





Figure 128 - selcogp pulse sequence 
The DOSY measurements described in Chapter 4 were measured using a bipolar LED 
pulse sequence (Figure 6). In this experiment D20 is the diffusion time and d21 is the 
eddy-current delay time. This pulse sequence is described in more detail within the 
chapter.  
For the experiments in the chapter values between 1.3 and 1 and 10 ms were used 
for δ and 99.9 and 100 ms for Δ were used. These values were optimised for each 
sample and each temperature used.   
 




T1 relaxation was measured using the saturation recovery pules sequence 
illustrated in Figure 7. This sequence was used for the measurements of T1 
relaxation described in Chapters 3 and 4. 
 
Figure 130 - invrec pulse sequence 
 Parahydrogen Rig 
A p-H2 rig was used to generate p-H2 of 99% purity. In brief, hydrogen gas is cooled 
to 30 K using a closed cycle helium refrigeration unit before being passed over 
paramagnetic iron oxide (Fe2O3), permitting the conversion of o-H2 to p-H2. Pressures 
of 4 bar p-H2 was used for SABRE hyperpolarisation experiments, unless otherwise 
stated.3 The p-H2 rig is explained in more detail in Chapter 1.4.2. 
The p-H2 enrichment used for SABRE hyperpolarisation experiments was typically 99 
%. However, in some cases the concentration of p-H2 was changed so that the 
theoretical enhancement at 99 % purity could be calculated. This is because 
Richardson et al.3 found that the substrate enhancement is directly proportional to 
the pH2 purity. This linear relationship between these two variables was observed for 




was used to overcome radiation dampening that was observed for the 
hyperpolarised SABRE sample containing [Ir(H)2(ITBXy)(4-methylpyridine)3]Cl and p-
H2. 
 Flow System 
A custom-built flow system was used in these studies.4 It comprises of a Bruker p-H2 
generator which electrolyses water to produce hydrogen. The hydrogen is then 
cooled to 38 K in the presence of an activated charcoal catalyst to provide a predicted 
92% purity p-H2.  
The p-H2 generator is connected to a flow cell containing the sample solution, which 
is introduced into the sample via a porous frit positioned at the base of the cell. The 
cell is encased in a copper coil solenoid which is used to generate a controlled 
magnetic environment between −150 G and 150 G in order to provide the required 
polarisation transfer field. The hyperpolarised sample is then transferred 
pneumatically under a flow of N2 gas (3.2 bar) to the flow probe which is integrated 
within the NMR spectrometer.4 
The transfer time for shutting of the hyperpolarised sample into the spectrometer is 
between 1-2 seconds. Each time the system was used, the transfer pressures and 
timings were adjusted to ensure the flow cell was completely filled with the sample 






Figure 131 – Schematic diagram of the automated flow probe. 1) A sample of [Ir(H)2(SIMes)(sub)3]Cl in 
methanol-d4 is contained in a flow cell where pH2 (4 bar) is bubbled through the solution, 2) The 
hyperpolarised sample is transferred into the spectrometer via a nitrogen flow, 3) The hyperpolarised 
spectrum is acquired using the one-shot pulse sequence described in Figure 28, 4) The sample is transferred 
from the spectrometer back to the flow cell using a nitrogen flow. Image adapted with permissions R. E. 
Mewis, K. D. Atkinson, M. J. Cowley, S. B. Duckett, G. G. Green, R. A. Green, L. A. Highton, D. Kilgour, L. S. 
Lloyd, J. A. Lohman and D. C. Williamson, Magn. Reson. Chem., 2014, 52, 358-369.6 
6.1.3.1  Variable Temperature 
The variable temperature experiments described in Chapter 3 using the optimum 
rate of dissociation were conducted using a variation of the flow system. In this 
modification, the sample chamber is surrounded by a water jacket connected to a 
variable temperature water bath capable of reaching temperatures between 277-
373 K. Water was used as the coolant in these experiments, however this 
temperature range could be extended by using alternative coolants. The 
temperature of the NMR spectrometer was also set to match that of the water bath. 
For the measurements described in Chapter 3.4.1.1, the temperature was varied 





Figure 132 – The modified flow cell used to study the temperature dependence of SABRE 
 Fourier Transform Infrared (FTIR) 
All FTIR spectra were measured using a Bruker Tensor 37 FTIR spectrometer with ATR 
and fibre optic probe attachment. Data was collected and processed using Bruker 
OPUS software. A ‘background’ reference spectrum was collected and then 
subtracted from the sample spectrum. Sample spectra were collected between 4000 
and 500 wavenumbers (cm-1) and is shown in transmission (%) mode. 
6.2 General Experimental Procedures 
 Synthesis of [IrCl(COD)(NHC)] and Isotopically Labelled Substrates 
The synthesis of [IrCl(COD)(NHC)] was completed by Dr Peter Rayner and Dr Vicky 
Annis using the synthetic procedures detailed in published literature records.5, 6 
The synthesis of isotopically labelled 15N-4-hydroxypyridine and 15N-isoniazid were 




The substrates used in this thesis were used as purchased. 4-Chloropyridine 
hydrochloride, 4-pyridinecarboxaldehyde, 4-hydroxypyridine and isoniazid were 
purchased from Sigma Aldrich. 4-Methylpyridine (4-picoline) was sourced from Alfa 
Aesar and 4-methoxypyridine from Fluorochem.  
 NMR Samples 
NMR samples were formulated using a substrate (50 mM), [IrCl(COD)(NHC)] (5 mM) 
and solvent (0.6 mL) in a 5 x 230 mm NMR tube fitted with a J Young valve. Addition 
of the substrate to the iridium catalyst forms the SABRE precatalyst 
[Ir(COD)(NHC)(substrate]Cl where the chloride is displaced by the substrate. 
Formation of this product is indicated by NMR characterisation ad visually by a colour 
change from yellow to orange. The sample is then degassed using a freeze-pump-
thaw procedure using a dry ice acetone bath for methanol-d4 samples or liquid 
nitrogen for dichloromethane-d2 samples. 
Hydrogen (4 bar absolute) is then added to activate the catalyst to form the SABRE-
active catalyst, which is typically of the form, [Ir(H)2(NHC)(substrate)3]Cl. Addition of 
hydrogen promotes hydrogenation of the COD ligand to form COA. Subsequently, 2 
substrate ligands from the excess solution bind to the catalyst along with hydrogen 
to form the octahedral SABRE catalytic species. Formation of this product is usually 
indicated by a colour change from orange to colourless.  
For manual shaking experiments, 4 bar (absolute) p-H2 was added using the p-H2 rig.  
 Manual Shaking Method 
NMR samples were prepared using the procedure outlined above.  
P-H2 (4 bar absolute) was added to the sample using the p-H2 rig described earlier via 
the Youngs valve. The sample was then shaken using the stray field of the 
spectrometer (approx. 65 G) for 10 seconds (unless stated otherwise) before being 
placed in the spectrometer for acquisition. The position for sample shaking was 




repeated a minimum of five times in order for the average enhancement and 
corresponding standard error to be calculated. 
For some experiments, a handheld magnetic array (60 G) was used. Once p-H2 (4 bar 
absolute) has been added to the sample tube, the sample is then placed inside the 
magnetic array before being shaken for 10 seconds (unless stated otherwise) before 
being removed and placed in the spectrometer for acquisition. Similarly to the 
manual shaking method, this experiment was repeated a minimum of five times in 
order for the average enhancement and corresponding standard error to be 
calculated. 
Hyperpolarised spectra were collected using a single scan experiment with a pulse 
angle of π/4 and a receiver gain of 1. 
More detail on these manual shaking methods and the corresponding advantages 
and disadvantages can be found in Chapter 2. 
 Flow System 
NMR samples were prepared using substrate (50 mM), [IrCl(COD)(NHC)] (5 mM) and 
solvent (3 mL) in a sample vial. This was then placed into the reaction cell described 
in section 6.1.3.  
The p-H2 bubble time and the transfer times to and from the flow probe is controlled 
by the user. A p-H2 pressure of 4 bar (absolute) was used. A single NMR scan was 
then collected using a receiver gain of 1 and a pulse angle of π/4.  
More detail on this method and the corresponding advantages and disadvantages 
can be found in Chapter 2. 
 Calculating SABRE Enhancements 




𝐸𝑛ℎ𝑎𝑛𝑐𝑒𝑚𝑒𝑛𝑡 𝐹𝑎𝑐𝑡𝑜𝑟, =  
𝐼𝑛𝑡𝑒𝑔𝑟𝑎𝑙 𝑜𝑓 ℎ𝑦𝑝𝑒𝑟𝑝𝑜𝑙𝑎𝑟𝑖𝑠𝑒𝑑 𝑠𝑖𝑔𝑛𝑎𝑙
𝐼𝑛𝑡𝑒𝑔𝑟𝑎𝑙 𝑜𝑓 𝑡ℎ𝑒𝑟𝑚𝑎𝑙 𝑠𝑖𝑔𝑛𝑎𝑙
 
Equation 22 
The thermal signal refers to the non-hyperpolarised spectrum. This was collected 
after the SABRE sample had been left for 10 minutes, allowing for the hyperpolarised 
signals to relax. The same acquisition parameters were used to collect both the 
hyperpolarised and thermal signals. The hyperpolarised signals are typically emissive 
and therefore the corresponding enhancement factors are quoted as negative 
values.  
The corresponding standard errors were calculated using Equation 23. 





 Measuring pKa 
The pKa values of Chapter 3 were measured as follows. 
The para-substituted substrates were dissolved in methanol-d4 with added HCl. HCl 
was used to control the pH of the solution, promoting formation of the acidic form 





Figure 133 - The two forms of the substituted pyridine in solution with methanol and hydrochloric acid (HCl) 
used to control the pH of the solution 






The pKa can then be written as: 





In NMR, the concentrations of each form can be substituted for the fractional 
populations (𝑥Band 𝑥BH+), therefore Equation 25 becomes:  





NMR cannot detect chemical change that occurs on a faster timescale than the NMR 
experiment itself, therefore there is only one observed peak which accounts for both 




populations and chemical shift of the pure acidic and pure basic forms. If the chemical 
shift of the protonated form (i.e. in strong acidic conditions, δA) and the 
deprotonated form (i.e. in strong basic conditions, δB) are known then the measured 
chemical shift (δm) can be described by Equation 27. 
δm =  𝑥BH+δBH+ + 𝑥BδB 
Equation 27 
As 𝑥Band 𝑥BH+  are fractional populations, they must sum to 1, therefore the 
proportion of the deprotonated form can be expressed as in Equation 28. 
𝑥B = 1 − 𝑥BH+ 
Equation 28 
The relative population of the protonated form can then be calculated using Equation 






Analogously, the fractional population of the deprotonated form can be expressed 






Finally, substituting Equation 29 and Equation 30 into Equation 26 and rearranging 
provides an expression for the measured chemical shift as a function of pH in the 










Therefore, it is possible to measure the chemical shift of a molecule by NMR for 
solutions of different pH levels and fit the data using Equation 14 to determine the 
pKa for the molecule.  
 Exchange Spectroscopy 
6.2.7.1 Calculating the Rate of Dissociation (kd) 
Exchange spectroscopy (EXSY) was used to monitor substrate dissociation from the 
bound SABRE-active species [Ir(H)2(NHC)(substrate)3]Cl into the free solution. The 
rate of dissociation is an integral SABRE parameter as it can indicate the SABRE 
efficiency of a system.  
The substrate bound trans to the hydride was selectively excited using a shaped pulse 
(Figure 127). The intensity of this signal was then compared to the intensity of the 
free solution and monitored over time. 





Figure 134 - Exchange species for substrate dissociation in [Ir(H)2(NHC)(substrate)3]Cl. The asterix, *, is used 
to denote the 1H resonance that is selectively excited. 
The rate equations for the formation of each of the individual species (A-E, X & Y) 
were then determined (Equation 32), where ka is the rate constant of association of 
the substrate and kd is the rate constant of dissociation of the substrate. 
[𝐴]
𝑑𝑡
=  [𝐴]0 + 𝑘𝑎[𝐵][𝑌] − 2𝑘𝑑[𝐴] 
[𝐵]
𝑑𝑡
=  [𝐵]0 + 2𝑘𝑑[𝐴] − 𝑘𝑎[𝐵][𝑌] + 𝑘𝑑[𝐶] − 𝑘𝑎[𝐵][𝑋] 
[𝐶]
𝑑𝑡
= [𝐶]0 + 𝑘𝑎[𝐵][𝑋] − 𝑘𝑑[𝐶] + 𝑘𝑎[𝐷][𝑌] − 𝑘𝑑[𝐶] 
[𝐷]
𝑑𝑡
=  [𝐷]0 + 𝑘𝑑[𝐶] − 𝑘𝑎[𝐷][𝑌] + 2𝑘𝑑[𝐸] − 𝑘𝑎[𝐷][𝑋] 
[𝐸]
𝑑𝑡
=  [𝐸]0 + 𝑘𝑎[𝐷][𝑋] − 2𝑘𝑑[𝐸] 
[𝑋]
𝑑𝑡






=  [𝑌]0 + 2𝑘𝑑[𝐴] − 2𝑘𝑎[𝐵][𝑌] + 𝑘𝑑[𝐶] − 𝑘𝑎[𝐷][𝑌] 
Equation 32 - Rate equations for the SABRE exchange species displayed in Figure 134 
In substrate dissociation from species [A] to form [B], either of the two excited bound 
substrate ligands can dissociation with equal probability. In substrate dissociation of 
[C] to form [B], only the bound, relaxed substrate ligand can dissociate. Therefore the 
probability of forming species [B] from [C] is half the probability of forming [B] from 
[A]. Consequently, the net rate of dissociation from [A] to [B] is 2kd. 
These equations were then inputted into a Microsoft Excel spreadsheet in order to 
determine the rate of dissociation (kd). To do this, a simulated data set was created, 
using the known concentrations of the free substrate ([X]) and the catalyst ([A]) and 
the delay time (D8). The delay time is the time allowed between measurements. 
Values of kd and ka were then estimated. The percentage intensities of the bound and 
free species were calculated from the simulated concentration of the different 
species. These were calculated according to Equation 33 and Equation 34. 
% 𝑏𝑜𝑢𝑛𝑑 =
2𝐴 + 𝐶
2𝐴 + 𝐶 + 𝑌
× 100 
Equation 33 
% 𝑓𝑟𝑒𝑒 =  
𝑌
2𝐴 + 𝐶 + 𝑌
× 100 
Equation 34 
The experimental data is also added to the same Excel spreadsheet, where the 
integrals of the interchanging species were converted into a percentage of the overall 
signal. For example, at the start of the measurement,  100% of the excited signal lies 
within the bound substrate (species A, B or C, which all contain at least 1 ‘excited’ 
bound substrate). At the end of the measurement, most of the excited signal (>50%) 
is observed in the free solution (species X) (Figure 135). Once the experimental data 
has been tabulated, the difference between this data set and the simulation is 




to have to same uncertainty and therefore the unweighted least squares method was 
used. Solver then minimises the value of the squared residuals, thereby fitting the 
simulated data set to the experimental data. A plot of the simulation was then 
compared to the experimental to ensure a suitable fit (Figure 136).6 
 
Figure 135 - Movement of excited signal from the bound substrate to the free substrate over time 
 
Figure 136 - Percentage signal intensity as a function of the delay time. The diamond and square markers are 
used to signify the experimental data set and the lines the simulation. Dark blue represents the bound 




6.2.7.1.1 Calculating Associated Errors in kd 
The errors in kd wre calculated using the Jackknife method described by Harris in 
1998.7  
kd was determined for each temperature from 10 separate experiments, each with a 
different delay time. To calculate the uncertainty, each experimental data point was 
subsequently deleted before a solution for kd was found using the solver method 
described above. This value was then restored before the following data point was 
deleted and solved to find kd. Once kd was calculated for each iteration, the results 
were tabulated (Figure 148) and the standard error was calculated using the standard 
deviation and the square root of the sample number. 
 
Figure 137 - Table showing how the uncertainties are generated using the Jackknife method alongside the 
experimental data set. 
6.2.7.2 Gibbs Free Energy 
The Gibbs Free energy of dissociation (ΔG≠) defines the amount of energy required 
to break a bond. Therefore it can be used to quantify the strength of iridium-
substrate ligation in SABRE-active species. This has been demonstrated in Chapters 3 
and 4.  
ΔG≠ is determined from the enthalpy (ΔH≠) and entropy (ΔS≠) of dissociation. These 
are calculated via an Eyring-Polanyi plot whereby 𝑙𝑛
𝑘
𝑇
 (where k = rate of dissociation 
and T = temperature) is plotted as a function of 
1
𝑇




determined from the gradient: (−
∆H≠
R








ΔG≠ can then be calculated using: 
∆𝐺≠ = ∆𝐻≠ − 𝑇∆𝑆≠ 
Equation 35 
6.2.7.2.1 Calculating Associated Errors in ΔH≠, ΔS≠ and ΔG≠ 
As described above, ΔG≠ is determined using an Eyring plot. This Eyring plot uses the 
linear form of the Eyring equation and graphically shows the relationship between 
the rate of dissociation (kd) and the reaction temperature. An example plot is shown 
in Figure 1. The enthalpy (ΔH≠) and entropy (ΔS≠) terms for the reaction can then be 
calculated using the gradient and intercept of the line of best fit that results from the 





Figure 138 - Eyring plot where ln(2kd/T) is plotted as a function of 1/T. The data is fitted using a linear fit of 
the form y = mx + c. 
The errors in ΔH≠ and ΔS≠ are then calculated directly using the 95% confidence limits 
provided by the linear regression analysis in Excel (Figure 2). The error can be 
calculated by calculating the minimum and maximum values of ΔH≠ and ΔS≠ using the 
upper and lower 95% limits. These upper and lower limits can then be averaged and 





Figure 139 - Summary output from the linear regression analysis from the Eyring plot shown in Figure 1. Red 
is used to indicate numbers relevant to the gradient and blue indicates those related to the intercept. In the 
equations, R = gas constant and T = temperature (K) 
Please note: 
ΔS≠ can be poorly defined using this method as its calculation requires extrapolation 
away from the experimental data points (where the error is relatively small), 
therefore the associated error in ΔS≠ are large. It is therefore important to obtain 
data over a wide temperature range. 
ΔH≠ is calculated from the gradient which uses the measured data and therefore the 




The error in ΔG≠ is calculated for a particular temperature, e.g. 298 K. It is possible to 
determine ΔG≠ using the Gibbs free energy relationship. This would involve 
propagation of the errors in ΔH≠, ΔS≠ and ΔG≠ resulting in a large error value. A better 
way to determine the error in ΔG≠ is to take the upper and lower limits from the 95% 
confidence plots of the Eyring equation and rearrange it for the determination of ΔG≠ 
(as shown in Figure 139). This reflects the fact that we have precisely calculated 
values for kd and the associated error. We can be confident that the error in kd is 
relatively small as it results from 10 separate measurements. If this approach is used, 
the error in ΔG≠ reduces as it is specific for the selected temperature and echoes the 
real data around the temperature at which ΔG≠ is calculated.   
 T1 Relaxation Measurements 
Relaxation quantifies the mechanisms that allow nuclear spins to lose energy and 
drop from the excited state to the ground state non-radiatively.8 Two forms of 
relaxation exist; spin-lattice relaxation and spin-spin relaxation. In spin-lattice 
relaxation, the spins of a nucleus are permitted to flip between the energy levels, 
thus establishing the Boltzmann population difference essential to the NMR 
experiment. As the nuclei return to the equilibrium state, the energy released is 
dissipated into the surroundings (the ‘lattice’)9. The process of spin-lattice relaxation 
is necessary to understanding how molecules behave in NMR and is characterised by 
a time T1 (spin-lattice relaxation time). There are several different relaxation 
mechanisms; however for spin 
1
2
 nuclei (such as 1H) the most dominant mechanism 
arises from dipole-dipole interactions. If a nucleus has spin 
1
2
 and is exposed to a 







grows exponentially with time (τ)9 (Figure 140). 
The T1 values were measured using the inversion recovery pulse shown in Figure 130. 
In NMR, there exists a bulk magnetisation (M0) lies along the z-axis at equilibrium. A 
180° (π) pulse is used to perturb the magnetisation into the −z orientation. After a 
variable time (τ), a read pulse (90°) is applied which places the magnetisation into 




each time iterating the variable time, τ. As the time is increased, the magnetisation 
returns to thermal equilibrium. The system reaches thermal equilibrium by waiting 
5*T1.  
The T1 relaxation time is then calculated from Equation 36 as shown pictorially in 
Figure 10. 




Equation 36, Where MXY is bulk magnetisation, M0 is magnetisation at thermal equilibrium, τ is the variable 
time and T1 is the spin-lattice relaxation time.  
 
Figure 140 - The magnetisation (MXY) for a spin ½ nuclei as a function of time (τ) after exposure of the system 
to a magnetic field. M0 is the magnetisation at thermal equilibrium and T1 is the spin-lattice/longitudinal 
relaxation time. 
 Hyperpolarised T1 Measurements 
The hyperpolarised T1 value is defined as the exponential decay factor determined 
from the relaxation of the established hyperpolarised signal built up in solution. It is 
assumed that the hyperpolarised T1 and conventional T1 should be equal due to the 




magnetisation. The hyperpolarised T1 values were measured using a variable flip 
angle single-shot sequence as described by Semenova et al.10 and Rayner et al.11 and 
derived from a similar method described by Shchepin et al.12 
 
Figure 141 - Single-shot hyperpolarised T1 variable flip angle pulse sequence 
In this method, a series of ‘n’ FIDs were recorded where each FID was associated with 
an RF pulse with a unique flip angle. In this thesis, 16 1H NMR spectra were acquired 
where the excitation pulse for each individual acquisition was measured using RF 
pulses of increasing flip angle (θ). The variable flip angles excited an equal fraction of 
the available magnetisation (Mxy) so in the absence of relaxation would give the same 
intensity each measurement. Therefore, the decrease in signal over time can be 
attributed to relaxation and quantified by using an exponential fit.  
During the variable flip angle pulse sequence, the transverse magnetisation is termed 
MXY,n, this magnetisation retains the same amplitude for the duration of the 
experiment. The longitudinal magnetisation is termed Mz,n, which describes the 
magnetisation that remains along the z-axis before the previous pulse (Mz,n-1). Mxy is 
defined by Equation 37, where the magnetisation is equal to the magnetisation in 
the z-axis in the previous pulse multiplied by sin of the flip angle. Mz,n is defined by 
Equation 38, where the remaining magnetisation leftover from the previous pulse is 
multiplied by the cosine of the flip angle. 





   
𝑀𝑧,𝑛 = 𝑀𝑧,𝑛−1cos (𝜃𝑛) 
Equation 38 
The effect of variable flip angle can then seen in Equation 39. 





The pulse duration (νp,n) can then be calculated using the duration of a standard 90° 
pulse length (d90) which is usually optimised prior to the HyperT1 experiment 






The sequence was optimised, such that the percentage measured at each point left 
no hyperpolarised magnetisation after the final point, which has the effect of 
maximising the signal to noise of the experiment. An example of these effects is 
shown in Table 1. 
N Mz,n Mxy,n θn νp,n 
0 100 0 0 0 
1 96.82 25.00 14.48 1.93 
2 93.54 25.00 14.96 2.00 
3 90.14 25.00 15.50 2.07 
4 86.60 25.00 16.10 2.15 
5 82.92 25.00 16.78 2.24 




7 75.00 25.00 18.43 2.46 
8 70.71 25.00 19.47 2.60 
9 66.14 25.00 20.70 2.76 
10 61.24 25.00 22.21 2.96 
11 55.90 25.00 24.09 3.21 
12 50.00 25.00 26.56 3.54 
13 43.30 25.00 30.00 4.00 
14 35.36 25.00 35.26 4.70 
15 25.00 25.00 45.00 6.00 
16 0.13 25.00 89.71 11.96 
Table 29 – Calculated parameters for Mz,n, Mxy,n, θn and νp,n for a d90 value of 12 μs. 
The experiment was then conducted using the variable flip angles shown in Table 29 
in conjunction with the hyperpolarised sample. A reference (thermal) measurement 
was also recorded in the absence of p-H2 which was then subtracted from the 
hyperpolarised spectra prior to T1 analysis. This ensured that thermal magnetisation 
was removed from consideration. Henceforth, the resulting T1 analysis was a true 
indication of the hyperpolarisation lifetime. The hyperpolarised T1 relaxation times 
were determined from an exponential fit of the signal decay using Equation 36. 
6.3 Diffusion Ordered Spectroscopy 
Diffusion ordered spectroscopy (DOSY) allows the separation of molecules in a 
system according to their diffusion coefficient. Measurements of this can indicate the 
size and shape of a molecular species. In Chapter 4, this method was used to examine 
two bis-substituted SABRE species to understand whether dimerization occurred in 
these systems. The diffusion coefficient is linked to structural properties of a system 









For an idealised case of a diffusing sphere of hydrodynamic radius (rH) and solvent 
viscosity (η), the friction factor is provided by: 
𝑓𝑇 = 6𝜋𝜂𝑟𝐻 
Equation 42 
Combining the above equations provides the Stokes-Einstein equation (), where the 
diffusion coefficient is inversely proportional to the radius of the diffusing species. 






The diffusion coefficients of Chapter 4 were measured using the BPP-LED pulse 
sequence shown in Figure 129. This sequence was chosen as it removes background 
magnetic field effects and allows eddy currents to delay.13-15  
The pulse sequence is iterated such that in each iteration, the gradient strength is 
incremented whilst the delays δ and Δ are kept constant. These constants were 
optimised for each of the samples measured and at each temperature. The signal 
intensity was then plotted against the gradient strength using Origin, allowing the 
diffusion constant to be calculated using a non-linear curve fit to the resulting decay 













Figure 142 - Signal intensity as a function of the gradient strength. The data has been plotted according to 
Equation 21. The delays used for δ and Δ have been indicated alongside the calculated diffusion coefficient 
(D) 
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Manual Shaking Method Using the Stray Field of the 
Spectrometer 
Shake Time (s) OrthoH Enhancement Factor 
a b 
5 -654±34 -542±141 
7 -578±37 -782±4 
10 -891±18 -842±43 
15 -767±25 -257±42 
Table 30 – OrthoH enhancement factor as a function of the shake time for the manual shaking method 
using the stray field of the spectrometer 
Automated Flow System 
Bubble Time (s) OrthoH Enhancement Factor 
a b 
5 -194±5 -178±8 
7 -205±7 -190±28 
10 -227±8 -135±84 
15 -220±8 -264±57 
20 -217±10 -61±7 
25 -200±7 -133±71 
30 -212±14 -100±39 
Table 31 - OrthoH enhancement factor as a function of the parahydrogen bubble time for the automated 
flow system 
Manual Shaking Using a Handheld Magnetic Array 
Shake Time (s) OrthoH Enhancement Factor 
a b 
5 -454±16 -356±15 
7 -489±15 -339±12 
10 -497±28 -339±20 
15 -442±11 -344±16 
Table 32  - OrthoH enhancement factor as a function of the shake time for the manual shaking method 





Measuring the pKa for the substrates in Chapter 3 
 


















































Figure 153 - Para 1H resonance in 4-methoxypyridine 
Characterisation of Substrates for the Substrates in Chapter 3 
4-Chloropyridine 
Position 1H-NMR T1 (s) 13C-NMR 15N-NMR 
ortho 8.555 
JHH = 4.46 
Hz 
15.91±0.65 150.1 295.81 
meta 7.616 
JHH = 4.46 
Hz 
16.35±1.40 124.9 - 
para  - 145.0 - 
Table 33 – NMR resonances and T1 values for the substrate 4-chloropyridine in CD3OD at 500 MHz 





Position 1H-NMR T1 (s) 13C-NMR 15N-NMR 
ortho 8.400 
JHH = 5.36 
Hz 
20.52±0.05 148.2 289.2 
meta 7.329 
JHH = 5.36 
Hz 
17.70±0.07 125.2 - 
para - - - - 
CH3 2.427 5.91±0.08 19.8 - 
Table 34 – NMR resonances and T1 values for the substrate 4-methylpyridine in CD3OD at 500 MHz 
spectrometer and 298 K 
4-Methoxypyridine 
Position 1H-NMR T1 (s) 13C-NMR 15N-NMR 
ortho 8.356 
JHH = 4.7, 
1.57 Hz 
15.57±0.16 150.1 276.2 
Meta 7.007 
JHH = 4.7, 
1.57 Hz 
10.53±0.08 110.4 - 
para - - 166.8 - 
OCH3 3.908 5.29±0.06 54.6 - 







Position 1H-NMR T1 (s) 13C-NMR 15N-NMR 
ortho 8.543 
JHH = 6.0 
Hz 
8.24±0.07 148.5 297.0 
meta 7.547 
JHH = 6.0 
Hz 
7.88±0.10 121.5 - 
para - - 151.4 - 
OHCCD3 5.554 - 95.5 - 
Table 36 – NMR resonances and T1 values for the methyl hemiacetal form of 4-pyridinecarboxaldehyde 
in CD3OD at 500 MHz spectrometer and 298 K 
Characterisation of [Ir(COD)(SIMes)(sub)]Cl for the Substrates 
in Chapter 3 
[Ir(COD)(SIMes)(4-chloropyridine)]Cl 
 
Position 1H-NMR 13C-NMR 15N-NMR 
FreeorthoH 8.547 
JHH = 6.2 Hz 
150.1 295.1 
FreemetaH 7.616 
JHH = 6.2 Hz 
124.9 - 
FreeparaCCl - 145.1 - 
Position 1H-NMR 13C-NMR 15N-NMR 
orthoHsub 7.739 
JHH = 6.6 Hz 
151.8 237.2 
metaHsub 7.507 























Table 37 - NMR Resonances for [Ir(COD)(SIMes)(4-Chloropyridine)]Cl in CD3OH. 1H at 500 MHz, 13C at 125 
MHz and 15N at 41 MHz at 235 K. 
[Ir(COD)(SIMes)(4-methylpyridine)]Cl 
 
Position 1H-NMR 13C-NMR 15N-NMR 
FreeorthoH 8.415 
JHH = 6.1 Hz 
148.4 288.1 
FreemetaH 7.359 
JHH = 6.1 Hz 
125.4 - 
FreeCH3 2.439 19.8 - 
Position 1H-NMR 13C-NMR 15N-NMR 
orthoHsub 7.593 
JHH = 6.5 Hz 
150.4 232.8 

























Table 38 - NMR Resonances for [Ir(COD)(SIMes)(4-Methylpyridine)]Cl in CD3OD. 1H at 500 MHz, 13C at 
125 MHz and 15N at 41 MHz at 235 K. 
 [Ir(COD)(SIMes)(4-methoxypyridine)]Cl 
 
Position 1H-NMR 13C-NMR 15N-NMR 
FreeorthoH 8.382 
JHH = 6.5 Hz 
149.9 273.4 
FreemetaH 7.007 
JHH = 6.1 Hz 
110.5 - 
Para - 166.7 - 
FreeCH3 3.908 54.6 - 
Position 1H-NMR 13C-NMR 15N-NMR 
orthoHsub 7.560 
JHH = 6.5 Hz 
151.5 232.8 
metaHsub 6.959 





CH3sub 3.961 55.59  


















Table 39 - NMR Resonances for [Ir(COD)(SIMes)(4-Methoxypyridine)]Cl in CD3OD. 1H at 500 MHz, 13C at 
125 MHz and 15N at 41 MHz at 235 K. 
[Ir(COD)(SIMes)(4-pyridinecarboxaldehyde)]Cl 
 
Position 1H-NMR 13C-NMR 15N-NMR 
FreeorthoH 8.571 
JHH = 6.1 Hz 
148.5 294.8 
FreemetaH 7.602 
JHH = 6.1 Hz 
121.8 - 
FreeOHCCD3 - 151.6 - 
Position 1H-NMR 13C-NMR 15N-NMR 
orthoHsub 7.769 
JHH = 6.5 Hz 
151.4 239.9 
metaHsub 7.418 
JHH = 6.5 Hz 
122.8  
























Table 40 - NMR Resonances for [Ir(COD)(SIMes)(4-Pyridinecarboxaldehyde)]Cl in CD3OD. 1H at 500 MHz, 
13C at 125 MHz and 15N at 41 MHz at 235 K. 




Position 1H-NMR 13C-NMR 15N-NMR 
FreeorthoH 8.548 
JHH = 6.4 Hz 
150.1 295.0 
FreemetaH 7.614 
JHH = 6.4 Hz 
124.8 - 
paraCCl - 145.2 - 
Position 1H-NMR 13C-NMR 15N-NMR 
orthoHsub 
(trans to H-) 
8.228 
JHH = 6.3 Hz 
155.1 250.6 
orthoHsub 
(trans to NHC) 
8.002 
JHH = 6.7 Hz 
156.2 236.3 
metaHsub 
(trans to H-) 
7.263 
JHH = 6.3 Hz 
125.8  
metaHsub 
(trans to NHC) 
7.121 
JHH = 6.7 Hz 
125.9  
CHAr,Mes 6.638 128.7  
N-CH2-CH2-N 3.901 50.3  
orthoCH3Mes 2.248 19.7  
paraCH3Mes 2.184 17.7  




Table 41 - NMR resonances for [Ir(H)2(SIMes)(4-Chloropyridine)3]Cl in CD3OH at 500 MHz spectrometer 
and  235 K 
[Ir(H)2(SIMes)(4-methylpyridine)3]Cl 
 
Position 1H-NMR 13C-NMR 15N-NMR 
FreeorthoH 8.413 
JHH = 6.0 Hz 
149.3 288.1 
FreemetaH 7.357 
JHH = 6.0 Hz 
125.3 - 
FreeCH3 2.439 19.8 - 
Position 1H-NMR 13C-NMR 15N-NMR 
orthoHsub 
(trans to H-) 
8.121 
JHH = 5.9 Hz 
153.6 247.2 
orthoHsub 
(trans to NHC) 
7.799 
JHH = 5.5 Hz 
154.2 233.1 
metaHsub 
(trans to H-) 
6.963 






JHH = 5.5 Hz 
125.9  
CHAr,Mes 6.616 128.5  
N-CH2-CH2-N 3.869 50.5  
orthoCH3Mes 2.235 19.83  
CH3Sub 
(trans to H-) 
2.170 17.67  
CH3Sub 
(trans to NHC) 
2.343 19.52  
paraCH3Mes 2.157 19.36  




Table 42 - NMR resonances for [Ir(H)2(SIMes)(4-Methylpyridine)3]Cl in CD3OD at 500 MHz spectrometer 
and 235 K 
[Ir(H)2(SIMes)(4-methoxypyridine)3]Cl 
 
Position 1H-NMR 13C-NMR 15N-NMR 
FreeorthoH 8.383 
JHH = 6.5 Hz 
149.7 273.4 
FreemetaH 7.070 
JHH = 6.5 Hz 
110.2 - 
FreeparaC - 166.8 - 
FreeCH3 3.920 55.6 - 
Position 1H-NMR 13C-NMR 15N-NMR 
orthoHsub 
(trans to H-) 
8.084 
JHH = 6.5 Hz 
155.0 232.9 
orthoHsub 
(trans to NHC) 
7.742 
JHH = 6.9 Hz 
155.7 218.0 
metaHsub 
(trans to H-) 
6.694 
JHH = 6.5 Hz 
110.9  
metaHsub 
(trans to NHC) 
6.556 
JHH = 6.9 Hz 
110.8  
CHAr,Mes 6.643 128.6  
N-CH2-CH2-N 3.864 -  
CH3Sub 
(trans to H-) 
3.870 50.33  
CH3Sub 
(trans to NHC) 
3.723 -  
orthoCH3Mes 2.251 19.8  
paraCH3Mes 2.172 17.9  








Position 1H-NMR 13C-NMR 15N-NMR 
FreeorthoH 8.563 
JHH = 4.2 Hz 
148.5 295.3 
FreemetaH 7.594 
JHH = 4.2 Hz 
121.8  
FreeOHCCD3 - 151.6  
Position 1H-NMR 13C-NMR 15N-NMR 
orthoHsub 
(trans to H-) 
8.28 150.0 254.4 
orthoHsub 
(trans to NHC) 
7.97 150.6 240.1 
metaHsub 
(trans to H-) 
7.18 122.53  
metaHsub 
(trans to NHC) 
7.04 122.59  
OHCCD3 
(trans to H-) 
- 154.0  
OHCCD3 
(trans to NHC) 
- 154.7  
CHAr,Mes 6.60 128.62  
N-CH2-CH2-N 3.89 50.39  
orthoCH3Mes 2.24 17.86  




H- -22.39 -  
Table 44 - Table of NMR Resonances for [Ir(H)2(SIMes)(4-Pyridinecarboxaldehyde)3Cl] in CD3OD at 
500MHz and 243 K 
Enhancements in [Ir(H)2(SIMes)(sub)3]Cl for the Substrates in Chapter 3 
p-substituent OrthoH Enhancement Factor 
SIMes d22-SIMes 
Cl -1340 ± 2 -673 ± 26 
CHO -571 ± 41 -803 ± 14 
OMe -767 ± 8 -915 ± 18 
Me -680 ± 11 -677 ± 10 
Table 45  
Exchange in [Ir(H)2(SIMes)(sub)3]Cl for the Substrates in 
Chapter 3 
 




























































































































































Table 47 - Calculated values of Kd and associated errors calculated using the Jackknife method for the 
substrates presented in Chapter 3 
 
Variation in enhancement factor with temperature used to calculate 
optimum rates of substrate dissociation 
 OrthoH Enhancement Factor 
Temp 
(K) 

























295 -99.30651 -99.93102 -89.04842 -46.3549 
300 -39.23032 -66.71993 -54.23912 -
37.03337 
310 -4.76145 -15.26367 -9.89929 -
14.93244 
320  -2.69508 -1.12857 -3.41554 




Measuring the 4JHH Coupling in [Ir(H)2(SIMes)(sub)3]Cl 
 



















Relaxation effects in [Ir(H)2(SIMes)(sub)3]Cl for the substrates 
in chapter 3 
T1 graphs for [Ir(H)2(SIMes)(sub)3]Cl 
Free Substrate OrthoH 
 





Figure 159 - T1 for 4-methylpyridine 
 






Figure 161 - T1 for 4-pyridinecarboxaldehyde 
Bound Substrate Trans to Hydride 
 





Figure 163 - 4-methylpyridine 
 




Bound Substrate Trans to NHC 
 
Figure 165 - 4-chloropyridine 
 
 





Figure 167 - 4-methoxypyridine 
 




T1 graphs for [Ir(H)2(d22-SIMes)(sub)3]Cl 
Free Substrate OrthoH 
 
Table 49 – T1 for 4-chloropyridine 
 





Table 51 – T1 for 4-methoxypyridine 
 




T1 graphs at optimum SABRE temperature 
 
Table 53 – T1 for 4-chloropyridine 
 





Table 55 – T1 for 4-methoxypyridine 
 
Table 56 – T1 for 4-pyridinecarboxaldehyde 
Changing the NHC for the substrates in chapter 3 




SIMes ITBXy IMesCl 




Me 62.82 ± 0.008 65.43 ± 0.002 68.46 ± 
0.0004 
OMe 62.94 ± 0.013 65.56 ± 0.003 68.51 ± 0.001 
CHO 64.45 ± 0.001 66.86 ± 0.002 69.90 ± 0.001 
Table 57 – ΔG≠298K for each substrate with the NHC modifications ITBXy and IMesCl compared to SIMes 
Relaxation Effects 
ITBXy 
Free Substrate OrthoH 
 





Figure 170 - T1 for substrate 4-methylpyridine 
 





Figure 172 - T1 for substrate 4-pyridinecarboxaldehyde 
IMesCl 
The T1 for 4-chloropyridine was calculated using a Hyperpolarised T1 pulse 
program. This is a single-shot experiment where various pulse durations are 
applied to the sample, yielding different flip angles. The first pulse has a small 
angle, with subsequent pulses having progressively larger durations. These have 
been calculated to provide the same signal on each acquisition in the absence of 






Figure 173 - A single-shot pulse sequence for measuring the lifetime of hyperpolarisation 
Time is plotted against the bulk magnetisation of the system, an exponential of 
the form displayed in Equation 36 is applied and the T1 is extracted. However, 
rather than the bulk magnetisation returning to 1 (from -1) as in normal T1s, the 
bulk magnetisation for hyperpolarized T1s instead returns to zero. In SABRE 
enhancements, the hyperpolarized signal is shown as negative, due to the 
selective population of the spin states of the proton. Therefore when the 
hyperpolarised T1 is measured, the magnetisation becomes less intense as it 





Figure 174 - Hyperpolarised T1 for substrate 4-chloropyridine 
 
 





Figure 176 - T1 for substrate 4-methoxypyridine 
 






 OrthoH Enhancement Factor 
p-substituent SIMes ITBXy IMesCl 
Cl -111 ± 18 -638 ± 49 -282 ± 10.17 
Me -495 ± 22 -980 ± 10 -500 ± 17 
OMe -601 ± 24 -691 ± 6 -756 ± 18 
CHO -370 ± 27 -323 ± 3 -223 ± 14 













20 −392 ± 26 −3 ± 0.1 
−231 ± 
12 
25 −486 ± 44 −10 ± 1 
−281 ± 
10 
30 −721 ± 31 −15 ± 20 
−696 ± 
17 
40 −891 ± 18 −20 ± 3 
−538 ± 
10 
50 −338 ± 61 −31 ± 1 −174 ± 8 
100 −269 ± 23 −18 ± 1 −159 ± 3 
Figure 178 - orthoH enhancement factor for different substrate concentrations for the substrates in 
Chapter 4 










































































































Figure 197 - dissociation constant (kd) 
Temp (K) Me Std Error Isoniazid Std Error OH Std Error 
240 
    
0.31477 0.00185 
245 
    
0.74035 0.00133 
250 
    
1.49719 0.00303 
255 0.08208 3.91E-04 
  
2.72426 0.01754 
260 0.18724 7.85E-04 
  
5.46654 0.01537 
265 0.40524 0.00149 
  
9.82456 0.01636 





275 1.51458 0.00309 
    
280 2.60901 0.00271 0.04149 1.79E-04 
  

















Figure 198 - dissociation constant (kd) and associated errors calculated using the Jackknife method for 
the substrates in Chapter 4 
Relaxation Effects in [IrCl(H)2(SIMes)(4-hydroxypyridine)2] 
and [Ir(H)2(SIMes)(Isoniazid)2]Cl 
Free Substrate (no catalyst) 
 





Figure 200 - isoniazid 
Free Substrate 
 





Figure 202 - isoniazid 
Bound Substrate Trans to Hydride 
 





Figure 204 - isoniazid (nitrogen bound) 
Bound Substrate Trans to NHC 
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